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ABSTRACT FOR DISSERTATION

SYNTHESIS AND CHARACTERIZATION OF ANTIOXIDANT CONJUGATED
POLY(ΒETA-AMINO ESTER) MICRO/NANOGELS FOR THE SUPPRESSION OF
OXIDATIVE STRESS
Oxidative stress is a pathophysiological condition defined by an increased production of
reactive oxygen species (ROS), which can result in the growth arrest of cells followed by
cell disintegration or necrosis. A number of small molecule antioxidants (e.g. curcumin,
quercetin and resveratrol) are capable of directly scavenging ROS, thereby short-circuiting
the self-propagating oxidative stress state. However, poor solubility and rapid 1st pass
metabolism results in overall low bioavailability and acts as a barrier for its use as a drug
to suppress oxidative stress efficiently.
To overcome this limitation, these small molecule antioxidants were covalently conjugated
into poly(β-amino ester) (PβAE) cross-linked networks to formulate prodrug gel
microparticles and nanoparticles (nanogels). Being hydrolytically degradable in nature,
these PβAE crosslinked systems released antioxidants in their original structural form in a
sustained controlled fashion.
Both quercetin and curcumin-PβAE nanogels showed prolonged suppression of cellular
oxidative stress induced by H2O2. Curcumin PβAE nanogels also demonstrated protection
against mitochondrial oxidative stress induced by H2O2 and polychlorinated biphenyls.
Curcumin-PβAE gel microparticles were also developed as a platform to treat oral
mucositis through a local antioxidant delivery route. The same synthesis chemistry was
transferred to formulate resveratrol PβAE gel microparticles for topical applications, to
treat UV radiation induced oxidative stress. Both formulations showed suppression of
induced oxidative stress. An in vivo trial with curcumin-PβAE microparticles further
showed relatively reduced the severity of induced oral mucositis (OM) in hamster check
pouch as compared to placebo.
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1. INTRODUCTION
Oxidative stress (OS) is a pathophysiological state, which is defined by the imbalance
of oxidants and antioxidants present in the body. This imbalance can be initiated by
increasing reactive oxygen species (ROS) and reactive nitrogen species (RNS)
production in a variety of scenarios, including exposure to environmental toxicants such
as polychlorinated biphenyls (PCBs), intake of cancer treatment drugs like doxorubicin
for chemotherapy, and radiation therapies. The lack of antioxidant capacity to balance
out this preliminary excess ROS production leads to the cascading ROS production
cycle involving processes such as ischemia reperfusion and lipid peroxidation. This
excess production, in turn, leads to the oxidation of cell components, such as cell
membranes, DNA, lipids etc., ultimately resulting in cell death. Common examples of
ROS include singlet oxygen (1O2), transition metal ions, superoxide radicals (O2.-),
hydrogen peroxide, hydroxyl radicals and peroxynitrite (ONOO-).

Mitochondrial

oxidative stress has been shown to play a vital role in development of several
neurodegenerative diseases like Alzheimer’s and Parkinson’s disease [1].
Administration of antioxidants as therapeutics is a potential solution to alleviate the
steady-state oxidative stress and help metabolism cope beyond its natural antioxidant
capacity against oxidants/ROS/RNS. Plants and fruit derived dietary small molecule
antioxidant scavengers, such as curcumin, quercetin, and vitamin E, have gained critical
interest in the area concerning mitigation of OS. In spite of their excellent selfsacrificial property to neutralize free radicals, these bioactive compounds have failed
to substantiate themselves as potential drugs for suppression of OS. Some of the key
underlying explanations behind this poor performance is due to their limited aqueous
solubility, structural instability in the physiological environment and hence overall low
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bioavailability [2]. Taken together, these properties greatly limit bioavailability,
preventing systemic drug concentrations from reaching the therapeutic window. While,
these are some interpretations derived from several in vivo and clinical trials, in vitro
studies shows evidence of suppressing oxidative stress [3]. The extent of this protection
is again limited due to their very low viable concentrations at the cellular level or
demonstration of pro-oxidant effects at high administered doses [4]. Thus, high levels
of antioxidants could be seen as a solution to inhibit cancerous cell growth but not a fix
for OS in healthy cells.
As a result, though highly potent, maintaining an effective drug concentration without
being toxic is a challenge with antioxidants. Further, preserving them in their active
form after administration is another barrier to effective drug delivery. An antioxidant
prodrug system with controlled drug release could be a possible solution to this
challenge and direct polymerization of antioxidants into a poly(β amino ester) (PβAE)
style polymer could be a possible way to achieve this approach. Synthesized via
Michael addition reaction of an acrylate with a primary or secondary amine, PβAEs are
hydrolytically biodegradable systems through their ester linkages. They can be
formulated into crosslinked networks via reaction of a multiacrylate compound with a
multifunctional amine [5]. Further utilizing the synthesis chemistry covalently
conjugating antioxidants into the crosslinked networks would protect the bioactive
functional groups from getting deactivated until released [6]. Upon hydrolytic
degradation, these PβAE crosslinked networks would release conjugated antioxidants
in their original structural form in a controlled manner.
Owing to these benefits of the synthesis chemistry, formulating the antioxidant PβAE
systems into microgels or nanogel networks would open up the options to various
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delivery routes including local, intravenous, inhalation and other injectable approaches.
Control over drug release kinetics and particle size would further make the system more
adaptable in drug delivery systems.
Therefore, development of robust and functionally active antioxidant-PβAE particles
in the nano to micro size range was pursued for local and systemic therapy applications.
A single step synthesis chemistry to conjugate polyphenolic antioxidant into PβAE
crosslinked systems, previously designed in the Dziubla lab, was adopted involving the
reaction of acrylate functionalized antioxidants with multifunctional amines [6]. While
the PβAE synthesis processes were modified according to the type of particle system
desired, different anti-inflammatory polyphenolic antioxidant drug molecules
(quercetin, curcumin and resveratrol) were also explored to analyze the pliability of the
formulation processes. Figure 1.1 summarizes the overall idea of the research goals and
is also discussed below.
Quercetin-PβAE nanogels (CHAPTER 4) were synthesized using a novel single step
reaction-precipitation method utilizing the Michael addition chemistry. Allowing
control over the nanogel diameter as a function of monomer concentration, the synthesis
process was also amenable to the formulation of curcumin-PβAE nanogels (CHAPTER
5 and 6). Curcumin-PβAE crosslinked systems were further explored to synthesize
antioxidant-PβAE gel microparticles systems (10-20 µm) via gel cryomilling method
(CHAPTER 7). The gel microparticle synthesis process was also successfully
employed in the formulation of resveratrol-PβAE gel microparticles (CHAPTER 8).
Being able to synthesize these prodrug systems in different particle sizes and with
different compounds demonstrated the flexible nature of the synthesis processes in drug
delivery applications.
3

The hydrolytic degradation rate of these crosslinked systems was studied to analyze the
antioxidant release rates. Both nano and microsystems showed a uniform and extended
release of the structurally active antioxidants with no burst release effects, which is a
critical requirement in most drug delivery applications. Further, tunable antioxidant
release properties of curcumin and resveratrol microparticle systems were observed due
to the incorporation of poly(ethylene glycol)diacrylate (PEGDA) as a co-monomer
during PβAE gel synthesis.
With control over the above mentioned physicochemical properties of these antioxidant
conjugated PβAEs, in vitro response of endothelial and dermal fibroblasts showed
prolonged protection against H2O2 induced cellular oxidative stress. The uniform
release profile of curcumin-PβAE nanogels with no burst release, in fact, resulted in a
reduced cytotoxicity of curcumin at higher concentrations, thereby increasing the safety
limit of the antioxidant. This characteristic allowed the antioxidant to be administered
at therapeutic levels and work against mitochondrial and cellular OS in endothelial
cells. The protective effect of these nanogels was also seen at mitochondrial levels with
cells exposed to PCBs, which are considered environmentally persistent toxicants and
are known to induce cellular disorders via OS route (CHAPTER 6).
While nanocarriers are the desired choices for systemic applications through various
injectable or inhalation routes, use of larger particles i.e. microparticle drug carrier
systems is not often favored for local drug delivery. Therefore, extending the
application of antioxidant-PβAE systems, curcumin-PβAE microparticles were
analyzed as a treatment therapy for oral mucositis through local delivery. Hence, a
preliminary in vivo study employing the hamster pouch model under induced oral
mucositis conditions was carried out. Locally delivering suspended curcumin-PβAE

4

microparticles during the developmental stage of oral mucositis showed decreased
levels of oxidative stress markers and a reduced intensity in epithelial layer damage as
compared to the placebo. Similarly, resveratrol-PβAE microparticles were also tested
for their protective application towards UV radiation-induced OS. Although this project
is currently at a partially completed stage, the system has shown promising results
towards cellular OS suppression but needs optimization in synthesis processes and
cleaner demonstration of the intended application.
Apart from the direct antioxidant conjugation method, another novel route through
transesterification was identified to chemically conjugate –OH group containing drug
molecules (detailed discussion in the Appendix). With the concept that an alcohol can
be substituted into an ester bond to form a new ester, different alcohols were substituted
into the already existing crosslinked PβAE gel matrix synthesized using PEGDA and
4, 7, 10-trioxatridecane-1, 13-diamine (TTD). Transesterification rate varied depending
upon various ambient parameters and showed faster degradation with increasing
polarity of gel matrix due to amine catalyzing effect. The effect was further enhanced
by using alcohols of different chemical nature. This approach was applied towards
conjugation of riboflavin into PEGDA-TTD gels and the rate of conjugation depended
upon the polar nature of the synthesized gels.

5

Figure 1.1 Figure 1.1 PβAE crosslinked prodrug network systems
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2

BACKGROUND: A FREE RADICAL PRIMER

Based on the book chapter to be published:
Prachi Gupta, Andrew Lakes, Thomas Dziubla, Free Radical Chemistry Primer;
To appear in ‘Oxidative Stress and Biomaterials: The Science, Challenges and
Opportunities’ (Elsevier)
2.1

Free radical biology – importance

Free radicals, represented with a superscript ‘dot’ (A), are defined as any atom or
molecule containing an unpaired electron which has a strong tendency to gain another
electron to achieve a non-radical state [7]. These molecules are considered to be highly
reactive, are capable of reacting with a non-radical molecule in their quest for selfstabilization. Radical species can be found through a variety of mechanisms, one of
which is an abstraction of an electron from an atom or a molecule. Radicals can also be
generated by the splitting of a molecule at a very high-energy state. A classic example
would be radiation induced homolysis of a water molecule into a hydroxyl radical and
a hydrogen atom [8](eq 1)
𝑯𝑯𝟐𝟐 𝑶𝑶 + 𝒆𝒆𝒆𝒆 → 𝑯𝑯+ + 𝑶𝑶𝑶𝑶−

(1)

As these radical ions exist in a high and unstable potential energy state, they can react
in a variety of ways. For example, two radica species can react with each other to form
a non-radical molecule or one radical can donate an electron to another yielding two
stable compounds [9].

7

As oxygen serves as the primary player in most biological free radical reactions, free
radicals are also commonly known as reactive oxygen species (ROS). In a similar way,
nitrogen base free radicals are called reactive nitrogen species (RNS). Table 2.1 lists
some of the most common free radicals/oxidants/ROS important in biology. Most of
the essential cellular matrix components (protein, cellular membrane, DNA, lipids,
polyunsaturated fatty acids etc.) in physiological systems are stable non-radical entities
and perform their regular function of energy production in the form of ATP and
maintain the cellular redox balance. But, the presence of more than the basal level of
free radical molecules/ROS can lead to reactions of ROS with alternative cellular
components in a quest to stabilizing themselves, damaging the chemical integrity of
cellular biomolecules [10, 11]. One well-known example is lipid membrane damage via
lipid peroxidation, where highly reactive hydroxyl radical react with polyunsaturated
fatty acids (PUFAs) of the cellular membrane by extracting an electron yielding a lipid
free radical. If this reaction phenomenon is not controlled in a timely manner, it can
initiate a chain reaction of free radical molecules with intact lipids resulting in overall
cellular membrane damage [12].

Figure 2.1 Lipid peroxidation cycle in presence of hydroxyl radical (OH●)
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Although most of the research concerning the role of ROS/RNS has been done towards
the potential cellular damage and subsequent pathological events, they do serve as a
beneficiary to the body under certain conditions. When present in optimum
concentrations, they help maintain the redox homeostasis in the cellular environment.
This helps in regulation of cell functioning, cell signaling and appropriate response to
endogenous and exogenous stimuli [13]. Under normal physiological conditions, a
balance between generation and elimination of ROS/RNS via endogenous antioxidant
enzymes/molecules helps the redox-sensitive signaling proteins to function properly
[14]. Endogenous ROS enzymes like myeloperoxidase, and NADPH oxidase (NOX),
also known as phagocyte oxidase, actually help the neutrophils perform their
phagocytic function against microbial intrusion in an event known as respiratory burst.
To briefly explain, NADPH oxidase catalyzed superoxide production forms hydrogen
peroxide with the help of superoxide dismutase (SOD), which in turn converts to
hypochlorous acid (HOCl) having bactericidal properties (eq 2) [15, 16].
Reaction:
𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵 𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐𝒐

𝑺𝑺𝑺𝑺𝑺𝑺

𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝑴𝒅𝒅𝒂𝒂𝒂𝒂𝒂𝒂

𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵𝑵 + 𝑶𝑶𝟐𝟐 �⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯� 𝑶𝑶𝟐𝟐−● �⎯� 𝑯𝑯𝟐𝟐 𝑶𝑶𝟐𝟐 �⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯� 𝑯𝑯𝑯𝑯𝑯𝑯𝑯𝑯
Table 2.1 Potential free radical species
ROS/RNS

Symbol

ROS/RNS

Symbol

Superoxide

O2-

Hydroxyl

OH●

Hydroperoxyl

HOO●

Peroxyl

ROO●

Nitric oxide

NO●

Nitrogen oxide

NO2●

Peroxynitrite

ONOO-

Singlet oxygen

Hypochlorous acid

HOCl
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1

O2

(2)

2.2

RED/Ox Chemistry

2.2.1

Oxidation/reduction reactions and voltage potentials

Originally, the term ‘oxidation’ was described as a process of any element, primarily
metals, to combine with oxygen to form metal oxides and ‘reduction’ was defined as a
process that will convert the metal oxide back to pure metal again. For example,
conversion of magnesium (Mg) to magnesium oxide is oxidation and back to
magnesium at high temperature in the presence of carbon is a reduction. Later, the
discovery of electrons changed the definition of oxidation-reduction to a phenomenon
of encountering any transfer of electrons from one species to another. As per the law of
conservation of mass applied to electrons, oxidation and reduction are always linked to
one another. Meaning, if one species is oxidized, the counter reactant species will be
reduced [17, 18].

(3)

(4)

By definition, oxidation of any given element or molecule will involve a loss of an
electron and the element/molecule will be known as a reducing agent while the
reduction of any molecule will be a gain of electron and that molecule will be known
as an oxidizing agent [19]. In reference to free radicals or ROS as such, they are
commonly known to be strong oxidizing agents or have a tendency to get reduced [20,
10

21]. This is because most radicals have one unpaired electron, and the addition of
another electron (or getting reduced) with opposite electron spin would help in
stabilizing the electron pair taking them to a more inert state. However, this is not
always true. The oxidizing tendency of any free radical will depend on its affinity to
gain an electron or its own reduction potential against the affinity or potential of the coreactant. It is possible that free radical ‘A’ gets reduced in presence of ‘B’ but might
get oxidized itself by losing another electron in presence of ‘C’ because the reduction
potential or electron gaining affinity of ‘C’ is greater than ‘A’.
2.1.1.1 Types of redox reactions

Corrosion and rusting:
Iron has served as a common example of corrosion, which is the electrochemical
oxidation of metals in the presence of oxygen to form respective oxides. In reference to
iron, it is specifically termed as the formation of ‘rust’ (eq 5) [22].
4𝐹𝐹𝐹𝐹 + 3𝑂𝑂2 → 2𝐹𝐹𝐹𝐹2 𝑂𝑂3 ………………..Oxidation of Fe to Fe+3

(5)

In presence of an acid, iron (II) is oxidized to iron (III) by reaction with hydrogen
peroxide, which acts as an oxidizing agent [23], although iron (III) can be reduced back
to iron (II) in presence of stronger reducing agents or free radicals such as superoxide
anion [24]. This oxidation-reduction chemistry of iron, popularly known in terms of the
Fenton or Haber-Weiss reaction mechanism, is very critical in maintaining the redox
state of the cell.
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2𝐹𝐹𝐹𝐹 +2 + 𝐻𝐻2 𝑂𝑂2 + 2𝐻𝐻 + → 2𝐹𝐹𝐹𝐹 +3 (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜) +

2𝐻𝐻2 𝑂𝑂(𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) ………………….Oxidation of Fe+2 to Fe+3

(6)

Nitrification and Denitrification:
Nitrification often occurs naturally and is a biologically oxidative process where
ammonia is oxidized to nitrite followed by formation of nitrate by nitrifying bacteria.
On the other hand, reduction of nitrate to nitrogen in the presence of an acid is termed
as denitrification and is often used as water purification process [25]. These nitrates
have the ability to diffuse through the cellular membrane and play a significant role in
the production of RNS in a cellular environment.
Nitrification:
𝑁𝑁𝐻𝐻3 + 𝑂𝑂2 → 𝑁𝑁𝑂𝑂2− (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜) + 3𝐻𝐻 + + 2𝑒𝑒 − (Ammonia

(6)

𝑁𝑁𝑂𝑂2− + 𝐻𝐻2 𝑂𝑂 → 𝑁𝑁𝑂𝑂3− (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜) + 2𝐻𝐻 + + 2𝑒𝑒 − (Nitrite to

(7)

to nitrite)

nitrate)

Denitrification: 2𝑁𝑁𝑁𝑁3− + 10𝑒𝑒 − + 12H + → N2 (reduced) + 6H2 O (Oxidized)

(8)

Dismutation reaction:
Dismutation or disproportionation is a specific kind of redox reaction where both
oxidized and reduced forms of a chemical species are produced. For example,
superoxide free radicals produced in mitochondria dismutate to hydrogen peroxide and
oxygen (equation 9) [26] or ascorbyl radical to ascorbate (vitamin C) and
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dehydroascorbate (DHA) (eq 10) in order to maintain intracellular nutrient
requirements for the cells [27, 28].
2𝑂𝑂2− + 2𝐻𝐻 + → 𝐻𝐻2 𝑂𝑂2 (𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟) + 𝑂𝑂 2 (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑑𝑑)

2𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 ● + 𝐻𝐻 + → 𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 (𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜) + 𝐷𝐷𝐷𝐷𝐷𝐷 (𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟)

(9)
(10)

Cellular respiration:
Oxidation of glucose to carbon dioxide with simultaneous reduction of oxygen to water
is another kind of natural oxidation-reduction reaction required for energy production
in living organisms. [29].
𝐶𝐶6 𝐻𝐻12 𝑂𝑂6 + 6𝑂𝑂2 → 6𝐶𝐶𝑂𝑂2 + 6𝐻𝐻2 𝑂𝑂

(11)

All the reactions (equation 5-11) showed their tendency to either undergo oxidation or
reductions is controlled by their reduction potential. Reduction potential (Eo) is defined
as a tendency of a chemical species to be reduced by gaining an electron and is defined
with electrochemical reference of hydrogen, which is globally given the reduction
potential of zero [30]. As this is an electric potential, it is measured in volts and each
chemical species has its own intrinsic reduction potential. Numerically, the more
positive the potential, the stronger is the affinity of the species to acquire an electron
and get reduced.
2.1.1.2 Redox potential:
A normal redox reaction example could be as given below (eq 12):
𝐹𝐹𝐹𝐹 +3 + 𝐶𝐶𝐶𝐶+ → 𝐹𝐹𝐹𝐹 +2 + 𝐶𝐶𝐶𝐶+2
And this can be broken down into two parts:
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(12)

𝐹𝐹𝐹𝐹 +3 + 𝑒𝑒 − → 𝐹𝐹𝐹𝐹 +2 …………reduction

𝐶𝐶𝐶𝐶+ → 𝐶𝐶𝐶𝐶+2 + 𝑒𝑒 − ……………oxidation

(13)
(14)

For a combined redox reaction, the overall redox potential is estimated by:
𝑜𝑜
𝑜𝑜
∆𝐸𝐸 = 𝐸𝐸𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎
− 𝐸𝐸𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑𝑑

(15)

The electrochemical potential or reduction potential stated above is directly related to
the Gibbs free energy (∆𝐺𝐺) of the reaction:
(∆𝐺𝐺) = −𝑛𝑛𝑛𝑛∆𝐸𝐸

(16)

where
n: number of electrons associated with the reaction
F: Faraday’s constant
For a reaction to proceed total Gibb’s free energy (∆𝐺𝐺) must be negative or ∆𝐸𝐸 should
be positive. In equation 14, Cu is the electron donor with redox potential of Cu+2 to Cu+

is +0.16 V and that of Fe+3 to Fe+2 is 0.77 V. Therefore overall redox potential becomes
+0.61 V.
To state this simply, for a system to undergo a redox reaction, the redox potential of a
species to be reduced should be higher than the species to be oxidized. Table 2 lists
some of the common redox potentials of certain half-cell redox couples and of some
biomolecules important to physiological redox environment.
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Table 2.2. Half-cell reduction potentials of biologically significant molecules
Redox couple

Eo (v)

𝑂𝑂2 + 4𝐻𝐻 + + 4𝑒𝑒 − → 2𝐻𝐻2 𝑂𝑂

+0.816

𝑁𝑁𝑁𝑁3− + 4𝐻𝐻 + + 3𝑒𝑒 − → 𝑁𝑁𝑁𝑁 + 𝐻𝐻2 𝑂𝑂

+ 0.96

𝐹𝐹𝐹𝐹 +3 + 𝑒𝑒 − → 𝐹𝐹𝐹𝐹 +2

+ 0.77

2𝐼𝐼2 + 2𝑒𝑒 − → 2𝐼𝐼 −

+ 0.54

2𝐶𝐶𝐶𝐶+2 + 2𝑒𝑒 − → 𝐶𝐶𝐶𝐶

+ 0.34

𝑁𝑁𝑁𝑁2 + 𝑒𝑒 − → 𝑁𝑁𝑁𝑁2−

+ 1.04

𝐻𝐻2 𝑂𝑂2 + 2𝐻𝐻 + + 2𝑒𝑒 − → 2𝐻𝐻2 𝑂𝑂

+ 0.82

𝑂𝑂2 + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝐻𝐻2 𝑂𝑂2

+ 0.68

2𝐻𝐻2 𝑂𝑂 + 𝑂𝑂2 + 4𝑒𝑒 − → 4𝑂𝑂𝑂𝑂 −

+ 0.40

2𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐 +3 + 2𝑒𝑒 − → 2 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑐𝑐 +2

+0.254

𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹 + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠

+0.031

𝐹𝐹𝐹𝐹𝐹𝐹 + + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝐹𝐹𝐹𝐹𝐹𝐹𝐹𝐹2 (free coenzyme)

-0.22

2𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑏𝑏 +3 + 2𝑒𝑒 − → 2 𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐ℎ𝑜𝑜𝑜𝑜𝑜𝑜𝑜𝑜 𝑏𝑏 +2

+0.070

2𝐻𝐻 + + 2𝑒𝑒 − → 𝐻𝐻2

0.00

𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂𝑂 + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚

-0.166

𝑁𝑁𝑁𝑁𝐷𝐷+ + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁 + 𝐻𝐻 +

-0.320

𝑂𝑂2 + 𝑒𝑒 − → 𝑂𝑂2−

-0.33

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙

-0.185

𝑁𝑁𝑁𝑁𝑁𝑁𝑃𝑃+ + 2𝐻𝐻 + + 2𝑒𝑒 − → 𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝑁𝐻𝐻 + + 𝐻𝐻 +

-0.324

𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆 + 𝐶𝐶𝑂𝑂2 + 2𝐻𝐻 + + 2𝑒𝑒 −

→ 𝛼𝛼 − 𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘𝑘 + 𝐻𝐻2 𝑂𝑂

𝑁𝑁𝑁𝑁+ + 𝑒𝑒 − → 𝑁𝑁𝑁𝑁
2.2.2

-0.324
-2.71

Thermodynamic treatment (Ellingham diagram)

A voltage potential is not the only way to determine the direction of the reaction. As
stated earlier, for a reaction to proceed, ∆𝐺𝐺 should be negative which requires ∆𝐸𝐸 to be
positive, but ∆𝐺𝐺 is also a function of temperature (Equation 17). An alternative to
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determine the direction of a reaction can be obtained by a thermodynamic analysis of
the reaction equilibrium.
∆𝐺𝐺 = ∆𝐻𝐻 − 𝑇𝑇∆𝑆𝑆

(17)

Where
T: reaction temperature
ΔS: Entropy change
ΔH: Enthalpy change
The temperature dependence of a reaction using equation (17) above is also utilized in
redox chemistry to drive the direction of reactions of metal oxides and sulfides to pure
metal. This phenomenon is usually illustrated in the form of an Ellingham’s diagram,
which represents the stability of a metal oxide as a function of temperature in reference
to ΔG (Figure 2.2). Each line for a particular metal shows the free energy values for its
metal oxide formation where slope depicts the ΔS values while the y-intercept gives
ΔH. The position of the line of a metal with reference to another helps in depicting the
metal oxide reduction ability in presence of another metal. To illustrate, the lower the
position of metal (𝑀𝑀𝑀𝑀 + 𝑂𝑂 → 𝑀𝑀𝑀𝑀𝑀𝑀) is on Elligham’s diagram, the more stable its oxide
4

2

is at a particular temperature than the one that lies above it (3 𝐴𝐴𝐴𝐴 + 𝑂𝑂2 → 3 𝐴𝐴𝐴𝐴2 𝑂𝑂3 ).

Therefore, magnesium can reduce aluminum oxide to metallic aluminum. Looking at

the diagram, all the metal oxide formations have a positive slope while carbon oxidation
to carbon monoxide has a negative slope and it cuts across many of the metals at
particular temperatures. Therefore, carbon becomes very useful as a reducing agent for
metal oxides at higher temperature. For example, carbon can reduce manganese oxide
16

(MnO) to its metallic form Mn once the reaction temperature goes above 1400oC while
it will be able to reduce TiO2 to Ti above 1600oC [31-33].
Therefore, with an analogous theory, the way reduction potential of two reacting
molecules decide their possibility to get reduced or oxidized, in a similar way, ΔG of
metal oxides of two interacting metal decides the fate of one getting reduced in presence
of another.

Figure 2.2 Ellingham’s diagram [34]
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2.2.3

Combustion sequences and/or metal oxides

Combustion is a classic example of free radical reactions and generation. It is a high
temperature exothermic process involving multiple redox reactions of a fuel
(hydrocarbons) with an oxidant, mostly oxygen, resulting in oxidized products
primarily carbon dioxide and water, to generate heat and light. The overall combustion
process of oils is described by the reaction below:

𝐶𝐶𝑛𝑛 𝐻𝐻2(𝑛𝑛+1) + (4𝑛𝑛 +

𝑛𝑛 + 1
)𝑂𝑂2 → 𝑛𝑛𝑛𝑛𝑂𝑂2 + (𝑛𝑛 + 1)𝐻𝐻2 𝑂𝑂
2

(18)

While this equation is simple and describes the process in a general fashion, the exact
chemistry of combustion is highly complex, multifaceted and not easy to describe.
As such molecular oxygen in its ground state is a very stable molecule and unreactive
to hydrocarbons until a catalyst is introduced but at elevated temperature as high as
2200oC, oxygen converts into highly reactive singlet oxygen (O21) [35] and is known
to have high oxidizing power. Singlet oxygen can react with and break carbon-carbon
or carbon-hydrogen bonds of large hydrocarbons into smaller molecules and,
subsequently, hydrogen and water. In the process, it is also capable of initiating
numerous radical chain reactions via reaction with molecular hydrogen (H2) resulting
in the hydroxyl radical (OH●) and a proton (H+). The combination of many such
reactions results in the generation and simultaneous consumption of hydroperoxyl
(HCOO●), formyl (HCO●) radicals, carbon monoxide [36, 37]. As for hydrocarbon
pyrolysis, the process involves generation of various aliphatic and aromatic radicals.
Below are some of the common series of radical reactions that can occur during
combustion process:
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𝑂𝑂2 + 𝐻𝐻 + → 𝑂𝑂.− + 𝑂𝑂𝑂𝑂 ●

𝑂𝑂21 + 𝐻𝐻2 → 𝐻𝐻 + + 𝑂𝑂𝑂𝑂 ●

𝐶𝐶3 𝐻𝐻8 + 𝑀𝑀 → 𝐶𝐶2 𝐻𝐻5● + 𝐶𝐶𝐻𝐻3● + 𝑀𝑀
𝐶𝐶2 𝐻𝐻5● + 𝑀𝑀 → 𝐶𝐶2 𝐻𝐻4 + 𝐻𝐻 + + 𝑀𝑀
𝐶𝐶3 𝐻𝐻8 + 𝑂𝑂𝐻𝐻 ● → 𝐶𝐶3 𝐻𝐻7● + 𝐻𝐻2 𝑂𝑂
𝐶𝐶3 𝐻𝐻8 + 𝐻𝐻 + → 𝐶𝐶3 𝐻𝐻7● + 𝐻𝐻2

𝐶𝐶3 𝐻𝐻8 + 𝑂𝑂●− → 𝐶𝐶3 𝐻𝐻7● + 𝑂𝑂𝐻𝐻 ●

𝐶𝐶3 𝐻𝐻7● → 𝐶𝐶3 𝐻𝐻6 + 𝐻𝐻 +
Decay to unsaturated hydrocarbons

(19)
(20)
(21)
(22)
(23)
(24)
(25)
(26)

These radical react with oxygen radical to produce formyl radical and formaldehyde
and CH3●, CH2, H2CO finally oxidize to CO2 and H2O.
𝐶𝐶3 𝐻𝐻6 + 𝑂𝑂●− → 𝐶𝐶2 𝐻𝐻5 + 𝐻𝐻𝐻𝐻𝐻𝐻
𝐶𝐶2 𝐻𝐻4 + 𝑂𝑂2 → 2𝐶𝐶𝐶𝐶 + 𝐻𝐻2
𝐶𝐶𝐶𝐶 + 1/2𝑂𝑂2 → 𝐶𝐶𝑂𝑂2

(27)
(28)
(29)

Production of oxygen radicals also result in nitrogen oxide species production via
reaction with atmospheric nitrogen as shown below:
𝑂𝑂●− + 𝑁𝑁2 → 𝑁𝑁𝑁𝑁 + 𝑁𝑁
𝑁𝑁 + 𝑂𝑂2 → 𝑁𝑁𝑁𝑁 + 𝑂𝑂

𝑁𝑁 + 𝑂𝑂𝐻𝐻 ● → 𝑁𝑁𝑁𝑁 + 𝐻𝐻 +
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(30)
(31)
(32)

Therefore, looking at all the reactions above that are involved in the process of
producing heat energy via oxidation of long/short chain hydrocarbon fuels it is clear, a
milieu of free radicals are generated. Analogously, a host of free radicals are produced
in the process of carbohydrate, glucose, or fructose metabolism to generate cellular
energy in the form ATP. These free radicals play a critical part in maintaining cell
function depending on their local and overall concentrations.
To explain this combustion further, a spatial relationship can also be generated
described by the ‘zone theory’. This concept divides the combustion process into four
distinct zones: zone 1-free flame zone (fuel zone), zone 2-high temperature flame zone
(>1200o C), zone 3-post flame thermal zone (600-1200o C) and zone 4-gas quench cool
and surface catalysis zone (<600o C) [38]. Usually radical formation and consumption
takes place during zone 3 and zone 4 combustion. As the process reaches the lower
temperature in the cool down zone (150 to 400o C), free radicals, mostly phenoxyl and
semiquinone exists. These aromatic compounds have resonating electrons and hence
tend to stabilize via surface-mediated reactions with any surrounding transition metal
ions. They tend to form a metal oxide complex and are known as persistent free radicals.
These radicals are sometimes very stable in ambient conditions and can become
environmentally persistent free radicals (EPFRs) [39]. These aromatic compounds
generated during combustion also known as organic aerosols, mostly come from
biomass ignition processes. The fact that EPFRs are stabilized due to interaction with
metal oxides, their half-lives consistently depend upon the kind of metal oxide they
interact with. As per the studies, EPFRs associated with zinc oxide (ZnO) were found
to have the longest half-lives ranging from 3 to 73 days depending on the adsorbate
[39].
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The combination of radicals/oxidants generated during cellular metabolism and
subsequent reaction combinations with transition metal ions also plays a similar role in
accelerating the production of more radicals just like EPFRs. Figure 2.3 illustrates an
analog of combustion zone theory with cellular respiration/metabolism at various
stages, where oxidative phosphorylation process can be compared with the flame zone
as the energy production step, heat energy for combustion and ATP for cellular
respiration. Following that, just like the post flame zone defines incomplete combustion
and initial production of radicals, partial oxygen reduction or proton leak during
phosphorylation processes results in superoxide generation, which subsequently lead to
H2O2 formation. In both cases, the role of radicals produced at this stage are boosted by
the presence of a transition metal ion. With combustion, transition metal ion
combination with radicals makes more environmentally stable EPFRs and are reactive
to other biological species. During cellular metabolism, transition metal ions act as a
catalyst towards production of more reactive and damaging oxidants namely hydroxyl
radical (OH●).

Figure 2.3 Analogous comparison of various stages of combustion zone theory with
cellular respiration during energy production along with free radical generation [3]
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2.2.4

Fenton/Haber-Weiss chemistry

Both the Fenton and Haber-Weiss reactions are associated with iron and the production
of hydroxyl radicals. The Fenton reaction describes the formation of hydroxide (OH-)
and hydroxyl (OH●) radical by reaction between of Iron (II) (Fe+2) with hydrogen
peroxide (H2O2) [40], Haber-Weiss reaction is where hydroxyl and hydroxide ions are
generated from the reaction of H2O2 and superoxide ion (O2●-) catalyzed by iron [41].
𝐹𝐹𝐹𝐹 +2 + 𝐻𝐻2 𝑂𝑂2 → 𝐹𝐹𝐹𝐹 +3 + 𝑂𝑂𝑂𝑂 − + 𝑂𝑂𝑂𝑂 ● ………………….Fenton

(33)

𝑂𝑂2●− + 𝐻𝐻2 𝑂𝑂2 → 𝑂𝑂𝑂𝑂 − + 𝑂𝑂𝑂𝑂 ● + 𝑂𝑂2………………………..Haber-

(34)

reaction

Weiss reaction

The Haber-Weiss cycle is actually a two-step reaction, where the ferric ion reduces to
ferrous ion via reaction with superoxide, which, in turn, reacts with H2O2 to form OHand OH● ions, converting ferrous back to ferric ion.
𝑂𝑂2●− + 𝐹𝐹𝐹𝐹 +3 → 𝐹𝐹𝐹𝐹 +2 + 𝑂𝑂2

𝐹𝐹𝐹𝐹 +2 + 𝐻𝐻2 𝑂𝑂2 → 𝐹𝐹𝐹𝐹 +3 + 𝑂𝑂𝑂𝑂 − + 𝑂𝑂𝑂𝑂 ●

(35)
(36)

Though these reactions are named after these three scientists, there is a lot of history
associated with the naming, discovery, and progression of this concept of iron redox
reaction involvement in radical production. Henry J. H. Fenton reported for the 1st time
the oxidation power of H2O2 and Fe+2 towards tartaric acid in 1876 but never mentioned
the existence of the hydroxyl radical intermediate in the oxidation process although the
reaction was named after him [42]. The existence of OH● was 1st proposed by two
German chemists, Fritz Haber and Joseph Joshua Weiss in 1934 via reaction of
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hydrogen peroxide and superoxide in presence of iron as a catalyst [43]. Formation of
this hydroxyl radical via transition metal catalyzed reaction has gained plenty of
attention over the years and is considered to be one of the key processes for the
production of the highly reactive OH● in the cellular redox chemistry.
Not only hydroxyl radicals, but Fenton/Haber-Weiss chemistry involving redox
coupling between iron and hydrogen peroxide gives rise to several other oxidizing
intermediates including hydro peroxides (HOO●), superoxide (O2-) etc during various
chain initiation and propagation reactions shown in equations 38-46. OH● act as the
chain carrier with the ability to react with Fe+2, H2O2 or any other organic species to
propagate the reaction. But in some instances chain termination also comes into effect
via combination of two radicals (OH●/OH● or OOH●/OH●) producing just hydrogen
peroxide, water and oxygen as shown in equation 45 and 46 [44]. The existence and
propagation of any of these reactions highly depends on the density of iron in its
required oxidation state as well as the rate constant. An important condition for iron
induced reduction of hydrogen peroxide is the low pH requirement between 3 and 6.
𝐹𝐹𝐹𝐹 +2 + 𝐻𝐻2 𝑂𝑂2 → 𝐹𝐹𝐹𝐹 +3 + 𝑂𝑂𝐻𝐻 − + 𝑂𝑂𝑂𝑂 ●

𝐹𝐹𝐹𝐹 +3 + 𝐻𝐻2 𝑂𝑂2 → 𝐹𝐹𝐹𝐹 +2 + 𝐻𝐻 + + 𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2−
𝑂𝑂𝑂𝑂 ● + 𝐻𝐻2 𝑂𝑂2 → 𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− + 𝐻𝐻2 𝑂𝑂

𝐹𝐹𝐹𝐹 +3 + 𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− → 𝐹𝐹𝐹𝐹 +2 + 𝑂𝑂2 + 𝐻𝐻 +
𝐹𝐹𝐹𝐹 +2 + 𝑂𝑂𝑂𝑂 ● → 𝐹𝐹𝐹𝐹 +3 + 𝑂𝑂𝐻𝐻 −

𝐹𝐹𝐹𝐹 +2 + 𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− → 𝐹𝐹𝐹𝐹 +3 + 𝐻𝐻2 𝑂𝑂2
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K=5.7x102 M-1s-1

(37)

K=2.6x10-3 M-1s-1

(38)

K=3.3x107 M-1s-1

(39)

K=3.1x105 M-1s-1

(40)

K=3.2x108 M-1s-1

(41)

K=6.6x106 M-1s-1

(42)

𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− + 𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− → 𝐻𝐻2 𝑂𝑂2
𝑂𝑂𝑂𝑂𝑂𝑂 ● /𝑂𝑂2− + 𝑂𝑂𝑂𝑂 ● → 𝐻𝐻2 𝑂𝑂 + 𝑂𝑂2
𝑂𝑂𝑂𝑂 ● + 𝑂𝑂𝑂𝑂 ● → 𝐻𝐻2 𝑂𝑂2

K=2.3x106 M-1s-1

(43)

K=8.9x109 M-1s-1

(44)

K=5.2x109 M-1s-1

(45)

Chain propagation and termination reactions associated with iron and hydrogen
peroxide with rate constant measured at pH=5 [45-47].
Fenton chemistry is utilized commercially to treat water pollution, contaminated soils,
sludge etc by oxidizing the pollutants like benzene, formaldehyde, rubber chemicals,
pesticides etc. The rate constant for the initial reaction between Fe+2 and H2O2 is
generally observed to be around 102 M-1s-1 but in biological systems, this rate of
reaction with free Fe+2 is not enough for the oxidation to occur. However, when bound
to ADP, ATP or citrate as a backbone, the oxidation rate goes up by at least two orders
of magnitude giving a significant rate of reaction for the iron-catalyzed redox process
to occur [48].
2.2.5

Thiol Chemistry (-SH -SS-)

Thiol-disulfide reactions are one of the most important redox reactions. In biology,
oxidation/reductions govern the metabolic redox state of a cell. Thiol-disulfide
interchange/exchange reaction is significant in itself where a thiol (RSH) reacts with a
disulfide molecule (R’SSR’’) to give a new oxidized disulfide (R’SSR) and the
corresponding reduced thiol (R’’SH) [49]. The reaction is base catalyzed and is proposed
to proceed through SN2, 2 step reactions as follows [50, 51]:
𝑅𝑅𝑅𝑅𝑅𝑅 ⇄ 𝑅𝑅𝑆𝑆 − + 𝐻𝐻 +
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(46)

𝑅𝑅𝑆𝑆 − + 𝑅𝑅 ′ 𝑆𝑆𝑆𝑆𝑅𝑅 ′′ ⇄ 𝑅𝑅′𝑆𝑆𝑆𝑆𝑆𝑆 + 𝑅𝑅′′𝑆𝑆 −
𝐻𝐻 + + 𝑅𝑅′′𝑆𝑆 − ⇄ 𝑅𝑅′′𝑆𝑆𝑆𝑆

𝑑𝑑[𝑅𝑅 ′′ 𝑆𝑆 − ]
= 𝑘𝑘𝑅𝑅𝑅𝑅− [𝑅𝑅𝑆𝑆 − ][𝑅𝑅 ′ 𝑆𝑆𝑆𝑆𝑅𝑅 ′′ ]
𝑑𝑑𝑑𝑑

𝑑𝑑[𝑅𝑅 ′′ 𝑆𝑆 − ]
= 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 [𝑅𝑅𝑅𝑅𝑅𝑅]𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡 [𝑅𝑅 ′ 𝑆𝑆𝑆𝑆𝑅𝑅 ′ ]
𝑑𝑑𝑑𝑑
𝑘𝑘𝑅𝑅𝑅𝑅− = 𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 (1 + 10𝑝𝑝𝑝𝑝𝑝𝑝−𝑝𝑝𝑝𝑝 )

(47)
(48)

(49)

(50)

(51)

R: Attacking group, R’: central group, R’’: leaving group

𝑘𝑘𝑅𝑅𝑅𝑅− : calculated rate constant dependent on thiolate concentration but independent of

pH

kobs: : observed rate constant dependent on total thiol concentration and pH
In the reaction mechanism, thiolate anion (RS-) acts as the active nucleophile or reactive
species to propagate the reaction. Concerning the cellular environment, glutathione
plays a key role in the thiol redox chemistry as it is the most abundant small molecule
cellular antioxidant (see section 2.3.2 for an in-depth discussion on glutathione redox
reactions). One of the important factors that contribute towards the occurrence of this
thiol exchange reaction is the pKa of the corresponding thiol and the pH of the reaction
environment [52]. For example, a thiol with pKa value of 10, 0.1% of the total thiol
will form thiolate at pH 7 while at pH 8, 10 times higher thiolate ions would be present
in comparison [50]. In other words, we can say that thiol-disulfide interchange is most
favorable at pHs near to the pKa values of the thiol. For example, oxidation of
glutathione (GSH) (pKa=9.33) to its oxidized form (GSSG) is faster at a higher pH of
9.43 with a rate constant k=45 L/mol.s as compared to at pH of 8.46 with k=9.1 L/mol.s
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[53]. As pKa is a function of the structure of the thiol molecule, chemical properties of
thiol molecules involved in the reaction will dictate the extent of reaction and their
existence in reduced or oxidized form. For instance, reaction of 2-mercaptoethanol
(pKa=10.14) with Ellman’s disulfide (5-(3-Carboxy-4-nitrophenyl)disulfanyl-2nitrobenzoic acid) (pKa=4.5) is faster than mercaptoethanol with oxidized glutathione
(GSSG) (pKa=9.33) by the order of 104 in water [54, 55]. Also, the exchange reaction
is faster when the pKa of a nucleophilic thiol (RSH) is as high as possible and that of
the corresponding disulfide molecule ((R’SH/R’’SH) is as low as possible. Stearic
interference is another factor that would affect the rate constants of the thiol-disulfide
exchange reactions. It is most pronounced when there is any carbon substitution at the
α-position to sulfur. For instance, reaction of bis (t-butyl) disulfide with 1-butylthiolate
(k=0.26 M-1s-1) is 106 times faster than that with t-butyl thiolate (k=10-7 M-1s-1).
Similarly, charge on the thiolate anion also affects the rate constants [56]. The effect is
higher when the charged entity is near to the sulfur group [57].
The rate of reaction is often correlated with the Bronsted plot, which display the
relationship between pKa of the reacting thiols/disulfide and the rate constant. The
slope of the plot is defined by the bronsted coefficient (β), which normally lies between
0.4-0.5 for different thiol-disulfide exchange reaction. Equation 53 is generally
recommended for calculating kRS- values for the thiolate content [58] and figure 2.4
shows the graphical association between pKa of thiol v/s log (kRS-) at pH 7 for a thioldisulfide exchange reaction. Figure 2.4 also shows the degree of dissociation (θ) of the
thiol and observed rate constant for the thiol/disulfide exchange reaction be predicted
by equation 54. Therefore, the highest observed rate constant for exchange reaction is
observed at pKaRSH equivalent to pH of the solution, pH=7 in the figure.
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log(𝑘𝑘𝑅𝑅𝑅𝑅− ) = 6.3 + 0.59𝑝𝑝𝑝𝑝𝑝𝑝𝑅𝑅𝑅𝑅𝑅𝑅 − 0.40𝑝𝑝𝑝𝑝𝑝𝑝𝑅𝑅
𝑘𝑘𝑜𝑜𝑜𝑜𝑜𝑜 = 𝜃𝜃𝑘𝑘𝑅𝑅𝑅𝑅−

′ 𝑆𝑆𝑆𝑆

− 0.59𝑝𝑝𝑝𝑝𝑝𝑝𝑅𝑅′′𝑆𝑆𝑆𝑆

(52)

(53)

Figure 2.4 Correlation between pKa of reacting thiol and rate constant (kRS-+)/degree
of dissociation (θ) where kRS- was calculated using the equation (53), considering
pKa of R’SH and R’’SH group as 8.5 [50]
2.3

Biological oxidation events

2.3.1

Oxygen and nitrogen currency

Oxygen and nitrogen are the most abundant diatomic gaseous molecules in the
atmosphere and play a significant role in regulating both, human and plant metabolism.
Nitrogen is known to be highly inert and even oxygen (O2) in its ground state is a stable
molecule. But O2 at a higher energy state form, such as singlet oxygen (O21) [59] or in
the reduced form of superoxide (O●−
2 ), it can become an active source of free radical

generation leading to disruption of the cellular redox state [60], while oxide forms of
nitrogen (NO, NO2) generally produced during combustion process can diffuse and lead
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to the formation of intracellular free radicals or RNS. The age old Superoxide Theory
of Oxygen Toxicity stated that the partially reduced form of oxygen i.e. superoxide via
enzyme, auto-oxidation, mitochondrial electron transport chain, heme proteins etc is a
primary cause of cellular toxicity [61]. Oxygen upon its one electron reduction to
superoxide can further yield hydrogen peroxide via the dismutation process [62].
Hydrogen peroxide can reduce to the hydroxyl radical in the presence of transition
metal ions like Fe+2/ Cu+2, a highly reactive radical in cellular biology capable of
reacting with DNA, lipid membranes, proteins etc.[7]. Reactivity and reduction
potential at various stages of oxygen radical production chains are different is shown in
figure 2.5 and these reactions are often enzyme catalyzed. For example, dismutation of
superoxide to hydrogen peroxide mainly occurs via superoxide dismutase (SOD)
catalyzed reaction [63, 64], but a part of hydrogen peroxide production also takes place
via a 2-step route of oxygen conversion to peroxyl radical followed by further reduction
to H2O2. In an oxygen derived free radical production chain, H2O2 is although not a
very reactive molecule species but serves as an intermediate to the production of
hydroxyl radical (OH●) [65] via the Fenton reaction, which is highly reactive towards
all cellular components and can lead to complete cell damage. Similarly, superoxide
ion by itself is not very reactive towards non radical species but it can react very quickly
with NO● or phenoxyl radicals [66]. This radical has a unique selectivity towards its
oxidizing properties. For example, it is not very reactive towards oxidation of NADH/
NAD+ but can readily oxidize enzyme-bound (lactate degydrogenase) NADH to NAD+
[67]. Apart from being an oxidizing agent (oxidation of ascorbate to ascorbyl radical),
superoxide can also act as a reducing agent where it can reduce cytochrome c or Fe+3
to Fe+2 which is one of the steps in cellular redox cycling discussed later in section 2.3.3
[68, 69].
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In reference to biological free radical production, oxygen nucleated free radicals are
produced from all the oxygen that is inhaled or consumed by organisms and
mitochondrion is considered to be the main source of superoxide radical production due
to oxygen leakage in electron transport chain during ATP production and is reported to
be produced by complex I and III [70-72]. Reported in vitro studies show that about 4%
of the oxygen consumed gets converted into superoxide, though in vivo analysis have
reported about 10-fold lower production i.e. about 0.4% of the total consumed which is
still a significant amount of production leading to about 10 µM of intracellular
concentration [73]. This charged radical readily diffuses through the mitochondrial
membrane to react with other biological entities like proteins, PUFAs or produce other
reactive species (H2O2, OH●).

Figure 2.5 Free radical production/reactive oxygen species with oxygen as a
precursor [7]
Although nitrogen is a stable and inert molecule by itself but its oxide form such as
nitric oxide (NO), act as precursor to a variety of free radicals collectively known as
reactive nitrogen species (RNS), which are equally capable of carrying out cell damage
if produced in excess. Nitric oxide (NO●), due to its lipophilic property readily diffuses
through cell membranes from the atmosphere where it is a byproduct of various
combustion processes [74] (figure 2.6). In cellular metabolism, it is also a product of

29

the reaction of L-arginine and oxygen with NADPH in the presence of nitric oxide
synthase (NOS) to give nitric oxide, L-citrulline and NADP+ [75]. Nitric oxide by itself,
is not very reactive towards non-radical species similar to superoxide anion, but can
generate highly reactive free radicals such as, nitrogen dioxide (NO●2 ) via slow reaction
with oxygen (O2) [76]. NO●2 with the Eo value of 1.04 V is a potent oxidant in metabolic
redox system and in RNS chains, it further reacts with NO● leading to the production

of N2O3, which eventually decomposes to give another reactive nitrite (NO2-) free
radical [77]. In the presence of superoxide, NO● reacts to form peroxynitrite (ONOO-),
which in itself is also a powerful oxidizing molecule [78, 79]. It is present in the form
of acidified peroxynitrous acid (ONOOH) or its activated form (●NO2…OH●), both
forms are capable of oxidizing most biological molecules such as DNA, proteins and
lipids. NO● also takes part in the modification of some biological molecules with thiols
or amine groups during the process called nitrosation via direct reaction with thiols or
via metal bound NO● reaction with thiols/amines resulting in formation of nitrosothiols
(RSNO) or nitrosamine (RN2O) which are also regarded as non-radical RNS [80, 81].
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Figure 2.6 Reactive nitrogen species production
2.3.2

Cellular redox chemistry

Within the cellular environment, there exists an equilibrium between oxidants and
antioxidants. Major players of these processes are defined in Figure 2.7. Of particular
note is the small molecule antioxidant, glutathione (GSH), which contains an
antioxidant thiol group and is the most abundant small molecule in eukaryotic cells,
roughly found intracellularly from 1-10 mM and about 1-10 µM extracellular. [82-85]
Synthesized within the cell from the three amino acids, glutamate, glycine, and
cysteine, GSH production is rate limited by cysteine content, a semi-essential amino
acid in biology. Cysteine is transported from extracellular space in the disulfide form,
cystine. [86] Reaction of cysteine with glutamic acid in the presence of glutamatecysteine-ligase (GCL) followed by reaction with glycine via glutathione synthetase
(GSS) results in GSH production. [86] GSH may act in several mechanisms as an
antioxidant, whether directly through electron donation to reactive oxygen or nitrogen
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species in the intracellular or extracellular space, or via enzymatic routes such as with
glutathione S-transferase (GST) to irreversibly reduce toxic species like lipid peroxides
and protein carbonyls. [87] In addition to direct chemical reaction with oxidative
species, GSH participates in several mechanisms to regenerate other important
antioxidant enzymes such as glutathione peroxidase (GPx), glutaredoxin (GRX), and
peroxiredoxins non-specifically. Oxidized glutathione (GSSG) may be reduced back to
GSH via glutathione reductase (GR), which is driven by NADPH and the glucose-6phosphate dehydrogenase (G6PD) cycle via oxidation of NADPH to NADP+. There are
also other thiol-based oxidoreductases such as thioredoxin, which utilizes cysteine
thiol-disulfide exchange (instead of GSH), and is regenerated with thioredoxin
reductase, similarly utilizing NADPH for regeneration akin to GSSG with GR.
Depending on the cellular compartment, redox equilibrium may vary. For instance, the
cytosol (GSH:GSSG 100:1) and nucleus (GSH:GSSG >100:1) maintain a reducing
environment [83, 88], whereas there are high concentrations of oxidants in the
endoplasmic reticulum (GSH:GSSG of 1-3:1 [89], where disulfide bonds fortify the
protein structures), mitochondria (GSH: GSSG of 20-40:1 [88]), secretory pathways,
and extracellular space (GSH:GSSG 20:1 [85]). It is important to note that
extracellularly while the GSH:GSSG ratio is around 10-20:1, cysteine and cystine are
in greater concentration by about an order of magnitude, and maintain the oxidative
environment around cysteine:cystine of 0.2:1 [85]. In a similar manner, NADPH is a
reducing coenzyme involved in processes like fatty acid synthesis and is required to
drive various redox reactions in the metabolic pathway. Therefore, NADPH:NADP+
(200:1) ratios are found to be in same order of magnitude as for GSH/GSSG redox
equilibrium to drive the reaction forward. On the other hand, another coenzyme NADH
plays an essential part in both reduction and oxidation in general, hence a significant
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concentration of both oxidized and reduced form is maintained in the cell with NAD+
at higher concentrations. Cytoplasmic NADH which is produced by oxidation of
cytoplasmic NAD+ acts as an electron donor and is transported to the mitochondrion to
reduce mitochondrial NAD+ to NADH, which in turn is oxidized again during oxidative
phosphorylation processes to generate ATP. It is postulated via several experimental
studies that the NAD+/NADH ratio in the cytoplasm is around 700:1 though the overall
cellular ratio varies between 0.5:1 to 4:1. This ratio is involved in regulation of several
metabolic enzymes such as glyceraldehyde 3-phosphate dehydrogenase, and pyruvate
dehydrogenase used in the conversion of pyruvate to acetyl-CoA.

Figure 2.7 Significant cellular redox molecule interactions. Green: glutathione
processes. Red: oxidant species reduced by glutathione processes.
2.3.3

Radical generation in metabolism and role of enzymes in redox cycle

ROS/RNS production takes place in a cellular environment via multiple metabolic
pathways with the aid of specific enzymes at various sites in a cellular matrix and its
organelles. In that, mitochondria are one of the most important cellular components
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with the highest potential to produce free radicals ranging from hydroxyl to
peroxynitrite to hypochlorite radicals. Figure 2.8 depicts the role of mitochondrion in
the redox of cycle of a cell. Mitochondria are known to be the energy producer or ATP
production center of the cell which takes place via tetravalent reduction of oxygen (O2)
in the presence of mitochondrial cytochrome c oxidase (COX) also called complex IV
[90]. About 2-4% of this oxygen taken by mitochondria undergoes univalent reduction
to superoxide ion (O2.-) via the complex I enzyme (NADH-ubiquinone oxidoreductase)
to a concentration of about 10 µM [73, 91]. Oxidation of NADPH to NADP+ by O2 in
the presence NADPH oxidase is another source of O●−
2 which occurs as an important
inflammatory response in phagocytes against bacterial infection and this process is
often termed as oxidative burst [92-94]. NADPH oxidase also facilitates O●−
2

production in non-phagocytic systems like fibroblasts, endothelial cells, smooth muscle
rd
cells, although the rate of O●−
2 production here is 1/3 than that in neutrophils [13, 95,

96]. This superoxide anion is further converted to hydrogen peroxide by mitochondrial

manganese superoxide dismutase (MnSOD) [97, 98]. Apart from controlling the O●−
2

concentrations inside the mitochondrion, cytosolic CuZn-SOD also catalyzes the
superoxide dismutation to H2O2, 104 times faster than an uncatalyzed reaction (k=2x109
M-1s-1) [99]. Hydrogen peroxide is also known to be formed by two electron reduction
of O2 by cytochrome P-450 or acetyl coenzyme A oxidase [100-102].
Hydrogen peroxide is relatively stable and a membrane permeable non radical ROS,
which either decomposes to water and oxygen with the help of catalase, glutathione
peroxidase (GPx) etc [103, 104] or can further reduce to a highly reactive hydroxyl
radical under transition metal ion catalytic conditions (oxidation of Fe+2 or Cu+2 to Fe+2
or Cu+3) (Figure 2.9) [105]. In this pathway, oxidized iron or copper (Fe/Cu+3) is
reduced back to ferrous or cuprous ions (Fe+2/Cu+2) by superoxide ions present in the
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vicinity, which in turn produce more hydroxyl radicals. The concentrations of
superoxide anion, and transition metal ions significantly define the free radical
production rates [106, 107]. Other active route of OH● production is through
disproportionation of peroxynitrous acid intermediate (HO…NO2) to hydroxyl and
nitrous oxide (NO2) radicals [108]. Due to the extremely high reactivity of the hydroxyl
radical, it is very difficult to monitor its real-time concentration in vivo.
Peroxynitrite is a product of reaction of superoxide with endogenously generated nitric
oxide (NO●) radical [109],[110]. NO is also generated in the cellular matrix via
reduction of L-arginine in presence of nitric oxide synthase (NOS). As such NOS has
three isoforms namely: (i) NOS1 (NOS I) found in neural tissues, (ii) NOS II or iNOS,
inducible NOS, which is found in various cell types stimulated upon inflammatory
response and (iii) eNOS found in endothelium [111]. Mitochondrial NOS (mtNOS) is
another isoform, which facilitates the formation of NO● inside the mitochondria. This
NO formation plays an important role in regulating mitochondrial respiration and has
the potential to reversibly inhibit cytochrome oxidase activity, which is responsible for
superoxide production [112]. Reaction of superoxide with nitric oxide under
physiological conditions to produce peroxynitrite is found to be 3 times faster than
hydrogen peroxide production and again is also a highly reactive RNS [113]. Hydrogen
peroxide also contributes to the production of hypochlorite radical upon reaction with
chloride ion (Cl-) in activated leukocytes by the action of myeloperoxidase (neutrophils
and monocytes) and eosinophil peroxidase (eosinophils) [114, 115]. Their ideal
function is to act as antimicrobial agents, but excess or unregulated production can
result in fragmentation and aggregation of proteins [115, 116]. As for the production of
singlet oxygen, it is known to be generated at the catalytic sites of multiple enzymes in
the cellular matrix or via dismutation of unstable oxidation products like superoxide
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both spontaneous and enzyme catalyzed. It is also known to be produced as a byproduct
of peroxyl radical reaction between hydrogen peroxide and hypochlorite via the Russell
Mechanism, found to occur in stimulated neutrophils mostly during the respiratory
burst phenomena (anti-microbial cell lyses process) [117, 118].
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Table 2.3 Role of enzymes in carrying out various redox reaction and maintaining
cell homeostasis
Enzyme

Function

Ref

SOD (CuZn-SOD, Mn-

Catalyzes dismutation of superoxide to

[119,

SOD, Fe-SOD)

hydrogen peroxide

120]

NOS (eNOS, iNOS,

Oxidation of L-arginine with production

[75,

NOSI)

of nitric oxide (NO)

121]

Superoxide production from dioxygen

[75,

molecule

122]

NADPH oxidase

Reduction of GSH to GSSG with
GPx

simultaneous conversion of hydrogen
peroxide to water

Myeloperoxidase
(abundant in neutrophils)

Catalase (in peroxisomes)

5-lipoxygenase

Cyclooxygenease

[123,
124]

Produces HOCl from H2O2 and Cl- ion,
oxidation of tyrosine to tyrosyl radical

[125]

in presence of H2O2
Decomposition of hydrogen peroxide to

[126,

water and oxygen

127]

Inducible source of ROS production in

[128,

lymphocytes

129]

ROS generation in TNF-α stimulated

[130,

cells

131]

Source of ROS in diabetes mellitus,
catalyzes oxidation of hypoxanthine to
Xanthine oxidase

xanthine with simultaneous production
of H2O2, xanthine further catalyzes to

[33]

uric acid and H2O2, sometimes can also
produce superoxide radical
monoamine oxidase

Catalyzes oxidative deamination of

(outer mitochondrial

biogenic amines, large source of H2O2

membrane)

and OH● radical as well.
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[132]

Figure 2.8 Examples of various routes of metabolic free radical production and
detoxification pathways [113, 133]

Figure 2.9 Concept of redox cycle in maintaining the healthy redox state of a cell.
2.4

Known targets and elements of concern

Proteins, polyunsaturated fatty acids (PUFAs) and carbohydrates are very common
targets to ROS. These molecules constitute very important cell organelles including
lipid membranes, mitochondria, DNA and other nucleic acids. Reaction with these
biological components starts with the excess production of ROS and insufficient
endogenous antioxidants available to stabilize them, resulting in disruption of the
cellular redox balance. Extent or affinity of ROS/RNS to react with the cellular
components varies with the type of ROS depending on its reduction potential. For
instance, hydroxyl and peroxynitrite radicals discussed in section 2.3.1 have relatively
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higher reduction potential amongst other oxidants (Table 2.2) and are considered to be
the most reactive towards lipids, DNA etc. It is difficult to detect or measure their
quantity in vivo as their rate constants are in the range of 107 to 1010 M-1s-1, which
almost matches their diffusion rates [133, 134]. In theory, oxidation of proteins,
peptides, and amino acids by these free radicals can take place via several routes
including hydrogen abstraction (favorable with aliphatic amino acids), electron
transfer, dimerization, disproportionation, rearrangement and many more [135, 136].
Protein and amino acids have multiple sites of attack on their backbone and their
reactivity depends on the stability of the resulting radical and degree of carbon
hydrogenation [37]. Aromatic amino acids have a tendency to undergo an addition
reaction with free radicals rather than hydrogen abstraction due to their stabilizing
resonance property forming hydroxylated/ quinone molecules after reaction with
hydroxyl radical [137, 138].
One of the most prone target sites to free radicals are mitochondria and their DNA
components (mtDNA) [139, 140]. This is because, mitochondrion is the key production
site of ROS/RNS where superoxide anion concentration is found to be 5-10 times higher
than in the cytosol, with mtDNA to the closest proximity in comparison to nuclear DNA
to the cytosolic ROS [141, 142]. There are numerous studies demonstrating that
mitochondrial dysfunction due to excess ROS/RNS production is a kick-off event
towards the final stage of cell apoptosis or necrosis [133]. The mitochondrial
dysfunction is thought to start via mtDNA damage and protein deactivation. This leads
to the incapability of the mitochondrion to maintain its membrane potential, resulting
in the net loss of ATP production, de-structuring of the mito-membrane (inner and outer
both), resulting in release of excess calcium ion (Ca+2), cytochrome c and lysosomes.
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These apoptogenic proteins/enzymes finally activate the apoptotic pathway leading to
cell death [143].
Another potential target of ROS like singlet oxygen, peroxynitrite or hydroxyl radical
is the cellular lipid membrane, which is made of unsaturated fatty acids. It is thought
that the central carbon of the unsaturated fatty acids (L) is attacked by ROS/RNS to
produce lipid free radical (L●), which oxidizes further to its alkoxyl (LO●) and peroxyl
(LOO●) radical form [144]. These radicals, considered to be important intermediates
in the lipid oxidation process, again reacts with another fatty acid chain (L) to produce
more L● radical and the chain reaction continues. In this propagation event, radicals
like NO● can act as an antioxidant towards termination of the chain by forming stable
alkyl nitrites (LONO2) or as pro-oxidant to form more LO● and NO2 through the
peroxynitrite pathway (eq 54, 55 and 56) [145]. Due to this process, lipid fatty acid
chains are often considered as secondary free radicals as they form reactive
intermediates that propagate the lipid peroxidation chain reaction resulting in
membrane degeneration and membrane protein dysfunction [113]. This degeneration
leads to loss of membrane integrity making membrane bound protein even more
susceptible to free radical attack. Alkyl peroxyl radicals (another form of secondary
radicals) generated by decomposition of alkyl hydroperoxide in the presence of
transition metal ion also contributes in the propagation of lipid peroxidation [146-149].
𝐿𝐿𝐿𝐿𝑂𝑂● + 𝑁𝑁𝑁𝑁● → 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿

𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 → 𝐿𝐿𝑂𝑂● + 𝑁𝑁𝑂𝑂2 ….. Chain propagation (14%)
Or 𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿𝐿 → 𝐿𝐿𝐿𝐿𝐿𝐿𝑂𝑂2 …...chain termination (86%)
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(54)
(55)
(56)

3

RESEARCH OUTLINE

3.1 Overall hypothesis:
Antioxidant conjugated PβAE crosslinked micro/nanoparticles can be synthesized
using the Michael addition chemistry of acrylates with amines, which exhibit tunable
degradation properties, capable of releasing active polyphenolic antioxidants as well as
increase the apparent solubility of these antioxidants. With controlled drug release
through these systems, the apparent safe concentrations of the antioxidants can be
increased, thereby opening the routes for prolonged suppression of cellular oxidative
stress (OS) at therapeutic levels.
3.1

Specific aim 1. Synthesis and characterization of quercetin conjugated

PβAE nanogels (Chapter 4)
a. Formulate quercetin-PβAE nanogels via single step reaction-precipitation
Michael addition under dilute conditions.
b. Evaluate the impact of synthesis parameters (e.g. feed reactant concentrations,
acrylate to amine ratio) on nanogel diameter and effect of PEG conjugation as
a second step towards their aqueous stability and protein binding properties.
c. Study quercetin release profile during hydrolytic degradation of nanogels and
the antioxidant activity of the degradation products.
d. Evaluate dose dependent cytotoxicity of nanogels and their ability to suppress
externally induced OS.
Hypothesis:
a. The hydrodynamic diameter of Quercetin-PβAE nanogels increases with
increasing feed reactant concentration and PEG conjugation helps in the
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aqueous stabilization of these hydrophobic systems as well as decreases
opsonization effects.
b. Hydrolytic degradation of quercetin-PβAE nanogels at the ester linkage
releases active quercetin in a steady state manner with bulk erosion kinetics.
Extended release kinetics allows the system to suppress induced cellular OS for
a prolonged period of time.
3.2

Specific aim 2. Synthesis and characterization of curcumin conjugated

PβAE nanogels (Chapter 5)
a. Formulate curcumin-PβAE nanogels using a reaction-precipitation method
under dilute conditions and study the curcumin release kinetics via hydrolytic
degradation.
b. Evaluate dose dependent cytotoxicity of curcumin-PβAE nanogels and compare
them with free curcumin at similar equivalent concentrations with endothelial
cells.
c. Evaluate their ability to prevent cellular oxidative stress and protection against
mitochondrial OS using a H2O2 injury model by monitoring real-time
mitochondrial bioenergetics.
Hypothesis:
a. Uniform and steady release kinetics of curcumin with no burst release effect
increases the in vitro viable concentration and hence widens the safety window
of curcumin towards endothelial cells
b. Non-toxic nature at higher concentrations via administration of curcumin via
curcumin-PβAE nanogels allows the OS injury to be treated at therapeutic
levels and suppresses the mitochondrial oxidative damage for at least 24 hours.
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3.3

Specific aim 3. Curcumin PβAE nanogels for the protection against

polychlorinated biphenyls (PCBs) induced toxicity (Chapter 6)
a. Study the dose dependent effect post PCB 126 and 153 treatment on overall cell
toxicity and mitochondrial bioenergetics.
b. Analyze the protection against PCB-induced mitochondrial OS with the help of
curcumin-PβAE nanogels by analyzing both overall cell viability and mitochondrial
bioenergetics at variable nanogels pretreatment conditions.
Hypothesis:
a. Mitochondrial bioenergetics are more sensitive towards PCB exposure
compared to overall cell viability and immediate toxic effects can be better
analyzed at mitochondrial level than overall cellular response.
b. Curcumin-PβAE

nanogel

pre-treatment

helps

prevent

mitochondrial

dysfunction of PCB-exposed endothelial cells. Longer the nanogel
pretreatment, better the suppression of OS during PCB exposure.
3.4

Specific aim 4. Synthesis and characterization of curcumin-PβAE gel

microparticles to treat oral mucositis (Chapter 7)
a. Formulate curcumin-PβAE gel microparticles of different compositions using
PEGDA as co-monomer to formulate tunable degradation systems.
b. Study the degradation kinetics of the curcumin-PβAE microparticles as a
function of co-monomer compositions and antioxidant activity of the
degradation products containing released curcumin.
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c. Evaluate dose dependent cytotoxicity of the released products in vitro and the
extent of protection against induced oxidative stress using Normal Human
Dermal Fibroblasts as the model cell line.
d. Test the treatment/protection efficacy of microparticles in vivo on hamsters with
induced oral mucositis injury using 5FU/scratch experimental model.
Hypothesis:
a. Increasing the content of PEGDA in curcumin-PβAE gel microparticles
accelerates the degradation rate due to increased hydrophilic content in the
gels.
b. Released products are active as free radical scavengers and microparticles with
similar curcumin loading show relatively less cellular toxicity when compared
with free curcumin.
c. Microparticles with high yet safe curcumin loading shows prolonged protection
against induced OS in vitro and reduces the extent of oral mucositis injury in
vivo with lesser dosage frequency.
3.5

Specific aim 5. Synthesis and characterization of resveratrol conjugated

PβAE gel microparticles (Chapter 8)
a. Synthesize resveratrol conjugated PβAE gel films with PEGDA as a comonomer (R-PβAE microparticles) and optimize antioxidant release kinetics
based on polymer composition.
b. Analyze dose dependent toxicity of the microparticles and anti-inflammatory
capacity to suppress H2O2 induced oxidative stress with normal human dermal
fibroblasts.
Hypothesis:
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a. Increasing resveratrol content intensifies the hydrophobic nature of the
crosslinked system leading to slower degradation kinetic and hence slow
resveratrol release.
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4

SYNTHESIS AND CHARACTERIZATION OF QUERCETIN
CONJUGATED POLY (β-AMINO ESTERS) NANOGELS

Based on the research articles published in:
Prachi Gupta, J. Zach Hilt, Thomas D. Dziubla, ‘Quercetin conjugated Poly (βAmino Esters) Nanogels for the Treatment of Cellular Oxidative Stress’, (Acta
Biomaterialia), 2015, 27, 194-204
Abstract
PβAE polymers have emerged as highly promising candidates for biomedical and
drug delivery applications owing to their tunable, degradable and pH sensitive
properties. These polymeric systems can serve as prodrug carriers for the delivery
of bioactive compounds, which suffer from poor aqueous solubility, low
bioavailability and are biologically unstable, such as the antioxidant, quercetin.
Using acrylate functionalized quercetin, it is possible to incorporate the
polyphenol into the backbone of the polymer matrix, permitting slow release of
the intact molecule which is perfectly timed with the polymer degradation. While
formulating the quercetin conjugated PβAE matrix into nanocarriers would allow
for multiple delivery routes (oral, intravenous, inhalation etc.), well- known oilwater nano-emulsion formulation methods are not amenable to crosslinked
hydrolytically sensitive nanoparticles/nanogels. In this work, a single-phase
reaction–precipitation method was developed to formulate quercetin conjugated
PβAE nanogels (QNG) via reaction of acrylated quercetin (4–5 acrylate groups)
with a secondary diamine under dilute conditions using acetonitrile as the reaction
medium, resulting in a self-stabilized suspension. The proposed approach permits
the post synthesis modification of the spherical nanogels with a PEGylated
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coating, enhancing their aqueous stability and stealth characteristics. Nanogel
size was controlled by varying feed reactant concentrations, achieving drug
loadings of 25–38 wt%. Uniform release of quercetin over 45–48 hours was
observed upon PβAE ester hydrolysis under physiological conditions with its
retained antioxidant activity over the extended times.
4.1

Introduction

Oxidative stress is a pathophysiological condition when endogenous antioxidants are
unable to counteract the production of oxidants, leading to cellular dysfunction. The
origins for this overproduction of the reactive oxygen and nitrogen species (ROS/RNS)
(e.g., hydroxyl radicals, singlet oxygen, hydrogen peroxide, peroxyl radicals) can be
caused by both endogenous sources and exogenous sources. Examples of endogenous
routes include ROS-generating enzymes such as nitric oxide synthase, xanthine
oxidase, amplified mitochondrial metabolism especially in aging cells resulting in
mitochondrial dysfunction, damaged membrane and hence leakage of ROS into the
intracellular environment [150-153]. Some of the exogenous sources include exposure
to ozone, UV, ϒ-irradiation, air pollutants penetrating through the skin or via
inhalation, intake of various drugs, xenobiotic and many more [153-158]. At a systemic
level, oxidative stress has been shown to play a role in the development and acceleration
of many diseases, including diabetes, cardiovascular diseases, Alzheimer’s and
Parkinson’s disease, acute renal failure, acute lung injury, radiation injury, etc. [159,
160].
Rationally, one would expect that the supplementation of dietary antioxidants would be
sufficient to reduce the excess ROS into non-reactive stable molecules, resolving the
oxidative stress and thereby mitigating many diseases. In fact, this beneficial property
of antioxidants, including polyphenol flavonoids, has been successfully demonstrated
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in vitro several times using different assays [161, 162]. But despite these in vitro
demonstrations, nearly all clinical trials with antioxidants have failed to demonstrate
substantial benefit [3, 163]. As a result of these outcomes, it was inferred that the major
limitation of dietary antioxidants was their inability to impact the oxidative stress levels
in the patients. Given the highly unstable nature of these antioxidants, their typically
poor aqueous solubility and lack of natural accumulation in tissues of interest, it is
unsurprising that these molecules were unable to perform their intended function. For
instance, quercetin has been shown in multiple in vitro and in vivo studies to possess
anti-inflammatory [34], anti-hypertensive [164], anti-allergic [165] properties and an
ability to control metabolic syndrome [166]. Yet, it has not been used therapeutically
for pharmaceutical applications due to its low bioavailability, which is likely due to its
poor aqueous solubility, structural instability and extensive first pass metabolism [167,
168]. It has been reported that the oral bioavailability of quercetin is 17% in rats and
merely 1% in humans [168, 169]. Moreover, upon intravenous injection, a 100 mg of
dose resulted in 12 µM plasma concentration after 5 minutes and 1 µM after 3 hours,
demonstrating the relatively short half-life of the compound [170].
In order to overcome this difficulty of low systemic bioavailability, one potential
solution is to deliver quercetin through encapsulation into nanoparticles, which can be
administered via a number of routes (e.g., intravenous, subcutaneous, inhalation, etc.)
with an objective of extended drug release and control the rate of first-pass metabolism
[171]. Several studies have demonstrated the ability to encapsulate quercetin into
nanoparticles composed of poly (lactic acid) (PLA), poly (lactic-co-glycolic acid)
PLGA, solid lipid nanoparticles (SLN). However, these approaches, while potentially
useful, possessed significant burst drug release and low overall drug loading, ranging
from only 0.05 to 2 wt% of the total particle weight [172, 173]. Incorporating
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antioxidants into the backbone of a polymer system could be an alternative towards the
effective antioxidant delivery as demonstrated by Wattamwar et. al. in his work on
enzymatically biodegradable poly(trolox) nanoparticle system to deliver trolox, a water
soluble analog of vitamin E [174].
Building upon this prior work, it may be possible to overcome drug stability, solubility
and drug release limitations by conjugating the drug into the backbone of a
hydrolytically biodegradable polymer, such as poly(β-amino esters) (PβAEs), to form
prodrug nanoparticles/nanogels [175, 176]. Our lab has shown previously that
antioxidants like curcumin and quercetin can be loaded into crosslinked PβAEs and
subsequently released into their original structural form upon hydrolysis [177]. But due
to the fast reaction kinetics and hydrolyzing property of PβAE, the bulk crosslinking
approach is not amendable towards typical nanoparticles synthesis approaches (e.g.,
o/w emulsion polymerization). To overcome this problem, we have synthesized
quercetin conjugated PβAE gel nanoparticles/nanogels using a novel approach of single
phase reaction-precipitation method in an organic solvent under dilute conditions
giving a stable suspension of uniformly sized particles. Covalently reacting terminal
amine groups with poly (ethylene glycol) monomethacrylate resulted in a coating that
minimizes post purification instability, is expected to reduce the rate of first-pass
metabolism and serves as an alternative to conventional surfactant based stabilization
of nanoparticles. Uniform degradation of these nanogels over 48 hours successfully
demonstrated release of active quercetin with negligible burst release. Particle sizes
were easy to control with resulting quercetin loading capacities of 25-38 wt%, which
possessed biocompatibility equivalent to pure quercetin and were able to suppress
cellular oxidative stress over 48 hours.
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4.2

Materials and methods

4.2.1

Reagents

Quercetin was purchased from Cayman Chemicals, Michigan, USA. Acryloyl chloride,
potassium carbonate, N, N’-dimethyl 1-3-propanediamine, polyethylene glycol methyl
ether methacrylate (Mn=4000) (PEGMEMA4000), potassium persulfate, 2, 2’-azo-bis
(3-ethylbenzothiazoline-6-sulphonic acid), and hydrogen peroxide were purchased
from Sigma-Aldrich. IgG antibody was purchased from Jackson Immuno Research
Laboratory Inc. For cell culture studies, EBM basal medium (phenol red free), EGM-2
growth factors, and Human Umbilical Vein Endothelial Cells were purchased from
Lonza. Calcein-AM red-orange and 2', 7 dichlorodihydrofluorescein diacetate
(H2DCFDA) were purchased from Life Technologies. Iodogen® iodination reagent (1,
3, 4, 6-tetrachloro-3α-6α-diphenylglycouril) was bought from Thermo Scientific,
Rockford, IL.
4.2.2

Quercetin functionalization to quercetin multiacrylate monomer

Quercetin multiacrylate (4-5 acrylate groups per molecule) (QMA) was prepared in
accordance with the protocol described by Wattamwar et. al. [178] with a slight change
of using potassium carbonates as the acid capturing agent instead of triethylamine.
Briefly, the reaction between quercetin (20 gms in 200 ml of Tetrahydrofuran (THF))
and acryloyl chloride was carried out in anhydrous THF. Potassium carbonate was
added to the reaction system to capture the hydrogen chloride forming its salt as the
reaction byproduct. The system was purged with nitrogen for 30 minutes initially and
then was further allowed to react overnight at room temperature to functionalize
quercetin phenolic groups into acrylate. Acryloyl chloride and potassium carbonate,
were added in the molar ratio of 1:1.2 with respect to the phenolic groups present in
quercetin. Quercetin has four phenolic groups, which can be actively functionalized.
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Therefore, for every mole of quercetin, five moles of acryloyl chloride and potassium
carbonate were added to the reaction medium. Acrylated quercetin solubilizes in THF
as the reaction proceeds. After the reaction, solubilized product was separated from the
precipitated salts via filtration. Subsequently, filtrated was vacuum dried to remove all
the THF and was re-dissolved in dichloromethane (DCM) in order to carry out an
aqueous-organic solvent extraction process to remove any unreacted acryloyl
chloride/acrylic acid and quercetin. A basic solution of 0.1 M potassium carbonate in
DI water was used as the extraction medium for acrylic acid and quercetin both. After
extraction, magnesium sulfate was added to the product solubilized in DCM to remove
any remains of water. Finally, the pure QMA was obtained as a dry product after
evaporation of DCM overnight. Characterization of the functionalized quercetin was
completed using 1H-NMR and mass spectroscopy to identify the number of acrylate
groups per molecule of quercetin.
4.2.3

Quercetin PβAE nanogel (QNG) synthesis

Quercetin PβAE nanogels were prepared using a single-pot dilute synthesis approach.
QMA was dissolved in anhydrous acetonitrile to specified concentrations of 0.75, 1.25,
2.5, 5 and 10 mg/ml. A stock solution of N, N’dimethyl-1-3 propane diamine (NNDA,
a secondary diamine) (100 mg/ml) was prepared in acetonitrile. Calculated volume of
NNDA stock: 3.67, 6.12, 12.25, 24.5, and 49 µl was added to the reaction solutions
with QMA concentrations: 0.75, 1.25, 2.5, 5 and 10 mg/ml respectively to achieve the
required reaction concentration, maintaining a stoichiometric ratio of acrylate to
reactive amine at 1:1.1. QMA-NNDA reaction in these diluted conditions resulted in
precipitation into nanogel form. These quercetin-PβAE nanogels will be further
referred as QNG (0.75), QNG (1.25), QNG (2.5), QNG (5), and QNG (10) for different
systems with feed QMA concentrations of 0.75, 1.25, 2.5, 5 and 10 mg/ml respectively.
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The reaction time of the nanogel synthesis was determined by analyzing the reaction
supernatant at different time point to observe the decrease in QMA absorbance peak.
After about 45 minutes of reaction, peak intensity does not change. Therefore with a
buffer of 15 minutes, the reaction was carried out for one hour, resulting in precipitated
nanogels. The hydrodynamic radius of the synthesized nanogels in acetonitrile was
determined using dynamic light scattering (DLS) (Malvern Zetasizer (ZS 90)).
Appropriate dilution using fresh acetonitrile were used in order to get the count rate
between 200 to 300 cps. Hydrodynamic diameter was reported as z-average. All the
parameters were set for acetonitrile medium at 25o C.
After completion of the reaction, 63 µl (32 mg) of a concentrated solution (500 mg/ml)
of polyethylene glycol methyl ether methacrylate 4000 (PEGMEMA4000) in
acetonitrile was added to 1 ml of the nanogel suspension along with gentle mixing for
few seconds to get 3% wt/vol PEGMEMA4000 in suspension. This system was allowed
to react for one hour, followed by centrifugation at 6700 rpm for 10 minutes (Figure
4.1). The pellets were re-suspended in fresh acetonitrile by sonication for 3-5 minutes.
Particles were then centrifuged and nanogels pellets were freeze-dried and stored at 80o C for further analysis.
Nanogels were also synthesized at variable acrylate to reactive amine hydrogen
stoichiometric ratios ranging from 0 to 10, in order to study the effect of reactant molar
ratio. For this system, QMA feed concentration was kept constant at 2.5mg/ml and
amine content was varied. Nanogel suspension obtained from each ratio was diluted
with DMSO, in order to dissolve any precipitated quercetin due to the excess amine.
The size of the nanogels in suspension was measured using DLS after adjusting the
instrument parameters according to the suspension medium.
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Figure 4.1 Schematic of Q-PΒAE nanogel synthesis
4.2.4

Size and yield of nanogel synthesis reaction

In order to determine reaction yield, concentration of unreacted QMA in the supernatant
obtained after first centrifugation was measured, via UV-VIS spectroscopy. The sample
was prepared by diluting 100 µl of supernatant with 1 ml of acetonitrile. The absorbance
of the diluted solution was measured at 350 nm using UV-VIS spectrophotometer
(Varian Cary 50 Bio UV-Vis spectrophotometer). The amount of unreacted QMA was
calculated using standard calibration curve of pure QMA dissolved in acetonitrile and
percent QMA reacted or yield was back calculated subsequently. The size of the
nanogels was measured using DLS at different stages of synthesis.
4.2.5

SEM imaging

In order to determine particle morphology, scanning electron microscopy was
performed on the synthesized nanogels. 50 μL of PEG coated nanogel suspension in
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acetonitrile (synthesized using 2.5 mg/ml feed QMA concentration) was diluted to 1 ml
with acetonitrile and probe sonicated 8-10 times at 2-6 watts. A drop of the solution
was dried on gold plated surface overnight in the bio-hood and covered with Kim wipes
as an added precaution to prevent dust settling. Next day the dried sample on a gold
surface was sputter coated with gold-palladium alloy and images were taken at various
magnifications using S-4300 Hitachi Scanning Electron Microscope.
4.2.6

Analysis of enhanced stability of nanogels after the reaction with
PEGMEMA4000

To determine the impact of PEGMEMA4000 treatment on nanogel stability, particle
size was analyzed at two stages, first before the PEGMEMA4000 reaction and second
after the PEGMEMA4000 reaction. To prepare the samples, 50 μL of nanogel
suspension was added to 1 ml of PBS (pH=7.4) to form a suspension. Size measurement
of the suspended nanogels in PBS was carried out using DLS without any further
agitation at an interval of 10 minutes for a total time of 50 minutes and recorded to
analyze the effect of PEGylation. The size measurement was done for nanogels
obtained at both the stages described above. Nanogels were also treated with only
polyethylene glycol methyl ether Mn=5000 (PEGME5000) for 1 hour and analyzed for
the size afterwards in order to determine the kind of linkage of PEG to nanogel surface.
4.2.7

PEG content analysis after nanogel formulation

Analysis of PEG content in nanogels was performed using the barium-iodide assay
[179]. To carry out the assay, two solutions were prepared. A) 60 mg/ml barium
chloride in 1.2 N HCl (HCl stock diluted in DI water), B) potassium iodide and iodine
in DI water with a final concentration of 20 and 12.5 mg/ml respectively. Separately, 1
mg of nanogels was rapidly hydrolyzed in 500 µL of 5 N NaOH for 4 hours at 80o C.
Hydrolyzed nanogels were neutralized by addition of 500 µL of 5 N HCL.
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PEGMEMA4000 dissolved in DI water was used for standard calibration within the
range of 0-10 µg per well in a 96 well plate. 20 µL of the hydrolyzed nanogel solution
was added to the wells. Sample and the calibration volumes were diluted to 170 µL
with DI water. 40 µL of solution A was then added to each well followed by mixing.
40 µL of solution B after doing 1/5th dilution was added subsequently to all the wells
and mixed. The reaction was allowed to develop for 10 minutes after which absorbance
was recorded at 550 nm using Varian Cary 50 Bio UV-Vis spectrophotometer.
Calibration curve of pure PEG was used to calculate the PEG content in the nanogels.
4.2.8

Antibody Binding studies of Q-PΒAE nanogels using IgG using
radiolabeling

125

I-IgG stock preparation: IgG was radiolabeled with 125I to serve as a tracer to protein

bound to the nanogels. Briefly, 200 µL of 2 mg/ml Iodogen® iodination reagent (1, 3,
4, 6-tetrachloro-3α-6α-diphenylglycouril) in chloroform was dried in a glass tube using
dry nitrogen gas to form a thin layer on the glass wall. 100 µL of 1 mg/ml Mouse IgG
was added to iodogen coated tube and radioactive iodine (Na125I) was added and
incubated for 5 minutes. Free iodide was removed from the protein using a Thermo
Scientific protein desalting spin column according to manufacturing instructions. Any
free iodine remaining in the spun down solution was determined using trichloroacetic
acid (TCA) precipitation. Gamma counts of both the precipitate and supernatant were
analyzed using a Perkin Elmer 2470 automatic gamma counter. The amount of free
iodine in hot IgG was found to be 5.6%.
IgG binding to quercetin nanogels: Three different formulations of QNG were used:
QNG (0.75), QNG (1.25), and QNG (2.5). IgG having 2 wt% 125I-IgG was added to the
nanogels (with and without PEG coating) suspended in PBS. Final concentrations of
IgG and nanogels in the buffer were maintained at 1.17 and 0.4 mg/ml respectively.
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After 3 hours of incubation, the suspension was then centrifuged at 6700 g for 20
minutes to collect the pellet at the bottom and supernatant from the top. Both pellet and
the supernatants of all the nanogel formulation were analyzed for the total gamma
counts using gamma counter.
4.2.9

Quercetin release profile of Q-PΒAE nanogels in PBS

QNGs were suspended in PBS buffer (pH=7.4) using probe sonication to a
concentration of 1 mg/ml. As quercetin has very limited aqueous solubility, degradation
buffer was prepared using 2 vol% DMSO in order to solubilize any released quercetin
during hydrolytic degradation. This suspension was incubated at 37º C in a shaker bath
at 70 RPM. Every 2 hours, nanogel suspensions were centrifuged at 6700 RCF for 10
minutes and the supernatant was collected and stored at -20º C for further analysis. The
centrifuged pellet was re-suspended in the fresh buffer to continue degradation.
Absorbance of the supernatant was measured at 370 nm using Varian Cary 50 Bio UVVis spectrophotometer to determine the amount of quercetin released. Degradation was
carried out for 50 hours and quercetin concentration in supernatants were analyzed after
each collection.
4.2.10 In vitro antioxidant activity capacity of the degradation products of
nanogels
Antioxidant activity of released quercetin and degradation products was evaluated
using the Trolox Equivalent Antioxidant Capacity (TEAC) assay, which is based on
scavenging of 2, 2’-azinobis-(3- ethylbenzothiazoline-6-sulfonate) radical anions
(ABTS.-). Briefly, 7 mM ABTS radical cation stock solution was prepared by mixing
1 ml of 8 mg/ml of ABTS solution with 1 ml of 1.32 mg/ml of potassium persulfate
solution, both prepared in DI water. This solution was allowed to react overnight to
form ABTS radical cation stock solution. After 24 hours, ABTS radical cation working
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solution was prepared by diluting the stock solution in PBS to an absorbance of 0.4 at
734 nm. For calibration purposes, a standard solution of trolox of known concentrations
(0 to 0.27 mM) in PBS were prepared and used for the assay. To carry out the TEAC
assay, 10 μL of the test sample (degradation supernatants/trolox standards) was added
in a 96-well plate. Subsequently, 200 μL of the ABTS radical cation working solution
was added to all the wells. After 5 minutes absorbance of all the samples was measured
at 734 nm. Trolox standard curve with respect to the obtained absorbance was prepared
and equivalent trolox concentration in the samples was calculated using the trolox
calibration curve. The equivalent quercetin concentrations were calculated by obtaining
the TEAC value of pure quercetin using the same assay.
4.2.11 Cell toxicity study of QNGs on Human Umbilical Vein Endothelial Cells
(HUVECs)
HUVECs were cultured in EBM basal medium (phenol red free) with EBM-2 growth
factors to an 80% confluence in a 48-well plate overnight. A range of concentrations
(from 1 to 70 µg/ml of equivalent quercetin content) of nanogels in media were
prepared and added to the well plate (n=4). After 24 hours, treated and non-treated
control cells were washed with fresh media followed by incubation in 1 mM Calcein
AM red-orange live cell tracer. After 1 hour, cells were washed again with fresh media
once, followed by addition of fresh media. Fluorescence was recorded at
excitation/emission of 540/590 nm using BioTek Synergy Mx, Gen5 2.0, Winooski,
VT to analyze the cell viability.
4.2.12 Cellular oxidative stress suppression
HUVECs were cultured in 48 well plate in EBM basal medium with EBM-2 growth
factors. In order to determine the ability of Q-PΒAE nanogels to block oxidative stress
injury, HUVECs exposed to hydrogen peroxide (0.5 mM) were treated with free
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quercetin and nanogels (QNG (1.25)) with equivalent quercetin concentrations of 5 and
10 µg/ml. DCF-DA to a final concentration of 10 µM was added at the time of treatment
and DCF fluorescence was used as a measure of oxidative stress levels in the cells.
Three similar 48 well plates were prepared. DCF fluorescence at 490/525 nm and cell
viability was measured at 24 and 48 hours using BioTek Synergy Mx, Gen5 2.0,
Winooski, VT.
4.3

Results

4.3.1

Hydrodynamic radius and yield of reaction of Q-PΒAE nanogels

The hydrodynamic diameter of the nanogels was determined using DLS before and
after PEGylation. The extent of reaction was evaluated by UV-Vis spectrophotometer.
As the concentration of reactants increased, nanogels size increased from 273 ± 6 to
642 ±21 nm, and reaction yields increased from 81.4 ± 2.6 % to 97.8 ± 0.54 % (Figure
4.2). A slight increase in nanogel diameter (approximately 50 nm), for smaller diameter
particles was observed after the reaction with 3 wt/vol% of PEGMEMA4000 (Figure
4.3). This increase can be likely be attributed to the attachment of PEG chains at the
surface of nanogels as shown in figure 4.1.
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Figure 4.2 Percent reaction yields and size variation of QNGs with respect to variable
reactant QMA concentration. All samples were analyzed with n=3.

Figure 4.3 QNGs size variation before and after PEGylatio with PEGMEMA4000.
Black circles: Nanogel diameter before reaction with PEGMEMA4000. Grey squares:
Nanogel diameter after reaction with PEGMEMA4000 followed by centrifugation and
re-suspension in fresh acetonitrile. N=3, error bars: std. dev.
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4.3.2

Analysis of shape and size of nanogels

Nanogels prepared using 2.5 mg/ml feed QMA concentration were imaged in SEM to
examine shape and size. Nanogels with diameter ranging from 100-250 nm with an
average of 197 ± 57 nm as analyzed using Image J software were observed (Figure 4.4
a, b). The nanogels’ spherical morphology was confirmed by imaging at an angled view
at 38o (Figure 4.4, c and d). There was an observed phenomenon of fusion at nanogel
surface as they are soft polymeric particles, which might be undergoing interfacial
attraction forces during solvent evaporation on the gold substrate.

Figure 4.4 Scanning electron microscopy of the QNGs synthesized with reactant
QMA concentration of 2.5 mg/ml. a, b: plain view (Top view); c, d: angled view,
38o.
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4.3.3

Effect of the acrylate to amine ratio on nanogel size (stoichiometric feed
ratio)

Different acrylate to amine ratios during the synthesis were investigated to study the
effect of stoichiometric ratios on nanogel diameter and reaction yield. Because of the
possibility that a higher amount of amine can result in hydrolysis of QMA and
precipitation of quercetin, 200 μL of DMSO was added to each 1 ml suspension of
nanogels to dissolve any precipitated quercetin but not crosslinked nanogels. The
dissolution of precipitated quercetin was verified by conducting a control experiment.
In the control experiment, highest possible amount of quercetin that could get
precipitated for the QNG (2.5) was suspended in acetonitrile, followed by addition of
200 μL of DMSO resulting in dissolution of suspended quercetin. It was observed (as
shown in figure 4.5), the highest hydrodynamic diameter (311 nm) was obtained with
an acrylate to reactive amine hydrogen ratio of 1:1.1 while higher or lower ratio resulted
in smaller sizes with either incomplete reaction of QMA or precipitation of nascent
quercetin. This ratio also gave highest yield of the reaction (89%) not shown in the
figure. For all further studies, QNGs were synthesized with feed ratio of 1:1.1, which
results in slightly excess of amine, which permits conjugation of the PEGMEMA4000
system

61

Figure 4.5 Effect of total acrylate to total reactive amine hydrogen on QNGs size.
Variable acrylate to amine ratio ranging from 0.1 to 10 was taken and size was
measured after 1 hour of reaction with 2.5 mg/ml of reactant QMA concentration
constant for all formulation changing the amount of amine added. (n=3). Nanogel
diameter at acrylate to amine ratio of 1.1 was found to be the highest with respect to
other stoichiometric ratios mostly due to the maximum extent of reaction. Hence, this
ratio was used for all the formulations with variable feed reactant concentrations. N=3,
error bars: std. dev.
4.3.4

Analysis of enhanced stability of nanogels after the reaction with
PEGMEMA4000

PEGylation of nanogels with PEGMEMA4000 resulted in the physical stability of
nanogel suspension in aqueous media (PBS. pH=7.4). As shown in figure 4.6,
PEGMEMA4000 treated retained their size from 373 ± 5.8 at t=0 to 364 ± 68 after 50
minutes of suspension. This could be due to the stearic hindrance of the PEG groups
that leads to the formation of stable suspensions in contrast to non-PEGylated nanogels
that aggregated with time in PBS giving the size of over 1 micron within 20 minutes.
Incubation of nanogels with PEGME5000 did not result in their stability in PBS either
but in aggregation of nanogels over time with an observed diameter of 2.5 µM within
50 minutes of suspension, confirming that the stability of nanogels after PEGylation is
due to the covalent bonding of PEG to its surface due to the reaction of mono acrylate
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from PEG with unreacted terminal amine hydrogen of the nanogels. The size of the
nanogels treated with PEGMEMA4000 after 30, 40 and 50 minutes of suspension was
significantly lower than the other two groups with p< 0.005, while did not show any
significant increase in size when compared at different time points of suspension.

Figure 4.6 Stability analysis of QNGs before and after reaction with
PEGMEMA4000 and PEGME5000 in PBS.
Size measurements were taken at various time intervals after suspension of nanogels in
PBS. Nanogels after PEGMEMA4000 coating were more stable than non-coated
nanogels. Nanogels were prepared with 2.5 mg/ml reactant QMA concentration and
reacted with 3 wt/vol% PEGMEMA4000. N=3, error bars: std. dev. Nanogel
PEGylation and protein binding
4.3.5

PEG content analysis after nanogel formulation

PEG content in the nanogels has been represented as PEG weight percent in the total
nanogel mass shown in figure 4.7. It was observed that nanogels synthesized from lower
QMA feed concentrations of 0.75 and 1.25 mg/ml had 40.7 and 30.4 wt% PEG
respectively, while the higher concentration systems, 2.5, 5, and 10 mg/ml, had lower
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PEG content at 7.6, 1.23 and 3.1 wt% respectively. The influence of this variable PEG
content was seen in the IgG binding capacity as discussed below.

Figure 4.7 PEG weight percent in QNGs after reaction with 3 wt/vol %.
Barium Iodide assay for PEG content determination was used with n=3 for each
formulation.
4.3.6

Decrease in QNG-antibody binding by using radiolabeled IgG

Nanogels without PEG coated system showed high IgG binding, 59.8 ± 1.6, 73.84 ±
2.1 and 71.25 ± 1.2 % surface coverage for QNG (0.75), QNG (1.25) and QNG (2.5),
respectively. PEG coated nanogels with the same formulations showed a substantial
decrease in IgG binding, 18.4 ± 4.8, 37.3 ± 7.4 and 50.6 ± 5.4 % surface coverage for
QNG (0.75), QNG (1.25) and QNG (2.5), respectively (Figure 4.8, bar chart).
Additionally, as the PEG weight percent decreased, the percent IgG bound increased,
indicating the presence of a PEG coating of the nanogels (Figure 4.8, line graph).
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Figure 4.8 Extent of IgG binding to non-PEG coated and PEG coated QNGs
compared in three different nanogel systems having different PEG wt% in them.
4.3.7

Quercetin release profile and antioxidant activity

Figure 4.9 a,b shows the released products and degradation profile of the nanogels in
PBS at 37° C. Supernatants containing the degradation products were analyzed using
UV-Vis spectroscopy. Quercetin release was linear for the first 36 hours, followed by
a plateauing profile, with approximately 95% total release in 35-40 hours. These
nanogels had initial burst release of 11.93 ± 1.5, 4.43 ± 0.4, 6.8 ± 0.27, 9.3 ± 1.6, 9.9 ±
0.97 % for QNG (10), QNG (5), QNG (2.5), QNG (1.25) and QNG (0.75), respectively.
This low level is likely due to unconjugated quercetin in the gel matrix. Taking into
account the first 60% of the total release, profiles were fit to the Korsmeyer-Peppas
model (Mt/Minf = Ktn) for the in vitro release model fit [180, 181]. To identify between
the diffusion, anomalous and erosion controlled release regimes, exponent ‘n’ values
were identified. For a spherical system, n=0.43 implies pure diffusion, n=0.85 suggests
erosion and 0.43<n<0.85 implies anomalous transport or a combination of diffusion
and erosion. The ‘n’ values of 0.55, 0.85, 0.69, 0.58 and 0.58 for QNG (10), QNG (5),
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QNG (2.5), QNG (1.25) and QNG (0.75) respectively, indicate the anomalous diffusion
release mechanism of nanogel degradation according to the model definition. R2-values
were within the range of 0.97-0.99. Since similar release profiles were seen for all
formulations irrespective of the different nanogels formulations, which gave varied
nanogel diameter and given the swellable nature of PβAE polymer, bulk erosion
phenomenon is likely to happen via hydrolysis instead of surface erosion for these
systems. This study was conducted in three different batches and was found to be
reproducible, although figure 4.9 shows data from only one batch. Figure 4.9
(a) represents the HPLC chromatograms of quercetin, quercetin multiacrylate and
degradation products of Q-PβAE bulk gel system and nanogel systems. HPLC Analysis
of degradation products of Q-PβAE bulk gels (#3) in the Figure 4.9 (a) identified release
of both quercetin and the monoacrylate form. However, degradation products of the
synthesized Q-PβAE nanogels (#4)) resulted in the release of pure quercetin, with no
detectable trace of mono or higher acrylate products, confirming the retrieval of the
original drug. Meanwhile, TEAC studies of the degraded product indicated that the
released compounds possessed antioxidant activity against free radicals for 36-40 hours
(Figure 4.9 (c)) and possessed a similar release profile as obtained from degradation
product UV-Vis analysis. Equivalent active quercetin was also calculated for each time
point taking 4.2 as the TEAC value of quercetin. It was observed that equivalent active
quercetin either complied with the released quercetin or was higher than that implying
no loss of quercetin activity during degradation and release. Higher values of equivalent
active quercetin is likely from oligomers released during hydrolysis and degradation
products of quercetin, which also have some inherent antioxidant activity. Taken
together, quercetin was successfully kept intact within the polymer matrix for an
extended period of time without loss of activity. This result is in contrast to the usual

66

behavior of quercetin, where structural stability and antioxidant activity is lost within 2
hours of incubation in aqueous media.

Figure 4.9 Degradation of QNGs at physiological conditions and subsequent
analysis.
(a) HPLC analysis of QNG degradation products to confirm the recovery of pure
quercetin and not any other mono or higher quercetin acrylates. This was confirmed
by comparing the nanogel degradation products with quercetin, QMA (monomer) and
degradation products of bulk Q-PΒAE gels, which results in quercetin and quercetin
monoacrylate release, (b) Degradation/quercetin release profile from QNGs in PBS
(pH 7.4 with 2vol% DMSO). 90% of the quercetin was released within 35 hours of
incubation. N=3 and the profile fits Korsmeyer-Peppas release kinetic model Mt/Minf
= Ktn with n values within 0.45-0.85 showing anomalous release. R-square ranged from
0.9737 to 0.9923, (c) Antioxidant activity profile of the degraded products of QNGs.
The study was done using the trolox equivalent antioxidant capacity assay (TEAC), and
the activity is expressed in terms of equivalent amount of trolox. n=3, (d) Instantaneous
active quercetin values calculated from TEAC values compared with instantaneous
quercetin released values obtained after each degradation time interval.
4.3.8

Effect of QNGs on human umbilical vein endothelial cells

4.2.1.1 Dose dependent cell toxicity
Cytotoxicity of quercetin-based nanogels in the biological environment was analyzed
by exposing HUVEC monolayers to quercetin nanogels. The cells were exposed to
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equivalent quercetin concentrations ranging from 1 to 70 µg/ml of nanogels for 24
hours followed by treatment with Calcein AM red-orange (fluorescent cell tracer), as a
measure of cell viability. Calcein AM red-orange was used as it does not interfere with
the fluorescence of quercetin itself, being in the different fluorescence wavelength
region. As shown in figure 4.10, cell viability starts to decrease to about 50% at 70
µg/ml of equivalent quercetin concentrations. All nanogel formulations showed similar
viability trends when compared within themselves as well as when compared with pure
quercetin for both 24-hour exposure time. This was confirmed after conducting twoway ANOVA test considering nanogel composition and treatment concentrations as
two groups. The two-factor analysis of variance showed no significant effect of
composition towards cell viability but dose dependent cytotoxic effect was statistically
different after 24-hour treatment. This demonstrates that presence of PβAE nanogels or
its degradation products apart from quercetin did not contribute to cell cytotoxicity.

Figure 4.10 Dose dependent toxicity of QNGs on HUVECS
(a) Cell viability after exposure of HUVECs with QNGs and pure quercetin for 24
hours. Calcein AM red-orange was used as a live cell tracer. (n=4), (b) Specific
viability of QNGs with respect to quercetin. A two-way ANOVA test was conducted
taking nanogel compositions and treatment concentrations as two variables. No
significant difference in viability was observed due to different compositions and pure
quercetin while treatment concentrations showed statistically significant difference in
cell viability.
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4.2.1.1 Effect of nanogels on H2O2 treated HUVECs for 24 hours
HUVECs at 80% confluence were treated with two different concentrations of QNG1.25 (5 and 10 µg/ml equivalent quercetin concentration) and 0.5 mM H2O2 as an
inducer of cellular injury and oxidative stress. 10 µM DCFDA was added to each well.
Cell viability and DCF fluorescence were measured at 24 and 48 hours and compared
with the no particle treatment and no H2O2 controls. Cell viability was maintained on a
concentration basis for only quercetin/QNG treatment after 48 hours. A slight increase
in viability was seen after 48 hours with the antioxidant treatments (Figure 4.11 (a) and
4.11 (b)). When looking at DCF fluorescence for the same treatment system,
antioxidant treatment suppressed the background oxidative stress to a significant level
at both 24 and 48 hours when compared with no treatment controls (Figure 4.12 (a)).
External oxidative stress induced using H2O2, as shown in figure 4.12(b), resulted in
cell viability dropping down to 10% after 24-hour exposure and 20% after 48-hour
exposure. H2O2 exposed groups treated with free quercetin or QNG showed different
responses after 24 and 48-hour exposure. For 24 -hour, all the treatments with either
free quercetin or QNGs, showed same protection from H2O2 with cell a viability of
approximately 50%. With 48-hour exposure study, though we saw equivalent
protection from both free quercetin and QNG with 5 µg/ml, QNGs at 10 µg/ml showed
improved performance than just quercetin despite having same inherent toxicity at that
concentration. Suppression of DCF fluorescence at both 24 and 48 hours for 10 μg/ml
QNG system was superior to pure quercetin.
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Figure 4.11 Cell viability of HUVECs treated with two different concentrations of
QNG (1.25): 5 and 10 µg/ml and/or 0.5mM H2O2.
Cell death analyzed after 24 and 48 hours of treatment. (a) Treatment with only
QNG/quercetin. (b) Treatment with QNG/quercetin and H2O2. * p<0.05

Figure 4.12 Oxidative stress suppression analysis using 10 µM DCF-DA as an
oxidative stress marker.
Two different of QNG/quercetin, 5 and 10 µg/ml were used. Fluorescence was
measured after 24 and 48 hours of treatment. (a) Treatment with QNG/quercetin. (b)
Treatment with QNG/quercetin and 0.5 mM H2O2. * p<0.05
4.4

Discussion

Numerous trials have been conducted over the years evaluating the continuous
administration of antioxidants and their effect on chronic diseases like atherosclerosis
or diabetes. Yet, results have been inconclusive and debatable towards their beneficial
effects [182]. However, as the use of antioxidants in sub-acute inflammatory diseases
(e.g., N-acetyl cysteine in acetaminophen toxicity) have shown clinical acceptance,
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there must be something more to this observed discrepancy [183]. One explanation for
the better in vivo performance of N-acetyl cysteine in this setting is the improved
natural accumulation in the intended site of action (e.g., the liver) and more favorable
circulation times over that of other antioxidants, which has a half-life of 6 hours
compared to minutes for many polyphenolic antioxidants [184, 185]. However the use
of N-acetyl cysteine is also complicated with side effects common of sulfur containing
compounds, including nausea, vomiting and risk factors of asthma, drug allergy etc.
[186]. As such, it may be possible to rescue small antioxidant therapy for short-term
oxidative stress disorders through changing their inherent pharmacokinetics.
The objective of this work was to design a biocompatible polymeric nanocarrier capable
of systemically delivering highly active though labile antioxidant, quercetin, over an
extended period of time to fight acute oxidative stress conditions. We have incorporated
PβAE gel synthesis chemistry in making quercetin conjugated PβAEs nanogels. Our
lab group and other researchers have previously reported successful synthesis of PβAE
bulk hydrogels using different co-monomers including polyphenolic antioxidants along
with PEGDA and DEGDA [178, 187, 188]. By taking advantage of its polyphenolic
structure, quercetin can be acrylated, which when reacted with an amine can form a
crosslinked gel via a Michael addition mechanism. However, due to rapid kinetics and
multifunctional nature of the monomer, translation from bulk gel to nanogel is a
technically challenging hurdle. Owing to the hydrolytically degradable property of
PβAEs, standard two-phase (oil-water or oil-oil) emulsion techniques are not feasible.
However, formulating quercetin-PβAE nanogels (QNG) via a single-phase reactionprecipitation method in acetonitrile under dilute conditions resulted in a nanogel
suspension as the reaction proceeded to completion, the spherical nature of which was
confirmed by SEM imaging (Figure 4.4). The presence of excess available terminal
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amines permitted the covalent linkage of PEG monoacrylate grafts to the nanogel
resulting in a stable coating. As PEG grafts are able to stearically stabilize
nanoparticles, PEGylation of the nanogels enhanced their post-purification stability and
improved their stealth characteristics. The single-phase reaction systems/ one-pot
synthesis simplified the synthesis process, eliminating the requirement of any stabilizer
and removal of the excess stabilizer added during purification. A very simple
purification step of centrifugation was used, after which nanogels restored their original
size without any aggregation (figure 4.1 and 4.3). PEGylation improved the stability in
organic-aqueous solutions. This is in contrast to QNGs incubated with PEGME5000
(MW in the range similar to PEGMEMA4000). The lack of the acrylate group
prevented covalent addition to the particles and was, therefore, unable to prevent
particle aggregation (Figure 4.6). This confirms the presence of covalent linkage
between PEG acrylate group and NNDA unreacted terminal hydrogen amines, which
eventually results in QNG physical stability.
Precise control of nanogel size was made possible by varying the feed reactant
concentration while keeping the stoichiometric ratio constant, with increasing
concentration increasing particle size (Figure 4.3). Interestingly, as the ratio of acrylate
to amine decreased, the excess amine catalyzes the hydrolysis of the acrylate groups.
To minimize the occurrence, the stoichiometric ratio of acrylate to reactive hydrogen
amine was limited to 1:1.1 which still offered maximum reaction yield, diameter and
provides the opportunity to covalently bind PEGMEMA4000 to terminal amines
(Figure 4.4). It was observed that after using the same concentration of
PEGMEMA4000 for all formulations, the smaller nanogels had a higher amount of
PEG attached (30-40% wt/wt) while the larger diameter nanogels had PEGylation of
only 3-5 wt% (Figure 4.7). This could be due to the presence of more amine reactive
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sites on smaller particles due to the overall higher surface area for the same quantity.
The PEG presence was further substantiated by performing a radiolabeled-IgG binding
studies where reduced amount of IgG binding was observed for PEGylated nanogels as
opposed to non-PEGylated nanogels (Figure 4.8). Also, as wt% of PEG decreased with
different nanogel formulations, percent IgG bound increased clearly implying that
presence of PEG was altering the antibody binding effect in a positive fashion.
These hydrophobic polymeric quercetin-PΒAE systems are hypothesized to degrade in
PBS via hydrolysis of ester bond to release quercetin. This was confirmed by injecting
degradation products through HPLC where we saw the most significant elution peak
coinciding with pure quercetin peak with no oligomer or other forms of quercetin
acrylate present (Figure 4.9 (a)) confirming the presence of original quercetin molecule
in the degradation product. Nanogels showed uniform degradation over 48 hours with
about 5-10% of the total quercetin released in first 30 minutes as analyzed by UV-Vis
(Figure 4.9 (b)). While the Korsmeyer-Peppas (K-P) release profile model for spherical
systems with 0.43<n<0.85 suggests the contribution of diffusion, as well as erosion
based degradation, similar release profile of all the formulations (QNG (0.75)-QNG
(10)) with variable diameter, confirms the bulk erosion instead of surface erosion
degradation mechanism, (Figure 4.9 (b)). An important fact to notice in the release
profile is that the value of ‘n’ obtained using the K-P model closely correlates with the
percent burst release considering it to occur at 1st sampling time point of 30 minutes.
The system with highest burst release of 11.93% (QNG (10)) fits with the ‘n’ value of
0.55 (near diffusion boundary) while QNG (5) with lowest burst release of 4.43%
amongst all the systems gives the ‘n’ value of 0.85 (pure erosion mechanism). This
trend of higher burst release with lower ‘n’ value clearly implies that the diffusion
contribution in the release model is largely coming due to the unconjugated quercetin
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being diffused through the spherical gel matrix at early time points while the quercetin
released due to the ester hydrolysis is derived by erosion based mechanism. Analyzing
the antioxidant activity of the released products using TEAC assay confirmed that the
products released at 24 hours or 48 hours still possess antioxidant activity and quercetin
conjugated to PΒAE backbone was structurally intact even after being incubated in
aqueous media for several hours (Figure 4.9 (c)). Comparing the equivalent quercetin
amount obtained from TEAC assay and actual quercetin release in figure 4.9 (c), it is
clear that the nanogel degradation products are showing higher activity than would be
estimated through pure quercetin release (Figure 4.9 (d)). One possible explanation for
the persistent excess activity throughout the degradation process could be due to the
auto-oxidation or molecular degradation of the released quercetin in the aqueous
environment resulting in metabolized fragments such as phloroglucinol, protocatechuic
acid etc [189]. These small fragmented molecules though not quantifiable at the same
wavelength as quercetin have some potential towards free radical scavenging which
could be contributing towards ABTS radical consumption in the TEAC assay [190].
Hence, even the fragmented degradation products contributed to the total antioxidant
potential of the system over time.
As a pharmaceutically active compound, quercetin like any other therapeutic compound
has a window of safety with TC50 value of 0.23 mM or ~ 70 μg/ml (Fig 4.10 (a)). When
loaded into a drug carrier system, it is important to investigate the potential toxicity of
the carrier system along with the loaded drug. As literature for PβAE systems indicates
low relative toxicity in vitro and in vivo, it is expected that quercetin PβAE nanogels
would have a similar safety window as for pure quercetin with no added effect due to
the polymer backbone. This was confirmed with the dose dependent cytotoxicity study
of all the QNG systems and when compared with quercetin, QNGs toxicity patterns the
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cytotoxic profile of quercetin directly confirming once again the viable nature of PβAE
nanogel by itself (Figure 4.10 (a) and (b)). These nanogels were further evaluated for
their ability to suppress oxidative stress due to external injury induced using 0.5 mM
H2O2 exposure. They not only showed ROS scavenging capacity against H2O2 induced
injury as good as pure quercetin at equivalent quercetin loading of 5 µg/ml, but the
treatments done with QNGs having 10 µg/ml of equivalent quercetin loading showed
enhanced protection against oxidative stress as compared to nascent quercetin after 48
hours probably due to prolonged supply of active quercetin during nanogel degradation.
This was verified by both viability and DCF fluorescence studies showing superior
properties of QNGs than pure quercetin even though present in same quantities (Figure
4.11 and 4.12). Therefore, with the ability to suppress oxidative stress in vitro, slow
uniform release, and longer circulation efficacy; these nanogels can serve as an
effective delivery system a therapeutically potential yet fragile antioxidant, quercetin,
which shows very low bioavailability in vivo otherwise.
4.5

Conclusions

Nanogels were synthesized using a novel but simple single-phase reaction-precipitation
system with control over the size through varying feed reactant concentrations. These
nanogels were able to be PEGylated post-synthesis through a secondary Michael
addition reaction with available amines on the nanogel surface, resulting in decreased
opsonization. The PΒAE chemistry to chemically conjugate quercetin protects
quercetin from losing antioxidant activity until the polymer degrades and releases the
quercetin. To the best of our knowledge, these nanogel systems when compared with
other nanocarriers have the highest reported quercetin drug loading. The uniform,
prolonged release of quercetin from QNGs due to hydrolytic cleavage showing
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equivalent antioxidant activity as pure quercetin potentially shows protection against
induced oxidative stress for as long as 48 hours.
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5

CURCUMIN CONJUGATED POLY (Β- AMINO ESTERS)
NANOGELS AND SUSTAINED SUPPRESSION OF
MITOCHONDRIAL OXIDATIVE STRESS

Based on the research to be published in:
Prachi Gupta, Mihail Mitov, J. Zach Hilt, Thomas D. Dziubla. Sustained
Suppression of Mitochondrial Oxidative Stress using Curcumin conjugated Poly (βAmino Esters) Nanogels (submitted)
Abstract
Mitochondria are considered to be the “power plant” of the cell, but can also initiate
and execute cell death, stimulated by oxidative stress (OS). OS induced mitochondrial
dysfunction is characterized by a loss in oxygen consumption and reduced ATP
production. Curcumin, with potential therapeutics and interventions, has been explored
as a potential candidate for mitochondrial OS suppression, but rapid metabolism and
aqueous insolubility prevent it from being an effective therapeutic. Further, effective
delivery of curcumin via incorporation into nanocarrier formulation has again been
limited due to low drug loading capacities and/or significant burst release effects
resulting in cytotoxicity. Hence, to increase therapeutic opportunities and ease toxic
effects of curcumin, self-precipitated curcumin conjugated poly(β-amino ester)
nanogels (CNGs) were synthesized using the Michael addition chemistry. With easy
control over the nanogel size, CNGs showed a uniform release of active curcumin over
48 hours with no burst release. This uniformly releasing system significantly increased
the safety limit for curcumin as a treatment drug (10xfree curcumin). Further, real-time
mitochondrial response analysis with Seahorse XF96 showed effective and prolonged
suppression of H2O2 induced mitochondrial oxidative stress upon pre-treating
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endothelial cells with CNGs and this potential of nanogels was studied at different pretreatment times prior to H2O2 exposure.
5.1

Introduction

Given its ubiquity in a number of disease states, oxidative stress (OS) and its consequent
effects are extensively researched topics in biological and pharmaceutical disciplines.
Its cascading effects are seen in diabetes, cancers, neurological disorders, cardiac
disorders and many more [191-193]. OS occurs when the natural balance of oxidants
and antioxidants is disturbed, leading to excess production of free radicals such as
reactive oxygen species (ROS) and reactive nitrogen species (RNS). Higher levels of
ROS and RNS lead to cellular damage by lipid peroxidation, protein carbonylation,
DNA damage, etc. [194, 195]. Mitochondrion, the central system for energy production
pathways and metabolism in most cells, is also a key organelle for ROS generation
[196, 197]. Interestingly, mitochondria are not just a key generating source of free
radicals but also a sensitive target to ROS and RNS damage [198]. Mitochondrion is
believed to be specifically affected by lipid peroxidation, leading to the generation of
hydrogen peroxide and superoxide radicals and hence resulting in additional ROS
production [199]. This cycle cascades in a feed forward fashion leading to cell necrosis
and apoptosis [199, 200]. Therefore, it is believed that when a cell is exposed to any
free radical or ROS, the mitochondria are the first one of the cellular organelles to be
targeted by ROS. This leads to mitochondrial dysfunction, disturbing the normal
respiration mechanism and loss in ATP production before finally losing a major energy
pathway of the cells. Mitochondrial protein, lipids and DNA (mtDNA) are considered
the primary target of ROS. As a result, mitochondrial oxidative stress (Mito OS)
becomes the indirect cause of many diseases, primarily neurogenerative disorders such
as Alzheimer’s and Parkinson’s disease, numerous metabolic disturbances,
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cardiomyopathies and metabolic complexities in patients suffering from diabetes
mellitus [1, 201-205].
Because mitochondrion becomes the generation source of more ROS, it is
important to control the damage to mitochondrial structure and function when the cells
encounter increased ROS/RNS. One potential solution to prevent mito OS is to reduce
excess ROS production in mitochondria by effectively supplementing with
antioxidants. Most attempts to accomplish this have failed in vivo due to the nonspecific delivery of antioxidants to mitochondria below therapeutic limits as well as in
vivo molecular instability issues with most of the antioxidants. Among the
molecules/compounds studied, curcumin has shown protective effects, including a
cytoprotective effect against aluminum induced neurogenerative disorders [206],
maleate induced oxidative stress [207], and preventing mitochondrial OS in high fat
diet induced obese mice [208]. Despite these promising findings in animal models, most
clinical studies performed with high and frequent oral doses up to 4 g/day for 48 weeks,
specifically for Alzheimer’s, have failed to show clinically significant improvement in
reducing symptoms for the disease [209]. Among limitations for curcumin, poor
aqueous solubility, and extremely low bioavailability are most significant because pure
curcumin has shown to be below detectable serum concentrations within a few minutes
of administration [210]. Attempts have been made to incorporate curcumin into any
viable polymeric or similar nanocarriers with the aim for higher curcumin loading,
sustained release characteristics and ability to perform its antioxidant function with no
cytotoxic effect. Unfortunately, curcumin drug loading capacities of most nanocarriers
have not exceeded more than 4 wt%, resulting in the higher amount of carrier material
but minimal doses of the functional drug [211]. Furthermore, little work has been
pursued using curcumin as a treatment targeted towards stressed endothelial cells for
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cancer and tumor treatment. In our approach to fight OS (specifically mito OS) with CPβAE nanogels, curcumin is chemically conjugated to the polymer backbone, which
upon hydrolytic degradation of the ester bonds releases pure curcumin. Theoretically,
chemical conjugation into the PβAE matrix gives curcumin a structural stability and
prevents deactivation prior to hydrolysis. Uniform drug release over 36-40 hours
resulted in protected functionality of curcumin for a longer period. A higher IC50 value
of more than 100 µg/ml of loaded curcumin in contrast to free curcumin (IC50=5.3
µg/ml) increased the safety window of this potential drug. An increased safety window
gives higher flexibility to work in therapeutic dosage amounts and reach adequate
curcumin levels to treat and or prevent OS. In contrast, free curcumin administered at
therapeutic levels will kill endothelial cells. A mitochondrial stress assay using
Seahorse XF96 analyzer with the ability to monitor real-time mitochondrial
bioenergetics was employed to analyze mitochondrial bioenergetics post induced
oxidative stress and protective effect of C- PβAE nanogels (CNGs) versus free
curcumin. CNGs with higher, yet viable, treatment concentrations (5 µg/ml) were able
to shield against dropping ATP production or basal respiration rates due to hydrogen
peroxide induced mito OS. On the other hand, free curcumin proved to be fatal at these
high treatment concentrations and showed no protection at safe concentrations of 1
µg/ml against mito OS.
5.2 Methods and materials
5.2.1

Reagents

Curcumin was purchased from Chem-impex Int’l ‘Inc, (Wood Dale, IL). 4,7,10
Trioxatridecane-1,13-diamine

(TTD),

acryloyl

chloride,

2,2′-azinobis-(3-

ethylbenzothiazoline-6-sulfonic acid) (ABTS), triethylamine (TEA) and potassium
carbonate were bought from Sigma-Aldrich (St. Louis, MO). Sodium chloride,
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potassium phosphate, sodium phosphate and sodium dodecyl sulfate (SDS) were
purchased from Fisher Scientific (Fair Lawn, NJ). Human Umbilical Vein Endothelial
Cell line (HUVECs), EBM-2 basal medium and its growth factors were purchased from
Lonza, (Walkersville, MD). All solvents were purchased from Pharmco-aaper
(Shelbyville, KY). All media kit and cell culture plates for XF96 Seahorse experiments
were purchased from Seahorse Bioscience (Massachusetts, USA). Calcein AM redorange tracer was bought from Invitrogen (Grand Island, NY).
5.2.2

Curcumin acrylate (CA) synthesis

Acrylation of the curcumin phenolic group was carried out via reaction of curcumin
with acryloyl chloride in the molar ratio of 1:3 with anhydrous THF as the reaction
medium. Triethylamine (TEA) was added in the same molar ratio as acryloyl chloride
to capture byproduct hydrogen chloride by forming a chloride salt with the progression
of the reaction. The reaction was carried out for 15 hours at room temperature in dark
(aluminum foiled). The acrylated product was filtered from the salts formed during the
reaction. The product was further purified via a solvent extraction process to remove
any unreacted monomers then vacuum dried to obtain dry curcumin acrylate product.
Obtained curcumin acrylate was analyzed using HPLC to verify product quality.
5.2.3

Synthesis of curcumin PβAE nanogels (CNGs)

CA solubilized in acetonitrile at known concentrations was reacted with TTD keeping
acrylate to reactive hydrogen amine ratio of 1:1. Curcumin has two phenolic groups
and upon acrylate functionalization should react to form curcumin diacrylate. TTD has
four reactive hydrogen amines. Therefore, for each mole of TTD (molecular weight
220.31 g/mol), two moles of CA (molecular weight~ 476 g/mol) are reacted to get the
required acrylate to reactive hydrogen amine ratio of 1:1. To formulate 1 ml of
curcumin conjugated PβAE nanogels with the starting CA feed concentration of 10
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mg/ml, 2.3 mg of TTD was added and allowed to react for 24 hours. Feed reaction
concentrations of CA were varied from 0.75 to 10 mg/ml, hence the amount of TTD
added to the reaction system was changed accordingly to keep the stoichiometric ratio
constant. After 24 hours and self-precipitation of CA and TTD into C- PβAE nanogels
(CNGs), the suspension was diluted in anhydrous THF with BHT as inhibitor, in a 1:4
ratio v/v (1 ml CNG suspension with 4 ml THF) as a purification step. An hour later,
the system was centrifuged at 6.7 RCF for 20 minutes. The supernatant was removed
and another wash with THF was given to remove any remaining unreacted monomers.
After the second purification step, the centrifuged pellet was re-suspended in 1 ml
acetonitrile via sonication and then freeze-dried overnight to get dry C- PβAE nanogels
(CNGs).
5.2.4

Yield of reaction, nanogel size and morphology characterization

Yield: Yield of the C-PβAE nanoparticle reaction synthesis was determined by
calculating the unreacted CA concentration in the supernatant after nanoparticle
centrifugation. The unreacted CA concentration was determined by analyzing the
degradation supernatants using a Varian Cary 50 UV-Vis spectrophotometer and
quantifying the absorbance at the curcumin characteristic wavelength of 420 nm. The
yield was determined by subtracting the amount of unreacted CA from the starting
amount added. An assumption that CA and TTD reacted in the same ratio was taken
into account while calculating the yield.
Size and morphology: Hydrodynamic radii of the different CNGs formulations were
measured using dynamic light scattering (DLS) after suspending dried nanoparticles in
acetonitrile and setting the measurement parameters according to the solvent used.
CNGs were scanned with electron microscopy to determine their shape and
morphology. To prepare the samples, synthesized nanoparticles were first suspended in
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acetonitrile at a concentration of 100 µg/ml using probe sonication. A drop of 10 µl of
this suspension was put on ODT treated gold substrate and allowed to dry for 2 hours.
The sample was then sputter coated using gold-palladium alloy and images were taken
at various magnifications using S-4300 Hitachi Scanning Electron Microscope.

5.2.5

Hydrolytic degradation of C-PβAE nanogels and the subsequent
curcumin release profile

In order to test the degradation of these nanogels with subsequent release of pure
curcumin upon ester hydrolysis, nanoparticles synthesized with 5 mg/ml as the CA feed
concentration were suspended in PBS buffer containing 0.1% SDS wt/vol (pH 7.4).
SDS was added to the buffer to enhance the solubility of released curcumin or its
oligomeric products for further quantification. The nanogels were suspended in the
buffer at a concentration of 100 µg/ml. At time points 0, 2, 4, 6, 8, 12, 24, 30, 36, 52
and 71 hours, the suspension was centrifuged at 6.7 RCF for 20 minutes and the
supernatant was collected and stored at -20o C for further analysis. The centrifuged
pellet was re-suspended in fresh buffer maintaining appropriate sink condition. A
degradation study was carried out over 72 hours under sink conditions at 37°C. To
determine the release rate of curcumin during hydrolytic degradation of CNGs, UV-Vis
spectrophotometry was used to analyze the curcumin concentration in the collected
supernatants. The absorbance of the supernatants was measured at 420 nm using Varian
Cary 50 Bio UV-Vis spectrophotometer followed by quantification of the amount of
curcumin released using a standard calibration curve.
5.2.6

Antioxidant activity of released curcumin

It was important to assess that the released curcumin from CNGs was still active with
its antioxidant potential intact as its phenolic groups were chemically altered during the
83

nanoparticle synthesis. Therefore, a trolox equivalent antioxidant capacity (TEAC)
assay was performed in order to verify the antioxidant potential or radical scavenging
property of released degradation products. TEAC is a colorimetric assay based on
scavenging of 2, 2’-azinobis-(3- ethylbenzothiazoline-6-sulfonate) radical anions
(ABTS.-) in the presence of an antioxidant. Briefly, 7 mM ABTS radical cation stock
solution was prepared by mixing 1 ml of 8 mg/ml of ABTS solution with 1 ml of 1.32
mg/ml of potassium persulfate solution in DI water overnight. This concentrated ABTS
radical stock solution was diluted in PBS to an absorbance of 0.4 AU at 734 nm to
prepare a working solution after baseline correction. Trolox, with known concentrations
ranging from 0 to 0.27 mM, was used for calibration. The assay was carried out in a 96well plate and 10 µl of the sample was added to each well, followed by 200 µl of ABTS
radical working solution. Five minutes later, absorbance was read at 734 nm using a
Varian Cary 50 Bio UV-Vis spectrophotometer. A trolox calibration curve was used to
determine equivalent trolox concentrations in the supernatant degradation products.
5.2.7

Dose dependent cytotoxicity of C-PβAE nanogels (CNGs) towards
HUVECs

HUVECs were cultured in EBM basal medium (phenol red free) with EBM-2 growth
factors to an 80% confluence in a 96-well plate overnight. Curcumin and CNGs (CA
feed concentration = 5 mg/ml) suspension in media with equivalent curcumin
concentrations ranging from 0 to 70 µg/ml were prepared. Wells containing HUVECs
received and were treated with antioxidant/CNG solution for 24 hours (n=5). After 24
hours, media with antioxidant was removed from the wells, then incubated in 1 mM
calcein AM red-orange live cell tracer. After 1 hour, cells were washed and fresh media
was added to each well. The well-plate was subjected to fluorescence measurement
with 540/590 nm as excitation and emission wavelength, respectively, using BioTek
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Synergy Mx, Gen5 2.0, Winooski, VT to measure dose dependent toxicity of C-PBAE
nanoparticles.
5.2.8

Effect of CNGs exposure on H2O2 induced cellular OS: cell viability
analysis

HUVECs cultured in EBM-2 basal medium were seeded in a 96-well plate and
incubated overnight to achieve 80% confluency with respect to well area. CNGs (CA
feed concentration = 5 mg/ml) at a concentration of 7.5 μg/ml (5 μg/ml equivalent
curcumin loading) were suspended uniformly in EBM-2 basal medium with the aid of
bath sonication. The media from the cells was removed and 200 μl of the CNG
suspension was added to the well of interest. 10 μl of 10 mM H2O2 stock solution
prepared in EBM media was added simultaneously to the CNGs containing to get final
exposure concentration of 0.5mM. A control group of only CNGs and only H2O2
exposed cells was also prepared. To all the wells, 10 μl of DCF-DA prepared in EBM2 media was added to get a final cell exposure concentration of 10 μM. 24 hours later,
DCF fluorescence was read at 490/525 nm as excitation/emission wavelength using
BioTek Synergy Mx, Gen5 2.0, Winooski, VT spectrophotometer. Post fluorescence
measurement, CNGs ± H2O2 solutions were removed and wells were washed with fresh
media, followed by addition of 1 mM Calcein AM red-orange live cell tracer. Cell
viability was measured by following the similar protocol as given in section 2.7

5.2.9

Measurement of mitochondrial OS changes after treatment with C-PβAE
nanogels (CNGs) using XF-96 extracellular flux analyzer.

A Seahorse XF-96 Flux Analyzer (Seahorse Bioscience, North Billerica, MA) was used
to analyze the effect of CNGs on cellular bioenergetics. HUVECs were seeded in a
Seahorse 96-well tissue culture plate at a seeding density of approximately 35,000
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cells/well. Cells were then allowed to adhere and grow for 24 hours. Prior to assay, the
cell growth media was replaced with 175 µL of FX media (FX Assay Modified DMEM
from Seahorse Bioscience with 5.5 mM glucose, 1 mM pyruvate, and 2 mM glutamix).
Wells and cells were washed once, media exchange was completed and then cells were
equilibrated for 60 minutes at 37° C in a non-CO2 incubator. The 96-well plate was then
subjected to Mitochondrial stress assay to analyze mitochondrial energetics and cellular
metabolic profile. The mitochondrial stress assay consisted of subsequent injections of
three mitochondrial inhibitor drugs: oligomycin A (1 µM), which act as ATP synthase
inhibitor; FCCP (1 µM), an uncoupling agent; and a mixture of 1 µM rotenone and 1
µM antimycin A, each used as inhibitors for mitochondrial respiratory chain complex I
and III to shut down the mitochondrial oxygen consumption. Oxygen consumption rates
(OCR) and extracellular acidification rates (ECAR) were measured using measurement
periods of 3 minutes minimum and 3 minutes maximum with drug injection series.
Once OCR/ECAR measurements were completed, the FX media was carefully
removed from all individual wells and replaced with 25uL of cell lysis buffer containing
0.32 mM Sucrose, 2 mM EDTA, 2 mM EGTA, 20 mM HEPES, pH 7.4, containing
protease inhibitors 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5 μg/mL aprotinin, and 0.2
mM PMSF. The plates then put in -20° C freezer overnight to disrupt cells membranes.
The next day, plates were taken out to room temperature and put on an orbital shaker
for an hour. Unknown protein levels (samples) of the wells were measured using the
modified BCA protein assay (Thermo Scientific, Rockford IL). Known amounts of
protein standards (2.5 μg, 5.0 μg, 10 μg etc.) were added in the background wells of the
plate to construct an optical density standard curve. Protein levels were determined after
the optical densities were measured on iMark plate reader (Bio-Rad, Hercules, CA).
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The OCR pmol/min were normalized to protein levels of pmol/min/μg or calculated as
percent change (%OCR) from the third basal measurement for each group.
To analyze the mitochondrial response towards free curcumin and CNGs, a 96-well
plate seeded with 35,000 cells/well was treated with curcumin/CNG (synthesized with
5 mg/ml as feed reactant concentration) at equivalent curcumin concentrations of 1 and
5 µg/ml. After 24 hours of treatment, media was replaced with XF media for 1 hour at
37° C. The plate was then subjected to the mitochondrial stress assay to analyze
mitochondrial energetics and metabolic profile. Metabolic respiration rates were
measured and quantified as OCR (pmol/min) at this step. After analyzing different
concentrations of curcumin and CNGs having the same equivalent curcumin
concentrations for mitochondrial respiration rates, viable concentrations of curcumin (1
µg/ml) and CNGs (5 µg/ml) were used for further analysis of protective effect against
OS. HUVECs in 96-well plates were first pre-treated with curcumin/CNGs at specified
concentrations (1 and 5 µg/ml) for 0, 12 and 24 hours, then followed by the introduction
of 0.25 mM H2O2 for 2 hours. Next, cells were washed and replaced with un-buffered
DMEM media and kept at 37° C for 1 hour, followed by mitochondrial stress assay.

5.2.10 Statistical Analysis
Data for figures 5.1 (A), (B), 6.2 (A) and (C) is presented as mean ± St. Dev., while for
figures 5.3 (A), (C), 6.4 (A), (B), (C) and 6.5 (A), (B) and (C) is presented as mean ±
SEM. The statistically significant differences between the mean values were calculated
using one-way ANOVA test followed by Bon-ferroni post hoc test with the help of
SigmaPlot software. A p value of <0.050 was considered to be representative of the
significant difference between the means under comparison.
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5.3 Results
5.3.1

Curcumin nanogel size, yield and morphology

CA with 2 to 3 acrylate groups was set to react with TTD in acetonitrile under dilute
conditions. Varying the feed concentration of CA and maintaining the total acrylate to
total reactive hydrogen amine ratio resulted in self-precipitated nanogels with variable
hydrodynamic diameter. Upon UV-Vis analysis of the supernatants obtained after
centrifugation, reaction yield was calculated to be 62.7%. Increasing the reactant
concentration resulted in an increase in diameter. As shown in figure 5.1 A,
hydrodynamic diameters of 64 ± 8, 87 ± 3, 131 ± 5, 221 ± 4, 416 ± 31 nm were obtained
for CA feed reactant concentrations of 0.75, 1.25, 2.5, 5, 10 mg/ml respectively. These
will be abbreviated as CNG (0.75), CNG (1.25), CNG (2.5), CNG (5) and CNG (10)
throughout this text.
After the washing and purification step in anhydrous THF, CNG (5) was again analyzed
on DLS giving the hydrodynamic diameter of 210 ± 20, similar to the pre-wash
diameter of the nanogels (Figure 5.1 B). This suggests little to no aggregation and no
morphological change of nanogels post purification steps. The spherical morphology
of the nanogel system was further confirmed after electron microscopy imaging (Figure
5.1 A inset) and an average diameter of 176 ± 26 nm was calculated using Image-J
software.
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Figure 5.1 Hydrodynamic diameter and SEM of precipitated CNGs after 24-hour
reaction of CDA with TTD in acetonitrile
(A) Different CDA feed reactant concentrations. Acrylate to reactive hydrogen amine
ratio was kept constant at 1:1 for all the formulations Inset: SEM image of nanogels
corresponding to 5 mg/ml feed concentration. (B) Hydrodynamic diameter of nanogels
(5 mg/ml feed concentration) pre- and post-wash with THF as a purification step
showing no significant difference at both the stages. N=3, error bars: std. dev.
5.3.2

Degradation, curcumin release and its anti-oxidant activity

Curcumin nanogels (CNG (5)) were suspended in 0.1% SDS-PBS buffer at a
concentration of 100 µg/ml. To dissolve released curcumin, 0.1% SDS wt/vol was
added. Released curcumin in the supernatant was quantified using a UV-Vis analytical
method by recording the absorbance at 420 nm to determine sample concentration and
cumulatively adding the obtained concentrations of each sample with increasing
degradation time to obtain the degradation profile of CNGs. As shown in figure 5.2 A,
90% of the total curcumin release was uniformly distributed over 36 hours, and the
remaining 10% release was spread throughout the next 30 hours. Meanwhile, taking
into account 62.7% wt/wt as the theoretical loading of curcumin to nanogels, 55.58±3%
of the total curcumin loaded was recovered during degradation. This lag in recovered
curcumin could be due to release of oligomeric/monoacrylated products and may be
underestimated in quantification during UV-Vis analysis. HPLC analysis of the
degradation products at characteristic wavelength of 420 nm showed elution of pure
curcumin (peak at 7.9 minutes) as the major product, but also constituted a minute
amount of other products (peaks at 2.9 and 11 minutes) also absorbing at 420 nm
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(Figure 5.2 B). These small peaks could count towards added value to curcumin
estimation but are not fully accurate due to peak shift artifacts commonly observed in
UV-Vis. Carrying out the TEAC assay on the released products supernatants gave an
estimate of releasing curcumin’s antioxidant capacity over 70 hours. All the
instantaneously collected samples were assayed for antioxidant activity and quantified
as mM of equivalent trolox because known concentrations of trolox were used as the
standards. Finally, equivalent trolox amount were cumulatively added with respect to
the degradation time to obtain a uniform increase in the antioxidant activity profile with
time from 0.031 mM at t = 0 to 0.502 mM trolox after 70 hours of incubation. This
implies that at each time point of hydrolytic ester cleavage, released curcumin was
active to scavenge free radicals.

90

Figure 5.2 Degradation of CNGs in PBS buffer with 0.1% SDS (pH=7.4) at 37°C in
a shaker bath.
(A) Curcumin release profile during hydrolytic degradation (B) HPLC chromatogram
of nanogel released products recorded at 420 nm showing elution of pure curcumin
with minor amount of monoacrylate. (C) Equivalent trolox amount of the released
products representing the antioxidant activity analyzed using TEAC assay. N=3, error
bars: std. dev.
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5.3.3

Dose dependent toxicity of CNGs on HUVECs and protection from
oxidative stress
HUVECs were treated with variable concentrations of CNG (5) with equivalent

curcumin concentrations ranging from 0.5 to 70 µg/ml. HUVECs were simultaneously,
yet separately, treated with pure curcumin as a control. After 24 hours treatment, pure
curcumin started showing toxicity towards HUVECs at 5 µg/ml (IC50 = 5.3 µg/ml)
while CNGs were non-toxic up to 20 µg/ml of equivalent curcumin and cells were still
60% viable at a concentration of 70 µg/ml (Figure 5.3 A).

Figure 5.3 Dose dependent cytotoxicity of CNGs towards HUVECs after 24 hours of
treatment and comparison with free curcumin.
(A) Cell viability calculated after carrying out the Calcein AM red-orange live cell
tracer assay (B) Mitochondrial oxygen consumption rate profile of a typical
mitochondrial stress assay conducted using the Seahorse XF96 instrument. (C) Basal
respiration rates of curcumin and CNG (5) represented at pmol/min after the
calculations as depicted in figure 5.3 B. (D) OCR (profile) of the controls and
curcumin/CNG at different curcumin concentrations in response to mitochondrial
stress assay reagents added in a series at selected time points. N=5, error bars: std.
err.
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5.3.4

Protection from cellular oxidative stress

Cell viability for each treatment group was measured keeping non-treated control group
as reference of 100% viability. Only H2O2 treated groups after 24-hour exposure
resulted in 53 ± 3 % viability, while only CNG treated groups showed no significant
change with respect to the control with percent viability of 108 ± 4 (Figure 5.4). With
simultaneous treatment of CNGs with 0.5 mM H2O2 exposure for 24 hours, 71 ± 4 %
viability which is significantly higher than only H2O2 treated groups. In order to get an
estimate of oxidative stress, amount of free radical generation was measured with DCF
fluorescence. Only H2O2 treated groups gave a measured DCF fluorescence of 12250
± 1220, which is significantly higher than non-treated control group with fluorescence
measurement of 8620 ± 1198. Only CNGs treated group did not result in major
difference w.r.t controls with DCF fluorescence of 7913 ± 980. Fluorescence
measurement of CNGs+H2O2 group demonstrated suppression in oxidative stress due
to H2O2 with lower values of DCF values of 8358 ± 1350 as compared to only H2O2
group.
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Figure 5.4 HUVECs cell viability and suppression in DCF fluorescence due to CNGs
(5 mg/ml feed concentration system) with simultaneous treatment of 0.5 mM H2O2.
DCF fluorescence and viability both were measures after 24 hours treatment with CNGs
and H2O2. CNGs with equivalent concentration of 5 µg/ml of loaded curcumin were
administered to the cells. ‘*’ significantly different from rest of the groups, p<0.05.
5.3.5

Protection from mitochondrial oxidative stress

To assess the potential of CNGs toward mitochondrial OS protection and its
comparison with pure curcumin, HUVECs were incubated with both CNGs and
curcumin at two different concentrations for 24 hours. This incubation was followed by
basal respiration rate measurements and a mitochondrial stress test. Basal respiration
rates, ATP-linked respiration, proton leak, maximum respiration and spare respiratory
capacity were calculated from the mitochondrial stress test drug-response OCR values
according to the calculation scheme shown in figure 5.3 B. The curcumin treatment at
1 µg/ml showed nominal OCR of 15.29 ± 0.73 pmol/min which is comparable to the
non-treated controls: 13.7 ± 0.9 but at 5 µg/ml of curcumin exposure, OCR values
dropped down drastically to 2.68 ± 0.35 (Figure 5.3 C). This clearly implies the
mitochondrial dysfunction at curcumin concentrations of 5 µg/ml.
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On the other hand, HUVECs treatment with CNG at 7.97 µg/ml having
equivalent curcumin concentration of 5 µg/ml retained its OCR at 16.6 ± 1.0 pmol/min
and showed no signs of mitochondrial dysfunction or damage to the cells. The overall
response of the curcumin/CNG treated cells in the mitochondrial stress assay can be
seen in figure 5.3 D, where a healthy response similar to non-treated controls was seen
for 1 µg/ml curcumin and CNG (5µg/ml equivalent curcumin loading). Curcumin with
5 µg/ml possessed no positive response towards the mitochondrial stress assay due to
mitochondrial damage at that concentration.
Therefore, all additional studies of mitochondrial oxidative stress protection,
viable concentration i.e. 1 µg/ml for free curcumin and 5 µg/ml of equivalent curcumin
for CNGs were used. To assess and test the prolonged protection of CNGs against
mitochondrial oxidative stress, two standards were set for the design of the experiment:
1) antioxidant treatment concentrations as stated above; and 2) concentration and
exposure time to cells of oxidative stress inducer, H2O2 which is 0.25mM and 2 hours.
This parameter was set so only mitochondrial bioenergetics were disturbed due to
exposure but not the onset of cell necrosis/apoptosis which could result in added
artifacts during OCR recordings. Mitochondrial respiration rate was measured as OCR
(pmol/min) and the bioenergetics parameters are represented as basic OCR (pmol/min)
as well as % OCR (after baseline normalization) to eliminate the effect of any variation
in starting cell density as shown in figures 5.5 and 5.6. Two hours H2O2 exposure by
itself led to a drop in basal respiration, ATP-linked and maximal respiration
respectively to 34.5 ± 3.0%, 21.6 ± 3.6% and 34.8 ± 11.3% OCR from 76.1 ± 6.0%,
60.7 ± 5.7% and 149.6 ± 20.0% of the non-treated controls as shown in Figure 5.6 A,
B and C. Curcumin treatments at 0, 12 and 24 hours prior to H2O2 addition did not aid
in recovery of the OCR, basal respiration or maximal respiration, which were observed
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to be 19.8 ± 10.2%, 25.0 ± 5.7% and 37.0 ± 26.7% respectively. In other words, viable
concentrations of curcumin did not show any effective protection against mitochondrial
OS. On the other hand, CNG (5) showed an enhanced OCR post H2O2 treatment at all
exposure times giving basal OCR: 47.17 ± 3.93, 60.0 ± 2.0, 94.3 ± 10.0 as %OCR,
ATP-linked OCR: 31.2 ± 7.5, 40.0 ± 14, 52.8 ± 5.2 and maximum respiration rates of
336.5 ± 12.5, 198.6 ± 37.3 and 161.7 ± 11.7 respectively for 0, 12 and 24 hours of prior
nanogel treatment.
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Figure 5.5 Mitochondrial function parameters after pre-treatment of curcumin/CNG
for 0, 12 and 24 hours followed by 2-hour exposure of 0.25 mM H2O2.
Cells were subjected to mito stress assay with real-time OCR measurements using
Seahorse XF96 instrument. (A) Basal respiration. (B) ATP-linked to mitochondria. (C)
Maximum respiration. All OCR values are displayed as pmol/min. N=5, error bars:
std. err.
5.3 Discussion
Significant efforts have been made to improve the delivery of mitochondria OS
targeting drugs (e.g., MitoQ) with the help of nanocarriers, for the purpose of
suppressing mitochondrial OS and reducing mitochondrial dysfunction [212, 213].
MitoQ is an ubiquinol moiety linked to a lipophilic triphhenylphosphonium (TPP) by a
ten-carbon alkyl chain. A part of the TPP chain helps in the rapid cellular uptake of the
drug loaded carrier across the cell membrane and further accumulation in mitochondria
[214]. In vivo, MitoQ and its analogs (MitoVitE, MitoPBN) have shown positive results
against Mito OS by inhibiting lipid peroxidation, ROS/RNS generation etc. [215]. TPP
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based targeted antioxidant delivery approaches are most effective in rapid accumulation
of antioxidants within the mitochondria, where the toxicity of the hydrophobic moiety
(TPP) can result in nonspecific mitochondrial dysfunction, resulting in disruption of
membrane integrity, respiration, and ATP production rate. This nonspecificity further
depends on the amount of compound internalized. Therefore, the constraint is the
amount of drug that can be delivered with TTP based nanocarrier so as to reach
therapeutic levels before reaching disruptive concentrations [202, 216, 217]. Also, the
ubiquinol based approaches may increase protection against peroxynitrite and
superoxide radicals, but their efficacy has been reported to be small to negligible for
one of the most significant oxidants (hydrogen peroxide H2O2) in cellular physiology
[218].
As an alternative, a number of studies have demonstrated the protective effect
of curcumin towards mitochondrial dysfunction and mitochondrial OS [219, 220]. Most
research has concentrated on neurodegenerative diseases and finding new therapeutics
for Alzheimer’s [221, 222]. Curcumin has been shown to inhibit the depolarization of
mitochondrial membrane potential as well as decreasing the levels of the pathological
marker for the Alzheimer’s disease amyloid-β [223, 224]. Similar results were observed
in aluminum induced mitochondrial dysfunction studies, malate induced OS commonly
known as nephropathy etc. [206] [225]. These positive results and outcomes from such
approaches are reported only from in vitro models, but there is very little evidence of
positive results in vivo. Faster in vivo metabolism and the inability of curcumin to reach
therapeutic concentration in the targeted micro-locations may be the cause of success
in vivo rather than in vitro.
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Figure 5.6 Mitochondrial function parameters presented as % OCR post total protein
content normalization.
Pre-treatment of curcumin/CNG (5) for 0, 12 and 24 hours followed by 2-hour
exposure of 0.25mM H2O2, subsequently subjected to mitochondrial stress assay with
real-time OCR measurements using Seahorse CF96 instrument. (A) Basal respiration.
(B) ATP-linked to mitochondria. (C) Maximum respiration. All OCR values are
calculated as pmol/min. N=5, error bar: std. err.
Using synthesized PβAE conjugated curcumin nanogels, our aim was to improve the
delivery of curcumin in its active and stable form at therapeutic, yet non-toxic
concentration, with enough time to treat the site of action before being metabolized.
With a mere change in monomer concentrations keeping the molar ratio constant, the
nanogel diameter could be varied from 50 to 250 nm, and the spherical nature was
confirmed by scanning electron microscopy (Figure 5.1 A). As no other competing
monomer in front of curcumin acrylate was present to react with the tetra-functional
amine (TTD), we expect the theoretical starting monomer composition of nanogel
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reaction to be the final composition of synthesized nanogel, which when calculated
gives 62.8% curcumin loading by mass. To our knowledge, this was the highest
curcumin loading ever reported in nanocarriers.
These nanogels were synthesized by functionalizing the alcoholic group of
curcumin into an acrylate conjugated into cross-linked PβAEs. At this point, hydrolysis
released curcumin in its original structural form (Figure 5.2 B). This functionalization
and conjugation step permits the structural stability of curcumin and prevents it from
metabolized until released, potentially solving one of the in vivo limitations. Adding to
the stability advantage, slow and uniform degradation of CNGs avoids the occurrence
of any burst release, even at initial time points as shown in Figure 5.2 A (15% of the
total released in first 10 hours or 28% release in first 20 hours). This is an important
point to consider because burst release from drug carriers or high bolus doses of free
curcumin start a pro-oxidant effect and, rather than act as a treatment drug, can be toxic
in vitro to healthy tissues/endothelial cells. The uniform release profile of curcumin
during degradation also helped increase the safety limit for curcumin treatment, giving
IC50 values of more than 100 µg/ml as compared to free curcumin with IC50 values of
5.3 µg/ml, observed after 24 hours of treatment with HUVECs (Figure 5.3 A). This
would provide an option to treat an injury at higher and more effective dosage levels.
Antioxidant potential of these nanogels with respect to time during degradation
was initially analyzed by carrying out the TEAC antioxidant activity assay on all
degradation samples. The cumulative increase in equivalent trolox content over time
confirmed the protection of curcumin from losing its antioxidant activity in aqueous
media until hydrolyzed from the polymer matrix (Figure 5.2 C). In other words, the
functionality of the drug was kept intact until released.
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Mitochondrial functional levels confirmed lower dose dependent cytotoxicity
compared to free curcumin and prolonged active antioxidant release of CNGs. Seahorse
XF96 analyzer recorded real time mitochondrial OCR in response to the treatments
and/or mitochondrial stress assays specifically developed to determine basal respiration
rates, ATP production, spare respiratory capacity, and maximal respiration. The dose
dependent response post 24-hour treatment with 1 and 5 µg/ml of equivalent curcumin
in CNGs showed no negative impact on OCR levels at either concentration. However,
mitochondrial function/OCR was completely shut down with free curcumin at 5 µg/ml
while 1 µg/ml was observed to be a safe concentration for mitochondria (Figure 5.3 C
and Figure 5.3 D). These results comply with the cell viability assay (50% cell death at
5 µg/ml) but show a more acute response, thus providing an opportunity to analyze our
material at more sensitive levels. With this understanding, non-fatal curcumin and
curcumin nanogel concentrations, 1 and 5 µg/ml respectively (Figure 5.3 C and 5.4 D),
were used to specifically observe any change in mitochondrial function upon induced
OS injury without causing cell death.
We used H2O2 for mitochondrial OS insult because H2O2 is believed to induce
mitochondrial dysfunction via sudden increase of ROS inside the mitochondria. This
activity results in OS initiating cell necrosis and apoptotic processes. For the Seahorse
XF96 studies, concentration and exposure time of H2O2 were selected to affect
mitochondrial function without reaching the cells’ necrotic or apoptotic state. This
allowed mitochondrial respiration and energy production potential to be monitored with
no cell death effects. H2O2 concentration of 0.25 mM with 2-hour exposure was enough
to show a decrease in ATP production (% OCR) from 60.8 ± 5.7 to 21.6 ± 3.6, drop
down of mitochondrial respiration from 76.0 ± 6.0 to 34.5 ± 3.0 (Figure 5.6 A and B).
Oligomycin, FCCP and antimycinA/rotenone were used as the titrant substrates
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(mitochondrial stress test assay) to analyze the functional state of the mitochondria post
H2O2 ± CNG/curcumin treatment. Interestingly, upon pre-treating the cells with CNGs
(5 µg/ml) or curcumin (1 µg/ml) for 0, 12, 24 hours before the 2-hour exposure to 0.25
mM H2O2, curcumin nanogels were able to retain and maintain the basal respiration
rates, leveling to non-treated controls. Also, ATP-linked and maximum respiration
analyzed after running stress assays for all treatment time scales was also higher than
the H2O2 injury control group. In contrast, groups with 0, 12 and 24 hours of curcumin
pre-treatment did not help the mitochondrion maintain basal respiration, ATP-linked
production rates or maximum respiration rates, but were similarly low compared to
H2O2 treated groups at those treatment times. As seen in Figures 5.4 and 5.5 A, B and
C, mitochondrial bioenergetics worsened in curcumin groups simultaneously treated
with H2O2 (t = 0), relapsing to H2O2 levels pretreatment time increased. A synergistic
effect of curcumin and H2O2, where the pro-oxidant effect might have increased in the
presence of another oxidant, may explain this. At t=0, when curcumin is at 20%
concentration of its IC50 concentration i.e., 1 µg/ml along with H2O2 starts showing the
pro-oxidant effect which decreases as curcumin active content starts reducing down
with time due to curcumin molecular degradation and by 24 hour, cells would encounter
the instant effect of H2O2 only. All this suggests that CNGs are benign to both the
mitochondrion as a PβAE polymer matrix by itself and at a higher equivalent curcumin
loading. This is due to the slow, steady curcumin release property of CNGs. Prolonged
protection from Mito OS for at least 24 hours confirms the release of active curcumin
when compared to no therapeutic effects shown by free curcumin. Therefore, a
continuous supply of active antioxidant at therapeutically effective yet non-fatal
concentrations would be capable of scavenging excess free radicals and suppressing
mitochondrial oxidative stress and cell apoptosis.
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5.4

Conclusion

Curcumin conjugated PβAE nanogels (CNGs) were synthesized, resulting in a slow and
steady release of active curcumin molecule and an increased limit for the safe
concentration of the drug. This work demonstrates the importance of delivery and
controlled release upon the functional impact of biologically unstable compounds such
as polyphenolic antioxidants. These spherical nanogels effectively suppressed
mitochondrial OS over a 24 hour period, which was confirmed by real-time
mitochondrial respiration state using Seahorse XF96 analyzer.
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6

PROTECTION FROM COPLANAR AND NON-PLANAR PCBS INDUCED
TOXICITY USING CURCUMIN CONJUGATED PβAE NANOGELS

Abstract
Curcumin-PβAE nanogels (CNGs) were analyzed for their therapeutic potential against
PCB induced toxicity/oxidative stress. Extensive studies conducted by the
Environmental Protection Agency (EPA) with these chlorinated aromatic compounds
have shown clear evidence of their carcinogenic and toxic effects on the immune
system, reproductive and also nervous system to count a few. As such PCBs falls into
two categories, coplanar and non-coplanar congeners and induce immunotoxicity
through activation of different cellular receptors. The protective effect of slow
curcumin releasing CNGs was analyzed against both coplanar (PCB 126) and noncoplanar PCBs (PCB 153). Since, mitochondria are a more sensitive marker to such
environmental toxicant exposure, real time mitochondrial bioenergetics were analyzed
in response to PCB ± CNGs exposure. A dose dependent effect of both PCB 126 and
153 was observed after 24-hour exposure with compromised mitochondrial function as
well as overall cellular toxicity in endothelial cells. It was also observed that PCB 153
induced higher toxicity to endothelial cells than PCB 126. As a potential treatment
strategy, prior treatment with curcumin-PβAE nanogels before PCB exposure resulted
in the restoration of mitochondrial bioenergetics and cell viability. This protective
response with curcumin-PβAE nanogels was seen with both PCB 126 and PCB153.
These results indicate that in spite of having different mechanisms for inducing toxicity,
oxidative stress plays an important role in both manifestations and progression of the
adverse effects. The fact that slow curcumin releasing CNGs protected cellular and
mitochondrial function from PCB induced oxidative stress makes them a more versatile
approach for PCB remediation.
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6.1 Introduction
Concern about environmentally persistent polychlorinated biphenyls (PCBs) mediated
chronic health effects is continuously increasing over the years [226]. A number of case
studies have shown that prolonged exposure to these chlorinated aromatic compounds
can result in the development of symptoms related to cancer and neurotoxicity [227229]. Owing to these discoveries, PCB usage in industries was banned since 1976. But
significant quantities of these compounds persist in soil, water, sea animals and in the
human population as well [230, 231]. One of the underlying mechanisms for the PCB
induced metabolic toxicity is thought to be oxidative stress, which is increased
production of reactive oxygen species (ROS) than required for normal metabolic
activity [232]. The continuous increased production of ROS can lead to cellular and
mitochondrial membrane dysfunction, DNA damage, and disruption of membrane
potentials leading to uncontrolled transfer of cytosolic nutrients and other components,
resulting in total cell disruption, apoptosis and unwanted mutations [233]. Coplanar
PCBs such as PCB 126 are thought to exert cellular toxicity via activation of aryl
hydrocarbon receptor (AhR) followed by uncoupling of cytochrome P450 1A1
(CYP1A1), a potential reason for increased ROS production [234, 235]. On the other
hand, exposure to non-coplanar PCBs activates the nuclear receptor proteins: PXR and
CAR. Continuous activation of these proteins can lead to cellular toxicity and other
adverse effects leading to unwanted mutations [236]. Studies have also shown evidence
of increase in mitochondrial superoxide (O.−
2 ) in MCF-10A and RWPE-1 epithelial cells

post PCB 153 exposure. This again proves the increased ROS production and also
mitochondrial dysfunction during the exposure time [237]. PCB 77, 126 and even 153
post 6-hour exposure also induced oxidative stress in endothelial cells specifically,
human umbilical vein endothelial cells (HUVECs). Because of the oxidative stress
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involvement with PCB induced toxicity, antioxidants like resveratrol, quercetin, Nacetyl cysteine, catalase, and epigallocatechin-3-gallate (EGCG) have shown potential
to suppress oxidative stress and hence PCB induced inflammation when cells were preexposed to these antioxidants before PCB administration [238-240]. An in vivo study
performed with continuous supplements of green tea extract to mice during PCB 126
exposure showed a significant decrease in oxidative stress markers after 12 weeks of
exposure as compared to non-green tea extract control [241]. These findings suggest
that metabolic PCB toxicity includes the incidence of oxidative stress significantly
where increased mitochondrial ROS or mitochondrial oxidative stress (mito OS) plays
an important part and that antioxidant supplementation can serve as a remedy treatment
to the exposed subjects by suppressing oxidative stress. To further explore this PCB
response in HUVECs, we studied the effect of coplanar PCB 126 and non-coplanar 153
on overall cellular viability post 24-hour exposure to both kinds of PCBs and more
importantly real time mitochondrial bioenergetics such as ATP production, maximal
respiration rate. Response of human umbilical vein endothelial cells (HUVECs) was
analyzed. Both of these studies showed a dose dependent decrease in viability and
mitochondrial bioenergetics upon PCB administration. Also, pre-exposure of slow
curcumin releasing curcumin-PβAE nanogels (CNGs) showed significant recovery in
cell viability as well as mitochondrial respiration upon 12 and 24-hour prior treatment,
demonstrating the anti-inflammatory properties against PCBs (both coplanar and noncoplanar) for a long period of time.
6.2 Materials and methods
6.2.1

Reagents

Curcumin was purchased from Chem-impex Int’l ‘Inc, (Wood Dale, IL). 4, 7, 10Trioxatridecane-1, 13-diamine (TTD), acryloyl chloride, triethylamine (TEA) and
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potassium carbonate were bought from Sigma-Aldrich (St. Louis, MO). Sodium
chloride, potassium phosphate, sodium phosphate and sodium dodecyl sulfate (SDS)
were purchased from Fisher Scientific (Fair Lawn, NJ). Human Umbilical Vein
Endothelial Cell line (HUVECs), EBM-2 basal medium and its growth factors were
purchased from Lona, (Walkersville, MD). All solvents were purchased from Pharmcoaaper (Shelbyville, KY) and were used as received unless specified. All media kit and
cell culture plates for XF96 Seahorse experiments were purchased from Seahorse
Bioscience (Massachusetts, USA). Calcein AM red-orange tracer was bought from
Invitrogen (Grand Island, NY). PCB 126 and PCB 153 were bought from Accustandard.
6.2.2

CA monomer and curcumin PβAE nanogels synthesis

Curcumin acrylate monomer was synthesized by reaction of curcumin with acryloyl
chloride at room temperature for 15 hours in the dark. The protocol for the reaction and
purification was adopted as described in section 5.2.2 To synthesize curcumin PβAE
nanogels, dried monomer product (CA) was dissolved in anhydrous acetonitrile at a
concentration of 5 mg/ml. A stock solution of TTD in acetonitrile at a concentration of
1 g/ml was prepared and 11.5 µl (11.5 µg TTD), was added to 10 ml of CA solution.
The system was allowed to react and precipitate into self-stabilized nanogels for 15-16
hours in the dark. The nanogel suspension in acetonitrile was purified by diluting the
suspension in anhydrous THF in the ratio of 1:4. After 2 washes, nanogels were
suspended again in acetonitrile, centrifuged and the pellet was freeze-dried overnight
to obtain dried nanogels.
6.2.3

In vitro PCB toxicity

In vitro cytotoxicity of PCB 126 and 153 on HUVECs was analyzed at three different
concentrations after 24-hour exposure. HUVECs were seeded in a 96-well plate to
about 80% confluency before the PCB administration. A 10 mM stock solution of both
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the congeners (PCB 126 and PCB 153) was prepared in DMSO followed by dilution in
EBM-2 media to a concentration of 15, 30 and 50 µM. Cells in each defined group were
treated with 200 µl of PCB 126 and 153 solutions at the given concentration for 24
hours. After the treatment, incubation media was removed and all the wells were
washed with fresh media followed by addition of 200 µl of 1 µM Calcein AM redorange live cell tracer. After 1 hour of incubation with live cell tracer, media was
removed from each well and fresh media was added. Fluorescence for the plate was
read with excitation/emission wavelengths of 540/590 nm using BioTek Synergy Mx,
Gen5 2.0, Winooski, VT fluorescence spectrophotometer to determine the viability of
the cells post PCB exposure.
6.2.4

Effect of CNG treatment on PCB induced toxicity

Protection from PCB induced toxicity or cell death with the help of CNG was also
analyzed after different antioxidant pre-exposure times. HUVECs were pre-treated with
10 µg/ml of CNGs for 0, 12 and 24 hour followed by 24-hour exposure to 50 µM PCB
126 or 153. Cells were subjected to Calcein AM red-orange fluorescence assay post
exposure to analyze the cell death due to PCB ± CNG after different pre-treatment
times.
6.2.5 Measurement of real-time mitochondrial bioenergetics due to PCB
exposure, with and without CNG
Seahorse XF-96 Flux Analyzer (Seahorse Bioscience, North Billerica, MA) was used
to monitor real-time respiration rates of mitochondrion after PCB 126 and 153 exposure
for 24 hours and also any protective effect due to CNG treatment. By measuring oxygen
consumption rates (OCR) and extracellular acidification rates (ECAR) with time,
various mitochondrion respiratory parameters of treated cells were analyzed including
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basal respiration, ATP production rate, maximum respiration rates and spare respiratory
capacity using mitochondrial stress assay.
To carry out the experiment, HUVECs were 1st seeded in a Seahorse 96-well tissue
culture plate at a seeding density of 35000 cells/well. Cells were allowed to adhere
overnight, after which different combinations of PCB ± CNGs treatment were given.
6.2.5.1 Effect of PCB exposure on HUVECs
As a first step, HUVECs were treated with 15, 30 and 50 μM of PCB 126 or 153 for 24
hours, after which cells were subjected to the mitochondrial stress assay. Prior to the
assay, cells were washed and the medium was replaced with 175 μL of FX media (FX
Assay Modified DMEM from Seahorse Bioscience with 5.5 mM Glucose, 1 mM
Pyruvate, and 2 mM Glutamix). Cells were incubated at 37° C in CO2 free incubator
after which the cells were subjected to the stress assay. The mitochondrial stress assay
consists of series of injections of inhibitor drugs: (A) Oligomycin A (1 µM), which act
as ATP synthase inhibitor; (B) FCCP (1 µM), an uncoupling agent; and (C) a mixture
of 1 µM Rotenone and 1 µM Antimycin A, each used as inhibitors for mitochondrial
respiratory chain complex I and III to shut down the mitochondrial oxygen
consumption. OCR and ECAR were measured for 3 minutes with 3 minutes interval
cycles. The inhibitor drugs were injected in series of A, B and C after the 3rd cycle of
the previous one.
After the measurement was completed, the protein content in each sample was
determined using BCA assay (Thermo Scientific, Rockford IL). Therefore, post stress
assay, media was removed from all the wells and replaced with 25 µL of cell lysis buffer
containing 0.32 mM Sucrose, 2 mM EDTA, 2 mM EGTA, 20 mM HEPES, pH 7.4,
containing protease inhibitors 4 μg/mL leupeptin, 4 μg/mL pepstatin, 5 μg/mL
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aprotinin, and 0.2 mM PMSF and plates were stored in -20o C overnight to lyse the cell
membrane.
Plates were taken out the next day and thawed to room temperature and put on an orbital
shaker for an hour. Known amounts of protein standards (2.5 μg, 5.0 μg, 10 μg etc.)
were added in the background wells of the plate to construct an optical density standard
curve. Unknown protein levels of the samples were determined by measuring optical
density using an iMark plate reader (Bio-Rad, Hercules, CA). Finally, the obtained
OCR values as pmol/min were normalized to protein levels as pmol/min/μg and finally
calculated as percent change (%OCR) from the third basal measurement for each group.
6.2.5.2 Analysis of protective effect of CNGs against PCB induced mitochondrial
toxicity
To analyze the protective effect of CNGs against PCB-induced cytotoxicity or cellular
oxidative stress, HUVECs seeded at a density of 35000 cells/well were first preincubated with 5 μg/ml of CNGs suspended in EBM-2 media for 12 and 24 hours.
Media from the well plates was removed and a solution of PCB 126 or PCB 153
prepared in EBM-2 media at a concentration of 30 μM was added to the pre-treated
cells for 24 hours. Cells were then subjected to the mitochondrial stress assay. The same
protocol for mito stress assay was followed as discussed in section 6.3.4.1 for just PCB
exposure. Basal respiration, ATP production, maximum respiration and spare
respiratory capacity for each treatment groups were again calculated in terms of percent
OCR after protein normalization. 5 μg/ml concentration of CNG was used after
verifying it to be a viable concentration for mitochondrial bioenergetics, while 30 μM
of PCBs was used in order to disturb the mitochondrial bioenergetics but not shut down
down the cellular metabolism completely.
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6.3

Results

6.3.1

Measurement of cell toxicity after 24 hour PCB 126 and 153 exposure

6.3.1.1 Cell viability
After 24-hour exposure of PCB 126 or 153 to HUVECs, dose dependent toxicity was
observed for both PCB congeners. Cell viability of PCB 126 exposure at 15, 30 and 50
μM was calculated to be 93 ± 4.7, 89 ± 2.5 and 79.8 ± 5 % of non-treated controls
respectively (Figure 6.1). On the other hand, PCB 153 was found to show higher
toxicity than PCB 126 at the same concentrations and cell viability post exposure was
found to be 97.9 ± 2.5, 74.4 ± 0.6 and 45.6 ± 4.5 % of non-treated controls for 15, 30
and 50 μM respectively (Figure 6.1).

Figure 6.1 HUVECs viability after 24-hour PCB 126 and 153 exposures.
Cell Viability was determined using Calcein AM red-orange live cell tracer. Dose
dependent exposure showed a decrease in viability with an increase in PCB
concentrations. N=5, error bars: std. dev.
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6.3.1.2 Mitochondrial bioenergetics
A more acute response on mitochondrial bioenergetics was observed at 30 and 50 μM
after 24-hour exposure with basal respiration, ATP production rates, maximum
respiration and spare respiratory capacity as well, when compared with cell viability at
similar exposure concentrations. Here also, PCB 153 showed more acute response than
PCB 126 at same concentrations (Figure 6.3). While basal respiration rates for PCB
126 as percent OCR were 76 ± 5, 53 ± 6 and 60 ± 5 after 24-hour exposure of 15, 30
and 50 μM respectively, PCB 153 exposure under similar conditions resulted in an
intense response of 74 ± 3, 49 ± 7 and 0 % OCR at given increasing concentrations
(Figure 6.3). These OCR values for 30 and 50 μM were found to be significantly lower
than the non-treatment control with basal respiration of 78 ± 5. In the case of ATPlinked with mitochondrial respiration, % OCR of 47 ± 7, 40 ± 3 and 28 ± 3 for PCB
126; for PCB 153, 59 ± 4, 15 ± 12 and 0 was calculated after 15, 30 and 50 μM exposure
respectively (Figure 6.3). Calculating maximum respiration gave the value of 183 ± 6,
145 ± 6 and 161 ± 3 for PCB 126; 179 ± 10, 82 ± 38 and 0 for PCB 153 with increasing
concentrations mentioned above (Figure 6.3). Spare respiratory capacity was also
calculated as % OCR 116 ± 10, 77 ± 12 and 78 ± 6 for PCB126; 104 ± 10, 53 ± 21 and
0 for PCB153 at increasing concentrations of 15, 30 and 50 μM respectively (Figure
6.3).
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Figure 6.2 Mitochondrial oxygen consumption rate profile observed during
mitochondrial stress assay.
All the bioenergetics shown in figure 6.3 and 6.5 were calculated according to the
schematic shown in this figure.

Figure 6.3 Mitochondrial bioenergetics parameters of HUVECs after 24-hour
exposure to variable concentrations of PCB 126 or PCB 153.
The cells were subjected to the mito stress assay measuring real-time OCR values using
Seahorse XF96 instrument. All the parameters after the assay were calculated in
accordance with figure 6.2. N=5, error bars: std. err.
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6.3.2

Protection from PCB 126 and 153 induced toxicity using CNG

6.3.2.2 Cell viability
A higher concentration of PCBs (i.e. 50 μM) was used in an in vitro cell viability assay
in order to get a significant difference in response with respect to non-treated controls.
As seen in figure 6.4, PCB 126 after 24-hour exposure resulted in 50% cell death while
PCB 153 showed 98% cell death. Increasing cellular viability was observed with
increase in CNG pre-exposure time and with 24-hour pre-exposure, cell viability was
increased to 83 ± 6% for PCB 126 exposed cells and 11 ± 2 for PCB 153 exposed cells.

Figure 6.4 HUVECs viability analyzed after 0, 12 and 24-hour exposure to CNGs
followed by 24-hour exposure to 50 μM PCB 126 or PCB 153.
Viability was determined using Calcein AM red-orange live cell tracer. 24-hour CNGs
pre-exposure significantly increased % live cells post PCB 126 or 153 exposures
showing effective protection against PCB induced toxicity. N = 5, error bars: std. dev.
6.3.2.3 Mitochondrial bioenergetics
To analyze the protective effect of CNG on mitochondrial function due to PCB 126 and
153 exposures, HUVECs were exposed to 5 μM (equivalent curcumin loading) CNGs
for 12 and 24 hours, post which cells were washed and incubated with 30 μM of PCB
for another 24-hour (Figure 6.5). CNGs after both 12 and 24-hour pre-exposure showed
partial restoration of healthy mitochondrial functions for all its bioenergetics properties.
Table 6.1shows the % OCR values for basal respiration, ATP-linked to the
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mitochondrion, maximum respiration rates and spare respiratory capacity for the treated
samples.

Figure 6.5 Mitochondrial bioenergetics of HUVECs after 12 and 24-hour exposure
of CNGs followed by 24-hour exposure to 30 μM PCB 126 or 153.
CNG were washed off the wells prior to PCB incubation. The cells were subjected to
mito stress assay measuring real-time OCR values using Seahorse XF96 instrument.
All the parameters after the assay were calculated in accordance with figure 7.2. N =
5, error bars: std. err.
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Table 6.1 Mitochondrial bioenergetics after PCB ± CNGs exposure to HUVECs as
% OCR after protein normalization.
CNGs pre-exposure for 12 and 24 hours resulted in partial restoration of healthy
mitochondrion function showing the protective effect of CNGs on PCB induced toxicity.
N = 5, error bars: std. err.
- CNGs

Basal
respiration

ATP linked

Maximum
respiration

Spare
respiratory
capacity

CNG pre-exposure
time
Control

+ CNGs
12 h

24 h

71 ± 5

-

80 ± 10
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Figure 6.6 Mechanism of free radical production due to intracellular PCB
metabolism for coplanar PCBs resulting in mitochondrial oxidative stress and finally
cell death.
6.4

Discussion

PCB induced toxicity is not an immediate or acute effect but a long term event of slow
cellular dysfunction that aggravates over time and leads to major metabolic disorder
eventually. This is because it is found at very low concentrations in soil, water, air and
sea animals. The underlying cause for this chronic response is due to development of
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an oxidative stress (OS) condition via different activation pathways. OS is an
imbalanced metabolic redox state in the body with increased oxidants or free radical
species/reactive oxygen species (ROS) concentrations. A simple mechanism is depicted
in figure 6.6, where superoxide anion produced due to enzymatic action 1st results in
mitochondrion OS (most prone sight for increased free radical production), dysfunction
of which ultimately leads to cell death.
To analyze the oxidative damage due to PCB exposure, HUVECs were subjected to
PCB 126 and 153 exposure for 24-hour at variable concentrations, which resulted in
increased toxicity with increasing concentrations (Figure 6.1). A more acute response
was observed at a mitochondrial level as compared to overall cellular function (Figure
6.3). This is because, oxidative stressed induced mitochondrial dysfunction occurs prior
to overall cellular toxicity. Therefore, monitoring mitochondrial bioenergetics served
as a sensitive marker to study the acute response due to these chemical pollutants. Use
of Seahorse Bioscience XF96 further aided the analysis because of its ability to monitor
mitochondrial respiration in real time, a novel and non-invasive strategy for the in vitro
systems.
Further, the loss in mitochondrial function was more severe with PCB 153 (noncoplanar) as compared to PCB 126 (coplanar), where at 50 μM, cells completely lost
its mitochondrion function shutting down the metabolic activities. This is opposite to
few studies in the literature showing more acute toxic effects due to coplanar PCBs
(PCB 77, 126 etc) than non-coplanar ones. A possible explanation to these observations
could be because most studies concentrated on analyzing the response by quantification
of AhR activation, which is well known and induction path for coplanar PCBs but not
for non-coplanar [242] [243]. But there have been other evidence showing toxic nature
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of PCB 153 via nuclear receptor proteins, chronic activation of which can result in
various disease syndrome and has been associated with breast cancer etc [227, 244].
As both the toxicity induction routes involve excess production of ROS, administration
of curcumin through conjugated prodrug PβAE nanogels (CNGs) system served as a
potential solution to prevent oxidative damage. These nanogel formulations are
hydrolytically degradation systems with steady and prolonged drug release kinetics.
Therefore, treating HUVECs with CNGs prior to PCB exposure showed reduced
toxicity as compared to only PCB treated controls (Figure 6.4). The effect was more
pronounced at the mitochondrial level, where partial to full recovery of mitochondrial
bioenergetics (basal respiration, ATP-linked, maximum respiration, spare respiratory
capacity) was seen with CNGs pre-treated groups (Figure 6.5). Also the fact that CNG
administration was able to inhibit mitochondrial as well as cellular toxicity due to both
coplanar and non-coplanar PCBs indicates the presence of oxidative stress in the injury
path, irrespective of the different receptors being activated. Hence, administration of
curcumin via CNGs becomes an adaptable approach to remediate cellular toxicity due
to all kinds of PCBs.
Another possible pathway behind inhibition of PCB induced toxicity would be direct
capturing of PCBs by polyphenolic curcumin via pi-pi bond interactions. This will
inhibit the interaction of chlorinated compounds with cellular components, thereby
reducing the possibility of fatal metabolic response.
6.5

Conclusion

PCB 126 and PCB 153 both showed toxic effects towards HUVECs, compromising
mitochondrial function after 24-hour exposure at variable concentrations. PCB 153
showed more acute response than PCB 126 which complies with a few studies in the
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literature while opposes most of the other studies with toxicity comparisons of coplanar
and non-coplanar. Irrespective of this difference, curcumin conjugated PβAE nanogels
(CNGs) with the slow and steady curcumin release property were able to suppress both
mitochondrial as well as overall cell toxicity. This response is thought to be through
either or a combination of two mechanisms, which includes suppression of oxidative
stress due to antioxidants and capturing of PCBs by curcumin through physical pi-pi
interactions.

122

7

SYNTHESIS AND CHARACTERIZATION OF CURCUMIN PβAE GEL
MICROPARTICLES TO TREAT ORAL MUCOSITIS

Based on the research article to be submitted:
Prachi Gupta, Sandeep Ramineni, J. Zach Hilt, Thomas Dziubla, Joseph Wyse,
Nihar Shah, Curcumin conjugated Poly (β-Amino Esters) gel microparticles to treat
oral mucositis (Biomaterials) (to be submitted)
Note: The information in this chapter is the intellectual property of Bluegrass Advanced
Materials LLC., not be disclosed in public.
Abstract
Oral mucositis (OM) is a very common and serious side effect of anti-cancer radiation
and chemotherapies that manifests as deep and painful mouth ulcers. Oxidative stress
(OS) is one of the key underlying mechanism in the development of OM. Therefore,
curcumin (an antioxidant) has been extensively studied as an antioxidant and antiinflammatory agent towards OS treatment. In the case of OM, it has shown positive
signs towards delaying the onset and also reducing the severity of OM. However, it
requires about 4-5 rinses per day, a total dosage ranging from 1-3 g per day, to stay in
the therapeutic window for treatment. This is because of a combination of fast
metabolism, rapid degradation and poor aqueous solubility of the hydrophobic
antioxidant. In order to improve the bioavailability of this drug in buccal tissues and
improve patient compliance, curcumin was converted into biodegradable curcuminpoly(beta-amino ester) (PβAE) polymer (poly(curcumin)) microparticles. These
poly(curcumin) microparticles provide slow sustained release of the original active
curcumin.

Synthesized via Michael addition, acrylate functionalized curcumin

(curcumin acrylate (CA)), PEGDA (co-monomer), and TTD (primary diamine
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crosslinker) were reacted together into a PβAE polymer film and cryogenically milled
into microparticles in the range of 20-25 μm. Poly(curcumin) formulations were
prepared with different co-monomer molar ratios (CA v/s PEGDA) showed variable
release profiles of active curcumin. Poly(curcumin) microparticles with a molar ratio
of 70:30 CA:PEGDA and RTAAP of 1.0 showed the best combination of drug release
profile and adhesion to buccal tissues. This selected formulation further showed
prolonged protection against H2O2 induced oxidative stress in vitro with normal human
dermal fibroblasts. A preliminary in vivo study in Syrian hamsters induced with OM in
their cheek pouches showed that treatment with poly(curcumin) microparticles reduced
the severity of induced OM, protein carbonyl content, and epithelial layer damage.
7.3

Introduction

Oral mucositis is a pathological condition in patients undergoing cancer treatments
resulting in inflammation of oral mucosa, which manifests as oral ulceration, erythema,
and severe pain. The discomfortness is a long-term and persistent response to patients
undergoing chemo- and/or radiation therapies as anti-cancer treatments [245]. This
response usually occurs after 7-10 days of undergoing anti-cancer treatment, peaks at
about 7-9 weeks after beginning of the therapy and persists for up to 2-10 weeks after
the end of the treatment depending on the patient’s physical conditions and type of
therapy [245, 246]. Though a side effect, this oral pain impacts the food intake of the
patient, leads to oral infections, dehydration, weight loss, sometimes requiring extended
hospitalization and even forcibly stalling the cancer treatment in between. On an
average about 5-15% of the patients undergoing any kind of anti-cancer therapy suffer
from OM. More acutely, 40% of the subjects getting treated with 5-fluorouracil and
about 50% with radiotherapy tend to get OM [247]. The severity increases with patients
suffering from head and neck cancer where 100% of the patients receiving cancer
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treatment suffer from this condition of OM [248]. Therefore, there has been a
continuous need for treatment and prevention of OM. Though the standard care
procedures include the use of palliatives including intravenous narcotic analgesics,
lubrication and analgesic mouth rinses (lidocaine), these have shown poor efficacy and
low patient compliance [249-251]. Palifermin has been the only drug approved by FDA
to be administered to the patients undergoing anti-cancer therapy [252]. Palifermin,
which is keratinocyte growth factor-1 (KGF-1), is thought to inhibit epithelial cell
damage, down-regulating pro-inflammatory cytokines as well as enhancing the growth
rate of epithelial cells during the infectious state [253, 254]. Besides being selectively
effective in patients suffering from hematological malignancies, Palifermin is an
expensive drug with an average cost of about 8000 euros per treatment for a 70 kg
patient over 6 days [255]. Other palliative treatments are also provided to patients, like
Mugard and NeutraSal in the form of oral rinse or gels. These can temporarily soothe
the oral discomfort conditions and provide primarily pain management solutions but
not treatment or curing solutions [256-258]. Practically no single preventive or curative
measure without side effects or limitations yet effective for the diverse population has
been found and approved towards oral mucositis while research still continues to find
the basic cause and solution to the problem.
Studies have shown that the long duration curve of this disease shows some lasting
effects or morphological changes in the tissues apart from the acute toxicity resulting
in instant cell death. The longer effect of OM is thought to be arising via a complex
trajectory of biomolecular, cellular changes leading to epithelial layer damage and subepithelial cells damage associated with upregulation of nuclear factor kappa beta
(NFkB) and interleuken-1 [259, 260]. These phenomena can be considered as a sensor
to oxidative stress (OS) where the physiological environment or the cellular matrix

125

encounters an increased production of free radicals or ROS. The increased ROS
production is a cyclic cascading event resulting in an imbalanced redox state of the cell.
This leads to DNA, cellular membrane damage and finally cell apoptosis and necrosis,
inhibiting epithelial layer proliferation ultimately resulting in ulceration [261]. Hence,
OS is one of the base causes of the initiation and propagation of the OM until the body
comes into its state of fighting OS naturally or by providing enough antioxidants to
restore the redox balance [262].
A few studies have shown that certain drugs/molecules with antioxidant properties like
hyaluronic acid (HA), vitamin E, curcumin and green tea extracts like epicatechin can
control the symptoms of OM. For example, a human trial with Gelclair (0.2% HA
containing gel) showed occurrence of fewer ulcers after day 5 of treatment as compared
to placebo. The underlying mechanism for this response is thought be due to the antiinflammatory nature of HA which upon rinsing coats the oral mucosa, enhances tissue
hydration and helps in decreasing inflammation [263]. Similarly, curcumin, extracted
from the spice turmeric has also been investigated for its antioxidant effect towards
treatment and prevention of OM. In a recent pre-clinical trial with beta-radiated rats,
administration of curcumin via oral gavage showed reduced incidence and severity of
OM due to inhibition of the activation of NF-kB factor [264, 265]. Similarly a recent
human clinical trial with subjects given turmeric mouth rinses showed delayed as well
as reduced intensity of radiation-induced OM at all times during the treatments as
compared to the placebo controls due to the presence of curcuminoid elements in
turmeric. But this treatment required multiple dosage regimes of oral rinsed 4 times a
day every 4 hours to see the effective treatment against OM [266-268]. Curcumin as a
polyphenolic molecule undergoes rapid metabolization and shows low bioavailability
once administered into the physiological environment [269-272]. This quick loss of
126

drug upon administration force the patient to go for multiple dosing frequency in order
to stay in the therapeutic window. This becomes a cumbersome treatment process for
patients already undergoing cancer therapy and can sometimes become a barrier during
chemo or radiation treatments. Therefore, as a proposed solution, in this work we have
aimed at formulating a mucoadhesive system with hydrolytically biodegradable PβAE
poly (curcumin) gel microparticles, These polymer microparticles are tuned to release
curcumin uniformly over 12-16 hours in order to fight and protect against oxidative
stress induced OM during cancer therapies. The prolonged delivery would increase the
efficacy in treating OM and improve the patient compliance in the long run, decreasing
the dosage frequency to as low as once a day. To formulate the curcumin conjugated
PβAE microparticles, phenolic groups of curcumin were 1st functionalized into
acrylates forming curcumin acrylate (CA). CA was then covalently conjugated with
TTD and its co-monomer PEGDA into PβAE gel films via Michael addition reaction.
The advantage of using PΒAE chemistry lies behind (i) its property of getting
hydrolyzed in an aqueous environment (ii) ability to tune polymer degradation based
on the hydrophilic/hydrophobic nature of the monomers and (iii) protection of the
active alcoholic groups of curcumin until released due to ester hydrolysis. Further
synthesized gel films were cryo-ground into microparticles and suspended in a
mucoadhesive solution, which served as a mouth rinse carrier to deliver the
poly(curcumin) microparticles. These micron-sized particles showed tunable
degradation properties by varying the molar ratios between curcumin acrylate and
PEGDA. A continuous and steady release of active curcumin ranging from 12-24 hours
was observed for different PΒAE gel microparticle formulations. The poly(curcumin)
microparticles were observed to be relatively less toxic than free curcumin towards
normal human dermal fibroblasts (NHDF). Also, they did not show any negative or side
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effect when administered to healthy hamsters for 10 days, implying a viable nature of
the system in vivo. Adding to this, these microparticles showed protection against
induced oxidative stress, in vitro for over 36 hours. Suspending the microparticles in a
pre-formulated mucoadhesive solution allowed ease for local delivery of curcumin to
buccal tissues of hamsters. Giving a daily rinse of this suspension over 10 days showed
reduced severity of OM in chemotherapy-induced OM hamsters.
7.4

Materials

All the solvents received were ACS/HPLC grade and were used as received. Other
chemicals were also used as received without any further purification. Curcumin was
purchased from Chem-Impex

International,

Inc, Wood Dale, IL. 4,7,10-

Trioxatridecane-1,13-diamine (TTD) (97% purity), poly(ethylene glycol) diacrylate
(PEGDA, average molecular weight 575), acryloyl chloride (≥97%, ~400 ppm
phenothiazine stabilizer), anhydrous potassium carbonate, magnesium stearate, 2,2′azinobis-(3-ethylbenzothiazoline-6-sulfonic
dihydrodichlorofluorescein

(H2DCFDA),

acid)

(ABTS),

Trolox,

2,4-dinitrophenylhydrazine

2,7-

(DNPH),

trichloroacetic acid (TCA), guanidine hydrochloride, and bovine serum albumin (BSA)
were bought from Sigma-Aldrich, St. Louis, MO. Sodium chloride, potassium
phosphate, sodium dodecyl sulfate (SDS) and potassium thiocyanate was purchased
from Fisher Scientific. Sodium hydroxide was purchased from EMD Millipore,
Billerica, MA. Potassium chloride, potassium phosphate monobasic, sodium phosphate
dibasic heptahydrate, calcium chloride dihydrate, and citric acid were purchased from
Amresco, Solon, OH. Sodium phosphate dibasic dodecahydrate and triethylamine
(TEA) (99%) was purchased from Acros Organics, NJ. Ham’s F-12 media with Lglutamine and without phenol red was purchased from Caisson Laboratories Inc.,
Smithfield, UT. Pen/strep/fungizone as a media supplement was purchased from Lonza,
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Walkersville, MD. Calcein AM red-orange was purchased from Life Technologies,
Carlsbad, CA, All solvents were purchased from Pharmco-Aaper, Shelbyville, KY and
were used in anhydrous form by drying over 4Å molecular sieves. Noveon AA-1 and
Carbomer 971P NF were generously gifted by Lubrizol Corporation, Cleveland, OH.
Eudragrit L100 was gifted by Evonik Industries, Tippecanoe, IN. Porcine buccal
tissues were obtained from Animal Technologies Inc., Tyler, TX.
7.5

Methods

7.5.1

Synthesis of curcumin acrylate

Functionalization of hydroxyl (-OH) groups of curcumin into acrylate esters was done
by reacting curcumin with acryloyl chloride as described in Wattamwar et al [178] with
few process variations. Briefly, acryloyl chloride (19.8 ml, 0.2442 moles) was added
dropwise to a solution of curcumin (30 g, 0.0814 moles) and trimethylamine (TEA,
34.1 ml, 0.2442 moles) in anhydrous tetrahydrofuran (THF), stirring continuously at
300 rpm. The reaction vessel was kept in an ice bath during the addition of acryloyl
chloride in order to dissipate heat generated from the exothermic reaction of acryloyl
chloride with curcumin. After purging the reaction vessel with ultrahigh purity nitrogen,
the reaction was allowed to proceed for about 16-18 hours in dark at room temperature.
The resultant product was vacuum filtered to remove the TEA-Hydrogen chloride salt.
The THF was evaporated under vacuum to obtain a semi-dry orange to a light brown
impure product. The product was re-dissolved in dichloromethane (DCM) and washed
with 3x volume excess of hydrochloric acid (0.1 M in DI water) followed by potassium
carbonate (0.1 M in DI water) to remove excess TEA and acryloyl chloride respectively.
Residual water was removed by adding anhydrous magnesium sulfate to the DCM
solution, which was removed by vacuum filtration at the end. The DCM was evaporated
using vacuum for 16-18 hours to obtain dry, crystalline, orange colored microparticles
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of curcumin acrylate (CA). The CA product was stored desiccated at -20°C until further
use. The CA was characterized using reverse-phase HPLC (Shimadzu Prominence)
with a Phenomenex Luna C18 column (4.6 x 250 mm, 5 µm particles) with 0.1% w/w
phosphoric acid in DI water and acetonitrile as the mobile phase. The products (residual
free curcumin, monoacrylate, diacrylate and triacrylate) were detected at 420 nm using
a UV-Vis detector (SPD-20A) attached to the HPLC.
7.5.2

Synthesis of poly(curcumin) film

Crosslinked poly(curcumin) PβAE films were synthesized via a single-step Michael
addition reaction between curcumin acrylate and the primary diamine crosslinker, 4, 7,
10-Trioxatridecane-1, 13-diamine (TTD). PEGDA was added as a diacrylate comonomer to control the hydrophilicity and hence the degradation characteristics of the
resulting films. Poly(curcumin) films with four different ratios of CA: PEGDA with
respect to number of acrylate groups, 60:40, 70:30, 90:10 and 100:0, were synthesized.
For example, in the 60:40 film, 60% of the acrylate groups were contributed by CA
versus 40% by PEGDA. These films and subsequently their microparticles will be
abbreviated as C60, C70, C90 and C100 respectively. The molecular weight of CA was
taken as 476.47 g/mole which is the molecular weight of its diacrylate form. Finally,
the amount of TTD required to synthesize the films was calculated based on three
different ratios of total acrylate groups to amine protons (RTAAP) of 0.8, 1.0 and 1.2.
As an example, a C60 poly(curcumin) film with RTAAP of 1.0 and target mass of 2 g
was synthesized by dissolving 0.913 g of CA in 1.5 ml of anhydrous methyl ethyl
ketone (MEK). PEGDA (0.735 g) and TTD (0.352 g) were reacted together for 5
minutes in 1.5 ml of MEK separately. After 5 minutes, the CA solution was quickly
added to the reacting PEGDA-TTD solution while gently vortexing the PEGDA-TTD
solution at low rpm. This reacting solution was quickly poured into an aluminum dish,
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covered with foil and allowed to react for 1 hour at room temperature. After 1 hour, the
aluminum dish was incubated at 50° C for another 23 hours, after which the crosslinked
poly(curcumin) film was peeled off from the dish for further processing. A similar
procedure was followed to synthesize C70, C90 and C100 PΒAE films with three
different RTAAP values (0.8, 1.0 and 1.2).
7.5.3

Washing and cryogenic milling of poly(curcumin) Films

7.5.3.2 Extraction of leachables
All freshly synthesized poly(curcumin) films were washed in anhydrous acetone to
leach out any unreacted monomers and un-crosslinked components. Each film was
placed in a 50 ml centrifuge tube, filled with 20 ml of acetone and covered with foil.
The sealed tube was rotated at 25 rpm for 4 hours with the acetone replaced every hour.
Every hour, an aliquot of the acetone containing the leachable from each tube was
stored at -20° C for quantification of the lost curcumin using UV-Vis
spectrophotometry. After washing, the films were lyophilized to remove residual
solvent.
7.5.3.3 Cryogenic milling
The washed and lyophilized poly(curcumin) films were milled into microparticles
under cryogenic conditions using a SPEX SamplePrep 6770 Freezer/Mill. Briefly, a
film was cut into smaller pieces and loaded into the grinding vial assembly along with
1% w/w magnesium stearate (as a glidant). The loaded sample was pre-cooled under
liquid nitrogen for 2 minutes followed by milling for 10 minutes with the stainless steel
impactor moving at a speed of 15 cycles per second. After the milling cycle was
complete, the vial assembly containing the poly(curcumin) microparticles was wrapped
in paper towels and allowed to equilibrate to room temperature for about 1 hour. The
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microparticle sample was then retrieved and the mass noted. The microparticle samples
were stored desiccated at -20° C until further use.
7.5.4

Particle size characterization

The particle size distribution of the poly(curcumin) microparticle formulations was
analyzed using a Shimadzu SALD-7101 UV particle size analyzer operated using
WingSALD software (ver. 1.02, Shimadzu). The refractive index was set to 1.4. The
quartz cuvette was filled with DI water and used to blank calibrate the instrument. Next,
about 2-3 mg of microparticle sample was added to the cuvette, mixed with the provided
L-shaped stirrer and then sonicated for 2 minutes. The sample was measured in the
instrument under stirring. The instrument software automatically provided the mean
particle size and the size distribution for each sample. Each sample was measured in
triplicate.
7.5.5

Poly(curcumin) microparticle degradation and curcumin release

Five milligrams of the poly(curcumin) microparticle sample were suspended in 10 ml
of phosphate buffered saline (PBS, pH 7.4) by bath sonication for 2 minutes. Since
curcumin has poor solubility in water, 0.1% w/w sodium dodecyl sulfate (SDS) was
added to the PBS to ensure complete solubility of the released curcumin. The sample
suspension was incubated at 37° C in a water bath with shaking at 70 rpm. Every 2
hours, the suspension was centrifuged at 5000 rpm for 5 minutes and the supernatant
was withdrawn and stored at -20° C for further analysis. The microparticle pellet was
re-suspended in the same volume of fresh buffer. This step was repeated until 24 hours
or until the poly(curcumin) sample had completely degraded. The collected
supernatants were analyzed using a Varian Cary 50 Bio UV-Vis spectrophotometer
with the absorbance measured at 420 nm (peak absorbance wavelength of curcumin).
A few of the supernatant samples were also analyzed using HPLC to verify the release
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of the original curcumin molecule by comparison with the chromatogram of curcumin
standards.
7.5.6

Antioxidant activity of released curcumin

We utilized the trolox equivalent antioxidant capacity (TEAC) assay to quantify the
antioxidant activity of the curcumin released after degradation of the poly(curcumin)
microparticle formulations [273]. The TEAC assay is a colorimetric assay used to
determine the antioxidant capacity of samples based on the suppression of the
absorbance of 2, 2’-azinobis-(3-ethylbenzothiazoline-6-sulfonate) (ABTS●+) radical
cations by antioxidants. Briefly, a 7 mM ABTS●+ radical solution was prepared by
reacting equal volumes of solutions of ABTS (8 mg/ml) and potassium persulfate (1.32
mg/ml) in DI water for 16-20 hours. The ABTS●+ radical solution was diluted in PBS
to obtain an absorbance not exceeding 0.4 at 734 nm for a 200 µl sample in a 96-well
plate. This diluted solution was used as the working solution for the assay. For the
assay, 10 µl of trolox standard solutions (concentrations ranging from 0-0.225 mM)
prepared in PBS and the degradation samples were added to individual wells of a 96well plate. To these wells, 200 µl of the ABTS●+ working solution was added and
allowed to sit for 5 minutes in dark. After 5 minutes, absorbance was measured at 734
nm. The absorbance of the trolox standards was used to generate a standard calibration
curve, which was used to calculate the equivalent trolox concentration for the
poly(curcumin) degradation samples.
7.5.7

In vitro cytotoxicity assay

Primary normal adult human dermal fibroblasts (NHDF) bought from PromoCell
GmbH, Heidelberg, Germany were cultured in Ham’s F-12 medium supplemented with
10% v/v fetal bovine serum (FBS) and 1% v/v Pen/Strep/Fungizone at 37° C in a 5%
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CO2 incubator. NHDF that were purchased at passage 1 (P1) were grown until P4 and
then used for experiments between P5 and P8.
Cells were seeded at 8000 cells/well in a 96-well plate and incubated overnight.
Poly(curcumin) microparticles with equivalent curcumin concentrations ranging from
0 to 500 µg/ml were suspended in cell culture medium. Solutions of free curcumin at
equivalent concentrations were also prepared in cell culture medium. 200 µl of test
suspensions and solutions were pipetted onto the cells in the 96-well plates (n=5 per
treatment group). After incubation for 24 hours at 37° C in a 5% CO2 atmosphere, the
cells were washed with fresh medium, followed by addition of 200 µl calcein AM redorange cell viability dye (1 µM in Ham’s F-12 medium) as a live cell tracer. Calcein
AM red-orange is a mildly fluorescent molecule which upon internalization by cells is
converted into the highly fluorescent calcein by cleavage of the acetoxymethyl ester
group by intracellular esterases typically found only in live cells. Measurement of the
fluorescence intensity can be used to quantify and compare the viability of the cells
exposed to various treatments. After incubation for 1 hour, the cells were washed once
more with fresh medium followed by addition of 200 µl of fresh medium for
fluorescence measurements at 540/590 nm excitation/emission wavelengths using a
plate reader(BioTek Synergy Mx, Gen5 2.0, Winooski, VT).
7.5.8

In vitro oxidative injury assay

Cells were seeded in a 96-well plate at a cell density of 8000 cells/well. Hydrogen
peroxide (H2O2) was used as a model reagent to induce oxidative stress in NHDF.
Poly(curcumin) microparticles and free curcumin suspensions in Ham’s F-12 media
were prepared at two concentrations: 1 and 5 µg/ml of equivalent curcumin loading.
0.5 mM of H2O2 was used as injury concentration. 10 mM of stock H2O2 was prepared
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in media, 10 µL of which was added to the wells of interest to get a final concentration
of 0.5 mM.
The protection offered by the antioxidant potential of the poly(curcumin) microparticles
against H2O2 injury was assessed with three different treatment regimens: (i)
Poly(curcumin) microparticles and H2O2 added simultaneously at t=0 and kept for 24
hours, (ii) Poly(curcumin) added at t=0 followed by H2O2 at t=12 hours, both kept until
t=24 hours, (iii) Poly(curcumin) added at t=0 followed by H2O2 at t=12 hours, both kept
until t=36 hours. At the end time points of each treatment regimen, cells were washed
with fresh media and then incubated in 200 µl of 1 µM Calcein AM red-orange for 1
hour. Cells were washed again and incubated in fresh media for fluorescence
measurement as described in section 7.3.7 to determine the cell viability and indirectly
the protection potential of the poly(curcumin) microparticles. The cell viabilities for
each time regimen (24 and 36 hours) were calculated with their respect no treatment
control groups.
7.5.9

Pre-clinical study in a Hamster model of OM

7.5.9.1 Study protocol and sampling
All animal studies were conducted at the University of Kentucky in accordance with a
protocol approved by the Institutional Animal Care and Use Committee. A total of 32
male golden Syrian hamsters (Harlan Laboratories, Indianapolis, Indiana) weighing 90
to 115 g were randomly divided into 4 groups as shown in table 7.1. Animals in the
control groups (1 and 2) remained disease free. Oral mucositis was induced in animals
in the OM groups (3 and 4) by administration of 5-flurouracil (5-FU, 60 mg/kg)
intraperitoneally on day 0 and 2, followed by abrasion of the left cheek pouch.
Treatments were administered into the left cheek pouches using needle-less syringes
once daily from day 0 until euthanasia, under mild isoflurane anesthesia. The control
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groups (1 and 3) received 200 μl of PBS while the treatment groups received 200 μl of
10% w/w suspension of poly(curcumin) microparticles (C70 PβAE formulation) in the
mucoadhesive vehicle. C70-PβAE microparticle formulation was selected because this
formulation scored highest in mucoadhesive amongst the three formulations analyzed
for curcumin release, where C70 gave a uniform 12-15 hour curcumin release profile.
On day 3, under ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia, the left
cheek pouches of the animals in the OM groups (3 and 4) were everted and mild
erythema was created via dragging an 18 gauge needle in two 3 cm long parallel lines
on the tissue surface. Once daily, all animals were weighed, their left cheek pouches
were digitally photographed, and also visually scored for OM severity according to
table 7.2 [274]. Animals were given 0.1-0.2 mg/kg buprenorphine once or twice daily
as needed. Animals with excessive inflammation of the cheek pouches or those under
significant distress (indicated by drastically reduced food intake and activity) were
euthanized before the end of the study. At the end of the study on day 11, all remaining
animals were euthanized by CO2 asphyxiation. The treated (left) and control (right)
cheek pouches were then excised. Half of the total number of cheek pouches were flash
frozen in liquid nitrogen and immediately stored at -80°C for the tissue biomarker
assays (TEAC and protein carbonyl, discussed later). The other half of the cheek
pouches were processed for histological examination as described below.
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Table 7.1 Pre-clinical study design and treatment plan

5-FU
No. of Injury
Injection
Animals Day
Days

Treatment (200 μl), Daily

No.

Group

1

No OM,
Control
(NOC)

5

None

None

PBS

2

No OM,
Treatment
(NOT)

5

None

None

10% w/w poly(curcumin)
suspension

3

OM,
Control
(OMC)

11

3

0&2

PBS

4

OM,
Treatment
(OMT)

11

3

0&2

10% w/w poly(curcumin)
suspension

Table 7.2 Scoring guidelines for visual observation of mucositis assessment of
hamster pouch
Score

Observation

0

No erosion or vasodilation

1

Erythema but no evidence of mucosal erosion

2

Severe erythema, vasodilation and superficial erosion

3

Formation of ulcers in one or more places, not covering more
than 25% of the surface area

4

Cumulative ulcer formation, about 50% of pouch surface area

5

Complete ulceration of pouch mucosa. Loss of pliability
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7.5.9.2 Protein carbonyl content of cheek tissues
Oxidative stress in tissues can damage proteins by oxidation resulting in the formation
of carbonyl groups in the protein chemical structure. The protein carbonyl content of
the cheek tissues was quantified using the 2, 4-dinitrophenylhydrazine (DNPH) assay
according to the manufacturer protocol (Cayman Chemicals). DNPH on reaction with
carbonyls

forms

the

corresponding

hydrazone,

which

can

be

detected

spectrophotometrically. Briefly, 200-500 mg of each tissue sample was homogenized
in PBS (200 mg tissue per ml) followed by centrifugation at 3000 rpm for 10 min. 200
µl of the supernatant was mixed with 800 µl DNPH and incubated for 1 hour in dark at
room temperature. An equal volume of supernatant was mixed with 800 µl of 2.5 M
HCl instead of DNPH as the control group. After 1 hour, the protein was precipitated
by adding 20% trichloroacetic acid (TCA) solution while incubating the samples in an
ice bath. After 5 minutes, the samples were centrifuged and the supernatant discarded
to remove excess DNPH. This precipitation step was repeated once more after which
the protein pellets were re-suspended in 1:1 ethanol/ethyl acetate mixture. The samples
were again centrifuged and the supernatant discarded. The protein pellets were resuspended in guanidine hydrochloride and centrifuged once more. The supernatants
were transferred into a 96-well plate (220 μl per sample per well) and absorbance was
measured at 360 nm using a Varian Cary 50 Bio UV-Vis spectrophotometer. The
protein carbonyl concentration (in nmol/ml) was calculated as follows:
𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛

𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃 𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶𝐶 �

𝑚𝑚𝑚𝑚

𝐴𝐴

� = �0.011� ∗ 2.5

Where ‘A’ is the absorbance of the samples.
The protein carbonyl content was finally reported as nmol carbonyl per mg of total
protein. Total protein content was quantified by treating the control (HCl) samples with
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guanidine hydrochloride solution in the ratio of 1:10 v/v, and then measuring the
absorbance at 280 nm. Solutions of bovine serum albumin (BSA) were used as the
standards to determine the total protein concentration.
7.5.9.3 Histopathological analysis
The freshly dissected cheek tissues (described above) were spread and pinned down to
Sylgard dishes and fixed in 4% paraformaldehyde solution in PBS for 24 hours. Tissues
were cryoprotected in 30% sucrose solution for 24 hours followed by embedding in
Tissue-Tek O.C.T. compound. Embedded tissues were then cryosectioned at 10 μm
thickness, mounted on slides and stained with hematoxylin and eosin (H&E). The
sections were observed and imaged using a Nikon Ti-U inverted optical microscope
(Melville, NY) attached to a Nikon DS-RI1 12 MP color CCD camera at a
magnification of 400x. All the section images were closely analyzed for any visible
injury. Following that, ImageJ software was used to measure the thickness of the
epithelial layer (outermost tissue layer) for each tissue as any disintegration and/or
disruption in the epithelial layer is an important marker of inflammation. About 10-12
thickness measurements were made for each tissue and the mean thickness for each
tissue was plotted against the respective OM score given during the study.
7.6

Results

7.6.1

Poly(curcumin) microparticles characterization

The curcumin conjugated PΒAE gel synthesis process was optimized by Patil et. al.
[275] with respect to the reaction temperature, reaction time, solvent selection and
concentration to achieve a high cross-link density, uniform poly(curcumin) film.
During poly(curcumin) film synthesis via reaction of CA, PEG(575)DA and TTD, the
reaction mixture was kept for 1 hour at room temperature prior to incubation ay 50°C
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in order to achieve an extent of reaction before the solvent evaporation process starts at
higher temperature with simultaneous progression of the reaction. Solvent evaporation
is an important phenomenon in this synthesis as we want to achieve a significant
crosslink density which would be possible with gradual loss of reaction medium
resulting in increased concentration with time giving higher probability of the
intermolecular reaction. Washing of poly(curcumin) films was an important
intermediate step in order to remove any unreacted monomers and other un-crosslinked
chains that could unpredictably impact the physical and chemical properties of the
polymers. Wash supernatants were analyzed using UV-Vis to quantify the loss of
curcumin and/or its acrylates from the polymers. Measurement of mass loss of the
polymer films and UV-Vis analysis of the supernatants post washing confirmed that
CA, PEGDA and TTD were lost in almost the same ratio as the starting stoichiometry
(data not shown).
The cryogenic milling process to obtain poly(curcumin) microparticles was also
optimized with respect to milling time (10 min), sample loading (2 g), milling speed
(15 cps) and magnesium stearate content (1% w/w) to obtain consistent particle size
distribution irrespective of the polymer formulation. Various poly(curcumin)
microparticle formulations were suspended in DI water and analyzed for their particle
size using a Shimadzu SALD-7101 laser diffraction particle size analyzer with a 375
nm UV laser source. Figure 7.1 shows the particle size distribution of the C60, C70 and
C90 poly(curcumin) microparticles measured after 2 minutes bath sonication. All three
groups show similar particle size distributions with average particle diameters of
20.7±4.3, 20.8±2.7 and 22.7±0.28 µm respectively.
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Figure 7.1 Particle size analysis of the poly(curcumin) microparticles with variable
CA to PEGDA molar ratios.
For analysis, particles were suspended in DI water and ultrasonicated for 2 minutes.
Variable CA to PEGDA molar ratios (60, 70 and 90%) did not affect the particle size
with an average size in the range of 22.5 µm to 25.0 µm.
7.6.2

Poly(curcumin) powder hydrolytic degradation and curcumin release
profile

Three poly(curcumin) microparticle formulations, C60, C70 and C90 were degraded
under physiological condition to study the impact of the polymer composition (i.e. CA
to PEGDA ratio) on the release profile of curcumin. The PBS was supplemented with
0.1% SDS in order to ensure the solubility of the released hydrophobic curcumin.
Figure 7.2 (A) shows the cumulative curcumin release profiles versus time for the three
formulations. All the formulations analyzed for curcumin release due to PβAE ester
hydrolysis showed steady and uniform release. It was observed that C60
poly(curcumin) microparticles showed rapid release of curcumin within 12 hours while
C70 took 15 hours and C90 took 24 hours to completely hydrolyze and release
curcumin. Analysis of the degradation samples using HPLC confirmed the presence of
pure curcumin post hydrolysis as shown in figure 7.3, where peaks eluting from the
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microparticle degradation coincide with those of a curcumin standard at 7.3, 7.7 and
8.1 minutes.
7.6.3

Antioxidant activity of the poly (curcumin) powder released products

The TEAC assay was employed to confirm and quantify the antioxidant capacity of
released curcumin for the three aforementioned formulations at every time point. As
can be seen in figure 7.2(B), the cumulatively trolox concentrations over time for each
formulation follow the release profiles of curcumin discussed above. A cumulative
equivalent trolox concentrations of 21.2, 23.3 and 14.2 µM at 12, 15 or 24 hours for
C60, C70 and C90 respectively was calculated showing the presence of active
degradation products in the supernatants (Figure 7.2 (B)).

Figure 7.2 Degradation profile of poly(curcumin) microparticles
(A) Curcumin release by hydrolytic degradation of poly(curcumin) microparticles.
Sustained release of curcumin over 10, 14, and 24 hours was observed for C60, C70
and C90, respectively, clearly showed a direct relationship between polymer
hydrophobicity and hydrolytic degradation. (B) Anti-oxidant activity profile of released
curcumin using TEAC assay. Plot represents the equivalent concentration of trolox
versus time, confirming retention of the antioxidant activity of the released curcumin.
(N=3, error bars are ± std. dev.)
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Figure 7.3 HPLC analysis of the products from degradation of poly(curcumin)
microparticles collected at 26 hours.
Peaks identical to a free curcumin standard at 7.21, 7.58 and 8.00 mins were observed
for degradation products as well, confirming the release of pure curcumin after
polymer degradation.
7.6.4

Tissue adhesion studies with porcine buccal tissue

Poly(curcumin) microparticle adhesion properties towards porcine buccal tissue were
analyzed in Bluegrass Advanced Materials LLC. laboratory in order to sort out
formulation with best adhesive nature based on the CA v/s PEG(575)DA molar ratio
and stoichiometric ratios (RTAAP). After analyzing the pictures post tissue-drip
experiment with the help of visual ranking obtained from random subjects, it was
inferred that C70 microparticles with RTAAP of 1.0 were best amongst other in
adhesive properties. The methods with detailed results and discussion is not included
in this document.
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7.6.5

Dose dependent NHDF cytotoxicity (In vitro)

NHDF were treated with various concentrations of poly(curcumin) microparticles
(C70, RTAAP 1.0) and free curcumin at equivalent curcumin concentrations for 24
hours to compare and quantify their relative cytotoxicity. Figure 7.4 shows the
cytotoxicity profile of poly(curcumin) microparticles and free curcumin versus the
equivalent curcumin concentrations. A sigmoidal curve fit (using SigmaPlot version
12.0) to the dose-dependent viability gave a TC50 value of about 12 µg/ml for curcumin
and 99 µg/ml for poly(curcumin) microparticles.

Figure 7.4 Dose dependent cytotoxicity of free curcumin and poly(curcumin)
microparticles towards normal human dermal fibroblasts (NHDF) after 24 hours of
exposure.
Cell viability was determined using Calcein AM red-orange cell-permeant fluorescent
dye with excitation/emission wavelength of 540/590 nm. Poly(curcumin) microparticles
resulted higher viability than free curcumin at corresponding same equivalent
curcumin concentrations, demonstrating safer nature of the drug conjugated polymer
system than free drug. N=5, error bars are ± std. dev.
7.6.6

Protection against H2O2 induced injury (In vitro)

Based on the results of the cytotoxicity assay above, non-toxic equivalent curcumin
concentrations of 1 and 5 µg/ml were selected to ensure that the inherent toxicity of the
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particles and free curcumin does not interfere with the oxidative injury assay. This was
confirmed via lack of cytotoxicity observed in the control groups treated with only
poly(curcumin) microparticles and free curcumin for 24 and 36-hour exposure but
without oxidative injury (Figure 7). NHDF cells, when treated simultaneously with 0.5
mM H2O2 and poly(curcumin) microparticles at 1 and 5 µg/ml equivalent curcumin
concentrations, showed significantly higher viability of 27.0±7.7% and 60.5±17.2%
respectively versus only 1.7±0.3% and 21.5±5.9% for cells treated with free curcumin,
after 24 hours of exposure (Figure 7.5). For the second regimen wherein the antioxidant
treatment (poly(curcumin) and free curcumin) was started 12 hours prior to the H2O2
exposure for 12 hours, cell viability increased from 57.3 ± 3.6% (unprotected control
group) to 97.6 ± 4.8% and 112.3 ± 4.5% for poly(curcumin) microparticles at 1 and 5
µg/ml respectively. In contrast, an insignificant increase in viability was observed with
free curcumin of 59.9 ± 2.3% and 68 ± 4.0% at 1 and 5 µg/ml respectively. In the third
regimen when the H2O2 exposure was extended to 24 hours post 12-hour pre-treatment
with the antioxidants, poly(curcumin) again increased viability to 54.5 ± 9.6% and 70.6
± 4.0% at 1 and 5 µg/ml respectively. On the other hand, curcumin at the same
concentrations increased viability to a meager 10.2 ± 2.9% and 24.6 ± 3.1%
respectively.
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Figure 7.5 NHDF viability analyzed after exposure to poly(curcumin)
microparticles/free curcumin and H2O2 to show protection against oxidative
injury.
The x-axis from top to bottom shows 1) the equivalent curcumin concentrations (µg/ml),
2) the timescale of antioxidant (AO) (Poly(curcumin) microparticles or free curcumin)
exposure, and 3) timescale of 0.5 mM H2O2 exposure. Poly(curcumin) controls at both
the concentrations did not show any toxicity after 24 and 36-hour exposure. Similar
observations were made with free curcumin except 24-hour of 5 µg/ml showed 25%
cell death. 12-hour AO pre-treatment resulted in higher cell viability than AO + H2O2
simultaneous treatment. For all the different treatment schemes, poly(curcumin)
microparticles showed superior protection than free curcumin with H2O2 induced OS.
N=5, error bars are ±Std. dev.; ‘*’ represents statistically significant difference
between the treatment groups with p<0.050.
7.6.7

Pre-clinical study in a Hamster model of OM

The efficacy and safety of poly(curcumin) microparticles locally delivered to the cheek
pouches was evaluated towards the prevention and treatment of OM in a hamster model.
The control group without OM injury treated with DI water (NOC) or poly(curcumin)
microparticles (NOT) did not show any sign of vasodilation or pouch erosion giving a
score of 0 on the scale of 0-5 on day 11 (0: no injury, 5: complete ulceration of the
pouch mucosa). The animal group with OM injury but without microparticle treatment
(OMC) on day 11 showed erythema and swelling surrounding the scratched area giving
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a score of 3.5 ± 1.8. On the contrary, the group with OM injury and treated with
poly(curcumin) (OMT) scored 0.5 ± 0.5 on day 11.
7.6.7.1 Protein carbonyl content of cheek tissue
The ability of the poly(curcumin) microparticle treatment to inhibit protein oxidation
in the tissues was analyzed using the DNPH based protein carbonyl assay. Protein
oxidation or indirectly carbonyl content is considered to be a major marker of oxidative
stress in tissues. According to the figure 7.6, tissues from the NOC and NOT groups
showed total protein carbonyl content of 0.4 ± 0.3 and 1.0 ± 0.2 nM carbonyls/mg of
protein. Tissues from the OMC group showed significantly higher level of protein
carbonyl at 3.9 ± 2.8 nM carbonyl/mg of protein. Interestingly, the OMT tissues showed
a significant decrease in the carbonyl content to 2.0 ± 0.8 nM carbonyl/mg of protein.

Figure 7.6 Protein carbonyl content in hamster cheek tissues.
Carbonyl content was calculated by reaction of carbonyls with DNPH followed by UVVis absorption analysis of reaction products at 360 nm. Carbonyl content in OMC was
8 times higher than non-treated controls (NOC) while with the injury group treated
with poly(curcumin) microparticles (OMT) showed a significant decrease (half of OMC
or 4 times that of NOC). NOT also showed some increase in carbonyl content probably
due to metabolic signaling in tissues upon administration of a foreign substance, but
was lower than both the injury groups. N=3, error bars are ± SEM.
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7.6.7.2 Histopathological analysis of cheek pouch tissues and effect on epithelial
layer thickness post OM injury
The epithelial layer thickness of the hamster cheek pouch was analyzed after OM
induced injury (OMC) and compared with the hamsters treated with poly(curcumin)
post OM injury. Figure 7.7 shows the histology images of cross-sections of cheek
tissues corresponding to NOC, NOT, OMC and OMT. For the NOC and NOT groups,
tissue from only one animal per group was analyzed as the remaining tissues were used
for the biomarker assays. For the OMC and OMT groups, tissues from at least 2 animals
per group were analyzed. ImageJ analysis determined the average epithelial layer
thickness of NOC and NOT tissues to be 35.9 ± 5.3 and 45.2 ± 3.2 µm respectively.
Figures 7.7 and 7.8 shows the disintegration of the epithelial layer in the OMC group
tissues, with an average thickness of 16.1 ± 10.2 µm and 30.0 ± 8.6 µm for OMC I and
OMC II respectively. The OMT tissues gave an average epithelial layer thickness of
35.7 ± 4.0 and 26.3 ± 6.4 µm for OMT I and OMT II respectively.

NOC

NOT
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OMC I

OMC II

OMT I

OMT II
Intact epithelial
Disintegrating/thinning epithelial
Damaged epithelial

Figure 7.7 Histopathological sections of hamster left cheek pouches.
Optical microscopy images of cheek tissue sections stained with H&E taken at 200x
magnification. NOC: No OM controls, OMC: Oral mucositis controls, NOT: No OM
treatment, OMT: Oral mucositis treated with C70 microparticles. Dark arrows depict
partially damaged or thinning layer with a disintegrating corneal layer of oral mucosa.
NOC group shows completely intact epithelium while NOT histoimage is folded and
shows very slight corneal disintegration. OMC group images shows instances of both
partial disintegration and completely damaged epithelium. OMT group shows either
intact or only partially disintegrated epithelium. Scale bars: 100 µm.
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Figure 7.8 Epithelial layer thickness with corresponding animal scoring on day 11.
Poly(curcumin) treated control without injury (NOT) showed an increase in thickness
as compared to NOC indicating epithelium proliferation. OMT stained tissue showed
an average higher thickness as compared to OMC samples indicating protection from
inflammation or healing of the inflammation. Epithelial layer thickness also complies
with the visual scoring for each tissue, i.e. higher the inflammation scoring, lesser the
thickness. Epithelial thickness was measured using ImageJ software. The bars
represent the average thickness measurements of at least 10 different locations per
stained tissue section. (Error bars: std. dev.)
7.7 Discussion
A recent human trial showed significantly delayed the onset and reduced severity of
OM after continuous turmeric (a source of curcumin) rinses without any added side
effects [276]. As the development of OM has been linked to the presence of oxidative
stress, the therapeutic significance of curcumin towards the treatment of this
uncomfortable, painful and currently unmanageable OM condition could be clearly
identified [277]. It was shown that slight increment of ROS production during cancer
therapies would result in activation of NF-kB. This would lead to the release of tissuedamaging cytokines, which in turn again increase ROS production [278]. This results
in a cascading cell apoptosis cycle, inhibiting oral epithelial cell proliferation,
consequently resulting in the formation of ulcers. Curcumin carrying both anti-oxidant
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and anti-inflammatory properties inhibits NF-kB, scavenges excess free radicals and
hence overall halts the cell apoptotic process, a possible prevention to the incidence of
OM. But its structural properties associated with poor bioavailability, rapid 1st pass
metabolism due to its poor aqueous solubility and structural stability would require
higher and frequent dosage quantities for OM treatment [279]. But increased dosage
still may not be effective due to aqueous solubility limitations. Converting the
polyphenolic antioxidant, curcumin into a crosslinked biodegradable PβAE polymer
matrix (poly(curcumin)) via Michael addition structurally protects the curcumin from
premature degradation, thus preserving its activity until released [178, 280].
Poly(curcumin) synthesized via a single-step reaction between CA, PEGDA and TTD
releases curcumin in its original structural form via hydrolysis of the ester bond present
in the polymer backbone. In addition to protecting a useful drug, the polymerization
process also enables controlled and sustained release of curcumin for extended time.
Since these polymers undergo hydrolytic degradation, it is logical that the
hydrophobicity of the polymer network would govern the rate of polymer degradation,
and hence the rate of drug release [281, 282]. Our goal was to identify formulations that
release curcumin continuously for 12 to 24 hours in a steady and uniform fashion. This
was readily achieved by varying the ratio of CA (hydrophobic) to PEGDA (hydrophilic)
during polymer synthesis. Films with different ratios of CA to PEGDA with respect to
a total number of acrylate groups were synthesized. For example, formulation C70
would have 70% of the acrylate groups contributed by CA, while the remaining 30%
contributed by PEGDA. Cryogenic milling was chosen to micronize the
poly(curcumin) films for two primary reasons: 1) to embrittle the polymer for effective
micronization, and 2) to prevent heat-induced degradation of the polymer. Additionally,
magnesium stearate, a widely used pharmaceutical excipient [283, 284], was added as
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a dry lubricant to reduce clumping. Cryogenic milling of the C60, C70 and C90
formulations yielded microparticles with an average diameter of about 25 ± 4, 23 ± 3
and 22 ± 1 µm respectively, implying that the polymer composition had minimal, if
any, effect on the milling process and particle size. Micronization of the bulk PβAE
polymer films was an important step for the intended application. Formulating into
microparticles followed by suspension in a mucoadhesive solution would allow ease in
local delivery through oral mouth rinse. It would also allow higher mucosal surface
coverage during rinses. Particulate morphology over bulk would minimize the
incidence of diffusion based curcumin release but largely hydrolytic degradation based
drug release.
Degrading the poly(curcumin) microparticles under simulated physiological conditions
showed a CA loading dependent release profile of curcumin. The polymer formulation
synthesized with the highest CA amount, C90, degraded the slowest in 24 hours,
presumably because of the higher hydrophobicity from the higher curcumin content.
The formulation with lower CA amount, C60, with relatively lower curcumin content,
completely degraded within 12 hours due to faster hydrolysis. HPLC analysis of the
degradation products detected the original curcumin confirming that the ester bond
hydrolysis occurring adjacent to curcumin molecule within the polymer does release
the pure polyphenol. The ability of tunable, sustained release of curcumin from the
poly(curcumin) microparticles enables development of clinically relevant antioxidant
delivery formulations. This is because longer release would reduce the dosage and
treatment frequency thereby giving minimum possible treatment interference to the
patients undergoing life-saving cancer treatments. Therapeutic application of curcumin
has been limited with in vivo trials because of its rapid metabolism. It has been shown
that increasing the amount of dosage has not improved total absorbed because of
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solubility limitation. This restricts the percent bioavailability of curcumin irrespective
of the dosage amounts [285]. Steady curcumin release with no major burst effect would
alleviate the solubility limitation of the highly hydrophobic drug and minimize the
overall systemic metabolism thereby giving an opportunity to utilize the major part of
the release towards OS suppression. It was important to analyze the antioxidant activity
of the poly(curcumin degradation products as that would decide the efficacy of the
system towards core function of serving as an antioxidant throughout the release.
Antioxidant activity was determined by analyzing the potential of degradation products
to scavenge the ABTS●– radical and reported as equivalent trolox concentration, a
widely used standard for such assays [162, 286]. The continuous increase in equivalent
trolox amount through the degradation time span confirmed the presence of active
compounds capable of suppressing OS. This indirectly implies the release of active
curcumin at all times and also proves the concept theory of preserving the structural
integrity of the labile molecule in the polymer matrix and protection from premature
deactivation prior to release.
The C70 poly(curcumin) microparticles showed dose dependent toxicity on human
dermal fibroblast (NHDF), with a TC50 value of 227 µg/ml of suspended microparticles
(99 µg/ml of equivalent curcumin dose) against TC50 of only 12 µg/ml for pure
curcumin. Two key observations can be drawn from the more than 8-fold higher TC50
values of the poly(curcumin) microparticles compared to pure curcumin: (i) within
appropriate dosage limits, the degradation products from the polymer backbone are
non-toxic towards fibroblasts, and (ii) the slow release of small doses of curcumin upon
degradation of the polymer is less cytotoxic than the traditional bolus delivery method
of free curcumin. More importantly, sustained release of active curcumin actually
improves protection of cells against oxidative injury. As shown in figure 7.5, in the case
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of all three treatment regimens, cells treated with poly(curcumin) followed by H2O2
exposure show significantly higher viability than just those treated with free curcumin.
In particular, 12-hour pretreatment with free curcumin shows minimal to no reduction
in cell death after H2O2 injury, while pretreatment with poly(curcumin) microparticles
had a significantly higher number of viable cells. Delivery of curcumin from polymer
microparticles is not only effective in suppressing oxidative stress-related injury but, in
fact, is more efficacious and less toxic than free curcumin. As explained earlier, one of
the key causes of the onset and incidence of the OM condition arises due to the
development of oxidative stress conditions, which is excess production of free radicals.
The in vitro results if translated towards OM management would imply both (i)
prophylactic action against oxidative stress during chemo and radiation therapy as well
as (ii) treatment of OM by suppressing OS via simultaneous treatment during the
developmental stage of the oral injury.
The viable or non-destructive nature of the poly(curcumin) microparticles were further
tested in vivo with a hamster model. No increase in protein carbonyl content, intactness
of epithelium observed with histopathological analysis for only poly(curcumin)
microparticle treated control groups (NOT) demonstrated the safe nature of
microparticles in vivo with no side effects or inflammation. Adding to this, higher
epithelium thickness of NOT groups (45.2 µm) as compared to NOC (no OM, no
treatment) control groups (35.87 µm) demonstrates the epithelium proliferation in the
presence of curcumin (figures 7.7 and 7.8). Though NOT showed some increase in
carbonyl content with reference to NOC group but this could be probably due to
metabolic signaling in tissues upon administration of a foreign substance, but was
significantly lower than both the injury groups. The Effect of poly(curcumin) on the
hamster pouch with induced OM condition though did not show full protection from
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the injury but showed a significant difference against inflammation with an average
OM score of 0.5 on day 11, lower total protein carbonyl content and more intact
epithelium when compared with the OM injury (OMC) control group with an average
score of 3.5 (Figures 7.6, 7.7 and 7.8). The results from the preliminary in vivo study
are not very concrete with a clear conclusion on the efficacy of the poly(curcumin)
microparticles towards OM prevention and treatment. The underlying cause of
variability might be arising due to the presence of human error during needle scratching
of hamster pouch and high death rate due to adverse systemic effects arising from the
strong 5-FU administration. In spite of these experimental irregularities, we did see
results indicating the protective effect of slow and steady releasing microparticles
developed in the form of oral rinse suspension for better patient compliance.
7.8 Conclusions
Curcumin conjugated PβAE gel microparticles (poly(curcumin) microparticles) were
synthesized for the application of treatment and prevention of oral mucositis. These
microparticles obtained by cryomilling PβAE gel films showed the uniform release of
active curcumin with no burst effect. PEGDA used as a co-monomer to CA during gel
film synthesis helped in tuning the curcumin release timescale ranging from 12 to 24
hours. The C70 poly(curcumin) microparticle system was selected for further in vitro
and in vivo application after testing various formulations for best mucoadhesive
properties. Protection against H2O2-induced oxidative stress was seen with both
simultaneous and pre-treatment of poly(curcumin) demonstrating preventive as well as
treating potential of the microparticle system. Both in vivo and in vitro studies
demonstrated the safe and viable nature of the product. In vivo administration of
poly(curcumin) through oral rinse to OM induced hamsters showed decreased protein
carbonyl content, intact epithelium and less severity of ulcers observed visually in
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comparison to non-treated OM controls. The microparticle containing mouth rinse
suspension would allow local and sustained delivery of antioxidant curcumin, increase
overall bioavailability and reduced dosage frequency thereby minimizing the
interruptions during cancer therapies. These synthesized poly(curcumin) microparticles
can serve as a treatment superior to just barrier rinse or free curcumin rinse towards the
management of OM.
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8

SYNTHESIS AND CHARACTERIZATION OF RESVERATROL
CONJUGATED PβAE GEL MICROPARTICLES FOR PROTECTION
FROM UV MEDIATED OXIDATIVE STRESS

Note: The information in this chapter is the intellectual property of Bluegrass
Advanced Materials LLC., not to be disclosed in public
Abstract
As induction of oxidative stress through UV radiation from sunlight is considered to be
one of the reasons for skin disorders, including sunburn, skin cancer and premature skin
aging, incorporation of resveratrol with its antioxidant properties could serve as a
protective strategy in topical application products. In order to consider this as a viable
approach for daily use, it is required for the UV-protective compound to act against
radiation-induced injury for at least 12-14 hours. However, the instability of resveratrol
under UV exposure results in its rapid deactivation and apparent depletion without
performing the intended function. A proposed solution to overcome these limitations is
to structurally protect the resveratrol via the PβAE conjugation approach and
subsequently release the bioactive compound uniformly for a longer duration of time.
To implement this idea, resveratrol was covalently conjugated into hydrolytically
degradable PβAE gels via reaction of acrylate functionalized resveratrol (RTA) with a
multifunctional amine (TTD). These gels were further cryomilled into microparticles
for easier fusion into cosmetic or dermatological products. Incorporation of PEGDA as
a co-monomer allowed tunable degradation of these gels (6-8 hours) and control over
the fast reaction kinetics of RTA with TTD. These microparticles also showed
protection against H2O2-induced oxidative stress in human dermal fibroblasts
equivalent to free resveratrol. Therefore, these microparticle systems have the potential
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to be considered for dermal application products but a more uniformly distributed and
longer resveratrol release profile (10-12 hours) is desired for intended action.
8.1 Introduction
With the incidence of skin cancer, premature skin aging, and topical erythema the
damaging effects of the UV part of solar radiation on skin are generally well known.
[287-289]. UV radiation is broken into three distinct bands, UVA (315-400 nm), UVB
(280-315 nm) and UVC (100-280 nm). While UVC is blocked by the atmospheric
ozone layer, we get sunlight radiation composed of about 95% UVA and roughly 5%
as UVB [290]. Both types of UV radiation serve as contributing factors to skin aging
and development of skin cancers. UVA penetrates to the dermis, increases reactive
oxygen species production, indirectly inducing DNA damage followed by mutagenesis
[291]. On the other hand, UVB is known to be the cause of non-melanoma cancer, is
absorbed at the epidermis level of the skin and results in direct DNA damage [292,
293].
While induction of oxidative stress is considered to be one of the reasons for skin
damage, application of antioxidants is a well-known remedy to suppress oxidative
stress and can be a possible solution to remediate UV exposed damage and prevent
degenerative biochemical processes [294]. Antioxidant molecules used in cosmetic and
dermatological formulations to protect skin from damage and premature aging include,
but are not limited to, vitamin E, curcumin, resveratrol, quercetin, and ascorbic acid. In
particular, resveratrol has gained a special interest in recent years as an antioxidant and
anti-aging compound [295]. Topical application of this antibacterial compound in
preventing UV-mediated oxidative and skin damage has been widely studied and has
shown promising results [296]. Recent studies have also shown that it has 17 times
greater antioxidant capacity than idebenone, an antioxidant widely used in anti-aging
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skin products [297]. But one of the greatest technical difficulties for the use of the above
antioxidant compounds is their instability under UV leading to molecular isomerization
and inactivation [298]. The strong chemical activation energy derived from ultraviolet
radiation induces hydrolytic reactions and degrades the antioxidant indiscriminately.
This results in exponential loss of the antioxidant without performing the action it was
intended to. This reduces the filtering and protection capacity of the cosmetic
formulation over time. A reduction of UVB filtering capacity leads to a reduction in
SPF of the formulation, and therefore to a higher burn risk. On the hand, the reduced
capacity to filter UVA radiation results in a greater risk of adverse chronic effects,
which might go unnoticed at initial stages.
A proposed solution to overcome these limitations is to structurally protect the
resveratrol until it is made available to protect the skin from injury. This idea was
implemented by converting antioxidants into biodegradable poly(beta-amino ester)
(PβAE) polymers. Specifically, polyphenolic resveratrol with three alcoholic groups
was first converted into its acrylate ester form (Figure 8.1). The phenol acrylate
(resveratrol triacrylate (RTA)) was then reacted with a primary diamine crosslinker,
like 4, 7, 10-Trioxa-1, 13-tridecanediamine (TTD), via the Michael addition to yield
crosslinked resveratrol conjugated PβAE (R-PβAE) gels. The hydrophilicity of the
polymer, and thus its degradation rate was controlled by including a diacrylate comonomer like poly(ethylene glycol) diacrylate (PEGDA, MW 575) in desired
proportions during the reaction. The gel films were further cryomilled to obtain RPβAE microparticles. Hydrolytic degradation of these gel microparticles demonstrated
resveratrol release in a sustained fashion.
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By going through this route, (1) resveratrol was structurally protected from premature
degradation compared to encapsulation/complexation technologies; (2) high resveratrol
loadings, exceeding 20 wt. % of the polymer were obtained, (3) tunable sustained
release durations ranging from 2 to 10 hours, (4) original, active resveratrol was
released upon hydrolysis of the polymer.
8.2 Methods
8.2.1

Resveratrol triacrylate (RTA) synthesis (Process developed by Bluegrass
Advanced Materials LLC.)

Resveratrol (20 g) dissolved in 160 ml of anhydrous THF was allowed to react with
21.36 ml of acryloyl chloride (molar ratio of 3:1 with respect to resveratrol), which was
added to resveratrol-THF solution dropwise (exothermic reaction). Triethylamine
(TEA) (36.64 ml) was added to the reaction mixture in the molar ratio of 3:1 w.r.t
resveratrol in order to capture released HCl forming TEA-HCl salts. The reaction was
allowed to proceed for 2 hours under the nitrogen purge at room temperature in the dark
(aluminum foiled). During the reaction, acryloyl chloride reacts with alcoholic groups
of resveratrol forming acrylate groups. Post reaction, the mixture in THF was first
filtered out to remove TEA-HCl salts and then was subjected to vacuum evaporation to
evaporate THF using liquid nitrogen vacuum trap. Following the complete evaporation
of THF, the obtained product was re-dissolved in 40 ml of ethyl acetate (EA). As EA
and water are immiscible solvents, product dissolved in EA was washed with 0.1 M
HCl solution in DI water (1:3 v/v-EA/HCl solution) in order to remove any unreacted
TEA in the product. After HCl wash, the product was subjected to base wash using 0.1
M K2CO3 solution to remove excess acrylic acid with the same EA/ K2CO3 ratio as for
EA/HCl wash. Any residual water after the washes was removed by adding magnesium
sulfate (MgSO4) until the bubbling stops. The hydrated MgSO4 was removed via
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filtration and the EA solution containing RTA was subjected to vacuum drying with
liquid nitrogen trap under stirring conditions to remove EA and get a semi-viscous RTA
product. RTA was stored at -80oC before further use. All solvents used were anhydrous.
The final product was run through HPLC to identify the nature of the resveratrol
acrylate obtained.

Figure 8.1 Reaction scheme of acrylate functionalization of resveratrol to resveratrol
triacrylate (RTA) via reaction with acryloyl chloride.
There is a possibility of all three kinds of acrylate; mono, di and tri as shown in the
figure. Three different forms of mono and diacrylate will exist depending upon the
location of acrylation.
8.2.2

Resveratrol-PEGDA (R- PβAE) film synthesis and microparticles
formulation

a. R-PβAE film synthesis (synthesized by Bluegrass Advanced Materials LLC.)
R-PβAE films were synthesized with different molar ratios of RTA (mol. wt. 390.39)
v/s PEGDA (mol. wt. 575) as the acrylate monomers. The amine monomer for the
Michael addition reaction used was a tetra functional amine; 4, 7, 10-Trioxa-1, 13tridecanediamine (TTD) (mol. wt. 220 gm/mol). The total acrylate to total amine proton
ratio (RTAAP) was kept at 1:1. Films with 20, 40, 60 and 80% RTA (molar ratio w.r.t.
total RTA+PEGDA) were prepared. As a sample example, for 80% RTA film (R80PβAE), 905 mg of RTA was dissolved in 1.88 ml of DCM and vortexed thoroughly.
161

To the RTA-DCM solution, 500 mg of PEGDA was added and again mixed thoroughly.
To this mixture, 479 mg of TTD separately dissolved in 1.88 ml of DCM was added
while vortexing and the reaction solution was quickly transferred to an aluminum dish
and was kept in an oven for 24 hours at 50o C. After the reaction was completed, a firm
thin crosslinked gel film was obtained, which was peeled off the aluminum dish and
subjected to acetone wash to remove any unreacted monomers or uncross-linked
oligomers. The washing solvent, acetone was removed and replenished every one hour
followed by mild mixing in the rotary shaker. After the 4th wash, most of the acetone
was removed and the film was lyophilized using freeze-dryer overnight.
b. R-PβAE film micronization
Dry film obtained from Bluegrass Advanced Materials LLC. was weighed out and
was cut into small pieces of dimensions less than 0.5x0.5 inch. The pieces were
added to the cryomilling tube with 3% wt/wt of magnesium stearate and an impactor
was inserted in the tube and closed. The film was subjected to cryomilling with the
milling frequency of 15 cps, 2 minutes sample precool, 10 minutes of milling and
2 minutes of post cool setup. After milling, microparticles was allowed to warm up
and come to room temperature after which microparticles were collected in a tube
for freeze drying to remove any solvent or condensed water. Dried microparticles
were stored at -20oC for further characterization (Figure 8.2).
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Figure 8.2 Photographic schematic of R- PβAE film to microparticle formation.
8.2.3

R-PβAE microparticle degradation

Degradation was carried out in a dissolution apparatus with a speed of 100 rpm at 37°C
in PBS buffer with 0.1% SDS. All formulations (R20, R40, R60 and R80) were
subjected to degradation. The amount of microparticle powder required for degradation
studies was calculated such that the final resveratrol concentration was 10 mg/L. A total
of 1-liter suspension was prepared for each formulation and the study was carried out
in replicates of three. Table 8.1 shows the total mass/liter required for each formulation
to get 10 μg/ml of loaded resveratrol.
Table 8.1 R-PβAE microparticles composition and degradation calculations

R-PβAE formulation

% Resveratrol
loading

Mass of R-PβAE
microparticles/liter
for 10 mg/L
resveratrol (mg)

R20

4.89

204.50

R40

10.88

91.80

R60

18.40

54.36

R80

28.09

35.60
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8.2.4

Dose dependent toxicity and protection against H2O2 induced oxidative
stress towards normal human dermal fibroblasts (NHDF)

Dose dependent cell toxicity due to resveratrol and R80-PβAE exposure towards
normal human dermal fibroblasts (NHDF) was analyzed after 24-hour treatment using
Calcein AM red-orange live cell trace assay. Briefly, NHDF were seeded in a 96wellplate and allowed to grow overnight. The next day, resveratrol/R80-PβAE
microparticles were suspended in the Ham’s-12 medium at different concentrations.
The suspensions were added to the seeded well plate and allowed to incubate for 24
hours at 37º C, 5% CO2.
Cells were then washed and incubated with 1 µM Calcein AM red-orange for an hour.
All the wells were then washed, replenished with fresh medium and the fluorescence of
all the groups was measured at 540/590 nm as excitation/emission wavelengths (BioTek
Synergy Mx, Gen5 2.0, Winooski, VT plate reader). Fluorescence intensities were used
to quantify percent viable cells and compared with different treatment groups.
Inhibition of H2O2 induced toxicity was also analyzed using the same live cell tracer
with 0 and 12-hour antioxidant pre-exposure followed by 12 or 24 hours of 0.5 mM
H2O2 exposure. Figure 8.3 shows the treatment sequence for three different
resveratrol//R80-PβAE microparticles + H2O2 exposure combinations.
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Figure 8.3 Treatment sequence timeline of resveratrol/R80-PβAE microparticles +
H2O2 exposure to NHDF.
NHDF cells were used as the treatment substrate to analyze the protective effect against
H2O2 induced oxidative stress.
8.3 Results
8.3.1

Analysis of RTA and R-PβAE microparticles size

HPLC elution of the acrylated product of resveratrol i.e. resveratrol triacrylate (RTA)
showed no peak elution coinciding with the free resveratrol residence time (Figure 8.4).
This clearly indicated that the final product did not contain any unreacted resveratrol.
Three distinct peaks were observed in the elution, with the major peak eluting at 37.7
minutes corresponding to triacrylate. This peak contributed 91% of the total product
based on area under the curve calculations. Other two peaks are assumed to be of mono
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and diacrylate and there can be three different structural forms of mono and di acrylate
depending upon the location of phenol conjugation.
Cryomilling of all different compositions of RTA-PEGDA-TTD conjugated gels gave
microparticles in the range of 6-8 µm (data not shown). The amount of magnesium
stearate content during cryomilling did not show any effect on the particle size.

Figure 8.4 HPLC of RTA and resveratrol
Gradient method file of 70% aqueous mobile phase (DI water with 0.1% phosphoric
acid) to 30% over 40 minutes against acetonitrile organic phase was used.
8.3.2

Degradation of R-PβAE microparticles and antioxidant activity of the
released products

Hydrolytic degradation under physiological conditions (PBS, 37º C) showed a similar
release trend with a degradation time varying from 6-8 hours for microparticles of
different chemical compositions (Figure 8.5). Performing the TEAC assay on the
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degradation products demonstrated sustained antioxidant potential during degradation,
reported as equivalent trolox (mM) (Figure 8.6).

Figure 8.5 Degradation of all R-PβAE microparticles
Microparticles were suspended in PBS buffer with 0.1% SDS under physiological
conditions: 37°C, in a dissolution apparatus. N=3, error bars: std. dev.
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Figure 8.6 Antioxidant activity profile of R-PβAE microparticles
Antioxidant capacity was analyzed using TEAC assay and represented as trolox
equivalents in mM. N=3, error bars: std. err.
8.3.3

Dose dependent toxicity and protection against H2O2 induced oxidative
stress towards normal human dermal fibroblasts (NHDF)

Normal human dermal fibroblasts were exposed to a variable concentration of R80PβAE microparticles and free resveratrol at similar concentrations for 24 hours. Dose
dependent cell viability curve showed more viable nature of R80-PβAEs compared to
free resveratrol at similar resveratrol loading (Figure 8.7). While TC50 value for free
resveratrol exposure was calculated to be 12.3 µg/ml, R80-PβAE microparticles
showed lower toxicity with TC50 of 52 µg/ml (resveratrol loading).
All three different sequences of resveratrol/R80-PβAE treatment did show significant
protection from 0.5 mM H2O2 toxicity. R80-PβAE did not show any superior properties
than free resveratrol in the form of cell toxicity (Figure 8.8 and 8.9).
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Figure 8.7 Dose dependent NHDF toxicity after 24-hour exposure to resveratrol or
R80-PβAE microparticles.
Cell viability was determined using Calcein AM red-orange live cell tracer. TC50 values
were calculated using 4-parameter sigmoidal curve model. N=5, error bars: std. dev.

Figure 8.8 Protection against H2O2 induced toxicity due to R-PβAE microparticles
exposure.
NHDF treated with 0 or 12-hour resveratrol/R80-PβAE pre-treatment were exposed to
0.5mM H2O2 for 24 or 12 hours respectively followed by Calcein AM red-orange cell
viability assay. N=5, error bars: std. dev.
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Figure 8.9 Protection against H2O2 induced toxicity.
NHDF pre-treated with resveratrol/R80- PβAE for 12 hours were exposed to 0.5mM
H2O2 for 24 hours followed by Calcein AM red-orange cell viability assay. N=5, error
bars: std. dev.
8.4 Comments and future directions
Utilizing the PβAE chemistry for conjugating resveratrol into the PβAE matrix, we
were able to formulate prodrug gel microparticles in the range of 6-7 µm. These
microparticles did show composition dependent release kinetics, where high PEG
content (R20- PβAE) result in faster degradation within 5-6 hours. But resveratrol
release from microparticles with the lowest PEG content i.e. R80-PβAE could only be
extended to 8 hours. To be considered for a cosmetic application such as for sunblock
products, a 10-12 hour release would be desired for sustained protection against UVinduced damage. Antioxidant activity of the degradation products shows the radical
scavenging potential for an extended period time showing the release of active
resveratrol upon ester cleavage. Also, R80-PβAEs are more viable in nature as
compared to free resveratrol and show protection against H2O2 induced cellular
oxidative stress. But, these systems did not show protective nature superior to free
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resveratrol for the different treatment experiments done. This could be because
resveratrol itself is a relatively stable antioxidant compared to many others in
physiological environments until attacked by free radicals. Therefore, given that total
resveratrol administered was same via free resveratrol and through conjugated systems,
both showed similar protection against induced cellular oxidative stress. More
experiments with different combinations of chemical compositions and experimental
design needs to be carried out in order to better understand the protective mechanism
of these gel microparticles. One proposed experimental design would be to
continuously expose the system to free radicals and then analyze the scavenging
potential of resveratrol conjugated PβAEs and its free form.
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9

CONCLUSIONS AND FUTURE DIRECTIONS

In this work, PβAE chemistry was explored as a platform to develop antioxidant
conjugated crosslinked networks for effective drug delivery. The system was developed
for three different polyphenolic antioxidants, which are therapeutically significant but
difficult to administer effectively due to their 1) poor aqueous solubility, 2) structurally
fragile nature and hence 3) extremely low bioavailability. PβAEs are biodegradable
polymer networks hydrolytically degradable through their ester linkages. This
characteristic was utilized as a release mechanism for covalently conjugated
antioxidants. In the current approach, direct conjugation of antioxidants into PβAE
crosslinked networks through their –OH groups served as a method to structurally
protect the molecule and release antioxidants in their active form upon hydrolytic
degradation. Optimization of reaction and processing parameters allowed us to
transform the crosslinked prodrug chemistry into micro or nanogel formulations,
creating a more adaptable technology for drug delivery applications.
a.

PβAE reaction chemistry under dilute conditions resulted in a self-precipitated

antioxidant nanogel suspension, which was amenable to formulate antioxidants
quercetin as well as curcumin conjugated system. Use of such synthesis method
eliminated the requirement of a surfactant for stabilization, which otherwise becomes a
controlling factor towards nanoparticle toxicity. A uniform release profile of
functionally active antioxidants, with little to no burst effects further helped in apparent
reduction of antioxidant toxicity. These physiochemical properties led to the
demonstration of prolonged protection against induced oxidative stress in endothelial
cells.
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The mechanism of protective action could be through (i) cellular internalization
followed by degradation of nanogels or (ii) extracellular degradation followed
by diffusion of free antioxidant. The existence of the 1st case would imply high
cytoplasmic concentrations of the antioxidants, which would be beneficial for
the treatment of acute damage but could also be a cause of local cellular toxicity.
Therefore, more insight into the working mechanism is needed to understand
drug response in a better manner.
b.

Aimed as a treatment solution to neurodegenerative disorders, curcumin-PβAE

nanogels further demonstrated their ability to suppress mitochondrial oxidative stress
without any mitochondrial specific targeting. Increased safety window of curcumin
through nanogel administration was one of the critical factors towards this result, which
allowed the administration of curcumin at therapeutic levels in a sustained fashion.
c.

The ability of curcumin-PβAE nanogels to mitigate cellular and mitochondrial

oxidative damage was further explored with the polychlorinated biphenyls (PCBs). The
analysis showed that pre-treatment of endothelial cells with curcumin-PβAE nanogels
helped in reducing PCB induced excess ROS production and restoration of otherwise
affected mitochondrial respiration. This observation was made with the exposure of
both coplanar (PCB 126) and non-coplanar (PCB 153) PCBs.
Although, curcumin-PβAE nanogels act against PCBs irrespective of the
different oxidative damage through different activation paths, the mechanism of
action needs to be analyzed in detail. Curcumin being a polyphenolic molecule
can capture PCBs through pi-pi interaction and inhibit the damaging action or
through scavenging of excess ROS/RNS.
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Further, nanogel synthesis via the method used in this work can be further
explored with other polyphenolic compounds with two or more –OH groups.
This will create a universal synthesis approach for antioxidant delivery through
nanosystems of high drug loading.
d.

Apart from nanogels, the curcumin-PβAE crosslinked system was also

formulated into microparticles. Being able to develop the same drug conjugated
systems in different size dimensions indicates the adaptable nature of the conjugated
PβAE chemistry in drug delivery. Use of PEGDA as a co-monomer in the synthesis
process added the ability to control hydrophobicity/hydrophilicity of the networks and
hence a degradable system with a tunable release profile. These microparticles also
successfully showed in vitro protection against induced oxidative stress, superior to free
curcumin. In an in vivo trial, a daily rinse of the microparticle suspension over 10 days
showed indications of reduced severity of oral mucositis (OM) in chemotherapyinduced OM hamsters (5 FU/needle scratch injury induction).
This injury model incorporates a high percent of human error and administration
of 5-FU drug results in systemic side effects, which indirectly interferes with
OM analysis. Therefore, a better design of experiment with least human error
and relatively less lethal injury model, such as γ-radiation, would allow better
assessment of curcumin-PβAE microparticles as a potential solution for OM
treatment.
e.

The antioxidant conjugated PβAE gel microparticle synthesis process was

further extended with another anti-inflammatory drug, resveratrol. Acrylate
functionalized resveratrol was successfully conjugated into the backbone of the PβAE
network and was further cryomilled to obtain microparticles. With the goal of

174

developing a slow and steady resveratrol releasing system to prevent topical UVinduced oxidative damaged, different polymer compositions were tried and analyzed
for their release profile. As such, these microparticle systems showed in vitro protection
against H2O2 but did not show properties superior to free resveratrol.
Although, some control over release kinetics was achieved (6-8 hours of resveratrol
release), an optimization and modification in synthesis process is required for
longer release profile (10-12 hours). Selection of different co-monomers or reacting
amine could lead to improved physicochemical properties of the gel matrix and help
attain better control over the release profile. Also, a more robust design of
experiment to demonstrate the UV-protection potential is needed. A proposed idea
is to continuously expose microparticle loaded systems with free radicals and study
the scavenging potential of UV light and compare with free resveratrol.
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APPENDIX
Based on the research article
Prachi Gupta, Caroline Lacerda, Vinod Patil, Dipti Biswal, Paritosh
Wattamwar, J. Zach Hilt and Thomas D. Dziubla, ‘Degradation of
poly(β-amino ester) hydrogels in alcohols through transesterification: A
method to conjugate drugs to hydrogel matrices. (to be submitted)
Abstract
Poly(β amino ester) polymers have received growing attention in the literature, owing
to their ease of synthesis, versatile co-monomer selection, and highly tunable
degradation kinetics. As such, they have extensive potential in many biomedical
applications. In this work, it is demonstrated for the first time that PβAE polymers
containing primary and secondary amine groups can undergo degradation by primary
alcohols through a transesterification process. While this work demonstrates an
important aspect of solvent compatibility limitation to these networks, it also represents
an interesting, simple mechanism for post synthesis drug incorporation, with riboflavin
conjugation being demonstrated as a model compound.
Introduction
Poly(beta-amino ester) (PβAE) hydrogels are hydrolytically degradable systems due to
the presence of β-amino ester linkages. This is one of the central features for their
applicability in biomedical applications such as gene and drug delivery and tissue
engineering considering it as a biodegradable system [299, 300]. Synthesized via
Michael addition reaction of an acrylate molecule with a primary or secondary amine,
the degradation rate of these polymers is considered to be dependent on several
structural and degradation medium factors. As such they have been shown to degrade
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faster in the presence of primary and secondary amines in the hydrogel matrix because
of the catalyzing action of amines [301, 302]. We have previously published a singlestep PβAE hydrogel synthesis reaction based upon primary diamine precursors that
serve as crosslinkers during polymerization. These networks were found to hydrolyze
much more rapidly than gels prepared by a two-step crosslinking system, which is
straight chain polymer synthesis followed by radical catalyzed cross-linking of acrylate
end-groups [303]. It was theorized that this effect was a result of unmodified amines
in the network backbone catalyzing the hydrolysis reaction [304, 305].
Based upon this observation, we hypothesize that these PβAE crosslinked networks
would also be sensitive to nucleophilic attack by primary alcohols and will highly
depend on the nature of alcohols. Herein, we report the first demonstration of PβAE
hydrogel degradation by alcohols through a transesterification mechanism, establishing
the effect of acrylate to amine ratio, alcohol chain length and degree of carbon
substitution on the degradation kinetics. This mechanism also permitted the post
synthesis modification of the hydrogels with alcohol functionalized drug molecules,
allowing for an easy approach to couple hydroxyl compounds into the backbone of the
polymer. Such modifications would allow for the gels to serve as drug release vehicles
for molecules having the -OH group.
Materials
Poly (ethylene glycol) 400 diacrylate (PEG400DA) was purchased from Polysciences
Inc., 4, 7, 10-Trioxa-1, 13-tridecane diamine (TTD) and riboflavin were obtained from
Sigma-Aldrich (St. Lois, MO). All organic solvents were either purchased from SigmaAldrich or Pharmco-aaper (Shelbyville, KY) and were used as received. All the other
chemicals were used as received without further purification.
Methods
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Poly(β-amino ester) hydrogel synthesis
A one-step Michael addition reaction between acrylates and amines was used to
synthesize PβAE hydrogels, as previously described [6, 301]. Figure 1 (A) and 1 (B)
depicts the reaction mechanism and the schematic of the predicted crosslinked gel
structure. Diacrylate monomer (PEG(400)DA) and primary diamine (TTD) were
weighed and mixed in dichloromethane (DCM) at 50% wt/wt with respect to total
monomers. This solution was transferred to an aluminum dish and monomers were
allowed to react for 24 hours at 50°C in an oven. PβAE hydrogels were then washed in
acetone 4 times with a cycle of 1-hour each to remove unreacted monomers followed
by freeze-drying to eliminate any residual solvent. The initial ratio of total acrylate to
reactive hydrogen amine groups (RTAAP) was varied from 0.6 to 1.65 to synthesize
different grades of PβAE hydrogels (Table 1) Note: 1 mol of diacrylate monomer
corresponds to 2 mol of reactive acrylate groups; 1 mol of primary diamine monomer
corresponds to total 4 mol of primary/secondary reactive amine groups.
Table 1. Different grades of PβAE hydrogels were synthesized by varying ratio of
total acrylate to amine protons (RTAAP)
Hydrogel
Identification
Code
R- 0.6
R-1.2
R-1.65

Diacrylate

Diamine

RTAAP

PEG(400)DA
PEG(400)DA
PEG(400)DA

TTD
TTD
TTD

0.6
1.2
1.65
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Figure 1 Synthesis of PEGDA-TTD PβAE cross-linked gels
A. Reaction scheme of PβAE hydrogel formation via reaction of PEG(400)DA and TTD
in DCM solvent. B. Schematic of transesterification of PβAE hydrogels in presence of
an alcohol. Ester bond of the PβAE matrix undergoes substitution with the reacting
alcohol forming another ester bond.
PβAE degradation in alcohols
Degradation of PβAE hydrogels was carried out in various alcohols at 37° C. 1 cm disc
were cut from the bulk hydrogel films, weighed and were then incubated in different
alcohols of interest such that discs were completely submerged. At given time points,
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gels were removed from the solvent and dried under vacuum to remove residual solvent.
The fraction of mass remaining was calculated from the ratio of the recorded final dry
mass (Wd) and initial (W0) mass values. The swelling ratio of the selected hydrogelalcohol incubation system was also calculated by recording the mass of alcohol swollen
hydrogels during degradation. Swelling ratio was calculated as the ratio of swollen gel
mass (Ws) with initial mass (W0).
𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅𝐅 𝐨𝐨𝐨𝐨 𝐦𝐦𝐦𝐦𝐦𝐦𝐦𝐦 𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫 =
𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒𝐒 𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫𝐫 =

𝐖𝐖𝐬𝐬
𝐖𝐖𝟎𝟎

𝐖𝐖𝐝𝐝
𝐖𝐖𝟎𝟎

A separate set of RT-0.6 gels were degraded completely in ethanol as well as in water.
Degradation products were freeze dried under vacuum and were subjected to FTIR
analysis.
Conjugation of PβAE hydrogels with Riboflavin
R-0.6 and R-1.2 PβAE hydrogel discs were cut in about 1-cm discs, weighed and
incubated in 1mg/ml riboflavin-DMSO solution at 37° C and allowed to react for various
durations of time up to 48 hours. After 6, 12, 24 and 48 hours, hydrogels were taken
out, washed twice in DMSO to remove unreacted riboflavin followed by a single wash
in acetone in order to leach out any residual DMSO. The hydrogel discs were then
freeze-dried overnight to remove any residual solvents. The next day, each hydrogel
disc sample was placed in separate wells of a 12-well plate and read at 444 and 600 nm
using Varian Cary 50 Bio UV-Vis spectrophotometer. Absorbance at 600 nm was
subtracted from absorbance value at 444 nm as a baseline correction to obtain the
absorbance only due to riboflavin conjugation and not the disc thickness/optical
density.
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Next, the riboflavin conjugated hydrogel discs were degraded in PBS (35 mg gel/ ml of
PBS) for hydrogels to undergo hydrolysis and release pure riboflavin. The degradation
products in PBS were analyzed once again under UV-Vis at 444 nm and riboflavin
concentrations were calculated using standard calibration curve.
Results
PβAE hydrogel synthesis
PβAE hydrogels synthesized with RTAAP of 0.6 (RT-0.6) and 1.2 (RT-1.2) resulted in
uniform gels while gels synthesized with RTAAP of 1.65 (RT-1.65) resulted in partial
conjugation and hence a semi-solid product. Since a properly conjugated hydrogel
wasn’t obtained with RT-1.65, further analysis of transesterification was limited to RT0.6 and RT-1.2. Post synthesis, gels were washed in acetone to remove unreacted
products and mass loss analysis was performed by weighing the gels before and after
washing (freeze-dried). Average mass loss of 4.87 ± 0.3% for RT-0.6 and13.1 ± 0.4%
for RT-1.2 was calculated.
PβAE degradation in alcohols (Mass loss and swelling ratio)
a. Effect of RTAAP on degradation and swelling ratio using ethanol as a
degradation medium
RT-0.6 degraded via transesterification in 12-hours and showed a faster swelling rate,
when compared to RT-1.2, with the swelling ratio of 3.5 ± 0.08 at 8 hours. After 8
hours of incubation, the gel started to lose mechanical integrity, suggesting the final
stage of complete degradation, as shown in figure 2 A and 2 B. On the other hand, RT1.2 showed very slow kinetics of transesterification derived hydrogel degradation, with
no effective mass loss observed in 1st 12 hours. Even after 25 days of ethanol
incubation, fraction of mass remaining was calculated to be 0.96 ± 0.01, which is 4%
mass loss. RT-1.2 did show a swelling ratio of 1.46 ± 0.01 after the 1st day but only
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increased to 1.65 ± 0.02 after 25 days implying extremely slow degradation kinetics in
ethanol.
A similar effect of unsubstituted amines on gel degradation, with water as the
degradation medium has been reported earlier. PEGDA-TTD gels synthesized with
RTAAP of 0.6 degraded within 40 minutes while gels with RTAAP of 1.2 degraded
completely in 130 minutes [5].

Figure 2 Effect of RTAAP on transesterification controlled degradation of PβAE gels
in 200-proof ethanol at 37o C.
A.) Mass loss analysis of PβAE hydrogels (R-0.6 and R-1.2) presented as a fraction of
mass remaining w.r.t. time. B.) Swelling ratio of R-0.6 and R-1.2 in ethanol w.r.t. time.
Gels synthesized with RTAAP of 0.6 showed faster degradation and swelling than gels
with RTAAP 1.2. N=3, error bars: std. dev.
b.

Effect of primary alcohol with different chain lengths

As RT-1.2 possessed very slow degradation kinetics in ethanol, RT-0.6 PβAE gels were
used to determine the impact of primary alcohols of different chain aliphatic lengths i.e.
ethanol, n-propanol and n-butanol. As observed in figure 3, the degradation rate in
ethanol and n-propanol was extended over 9-12 hours. However, n-butanol mediated
degradation of RT-0.6 was slower extending up to 28-30 hours
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Figure 3 Degradation of PβAE hydrogels in primary alcohols of different chain
lengths.
R-0.6 PβAE hydrogel was incubated in ethanol, n-propanol and n-butanol at 37o C.
N=3, error bars: std. dev.
c.

Effect of Alcohol Class on Degradation Kinetics

To elucidate the mechanism of gel degradation, the impact of primary, secondary, or
tertiary substituted alcohol was conducted in two separate studies. First, RT-0.6
degradation was carried out with alcohols containing the same number of carbon chains
but different degree of substitution i.e. n-propanol (primary, 3-carbon) and iso-propanol
(secondary, 3-carbon) (figure 4 and 5). It was observed that PβAE gel incubation in
primary alcohol (n-propanol) degraded within 12 hours, which is significantly faster
than in secondary alcohol (iso-propanol) showing only 50% mass loss in 13 days. In
the second study, RT-0.6 was incubated in primary, secondary and tertiary alcohol with
different chain lengths. Ethanol (primary, 2-carbon), iso-propanol (secondary, 3carbon) and tert-butanol (tertiary, 4-carbon) were used for transesterification. As the
mass loss in tert-butanol was too slow to show significant differences over the study
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time, swelling ratio for different alcohols was analyzed instead. As shown in figure 5,
ethanol hydrogel incubation resulted in a swelling ratio of 3.5±0.08 within 8 hours after
which it disintegrated. Iso-propanol resulted in slower kinetics giving a swelling ratio
of 2.45±0.16 after 4 days and 4.61±0.6 after 9 days. Tert-butanol incubation showed
even slower kinetics with swelling ratio of 1.94±0.05 after 4 days and 2.48±0.16 after
9 days. Therefore, PβAE degradation kinetics was faster in ethanol than in iso-propanol
than in tert-butanol.

Figure 4 Effect of the degree of carbon substitution on degradation kinetics of R-0.6
PβAE hydrogels in primary and secondary alcohols.
Data presented as mass loss analysis of PβAE hydrogels degraded in n-propanol and
iso-propanol at 37oC. N=3, error bars: std. dev.
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Figure 5 Swelling ratio of R-0.6 PβAE hydrogels in primary, secondary and tertiary
alcohols i.e. ethanol, iso-propanol and tert-butanol respectively.
Rate of swelling and degradation decreases with increase in chain length and degree
of carbon substitution. N=3, error bars: std. dev.
In a separate study, with RT-0.6 were hydrolyzed completely in ethanol and water.
FTIR analysis of both the systems were compared to identify the nature of degradation
products. The degradation products obtained from water showed the presence of strong
acid peaks at around 1584cm-1 clearly indicating the hydrolysis to the corresponding
acids. However, the presence of a peak near 1732cm-1 in ethanol degradation products
confirmed the formation of the corresponding ester products (Figure 6).
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Figure 6 FTIR spectra of PβAE hydrogel RT-0.6, and the degradation products
obtained by the hydrolysis of in water and ethanol.
Riboflavin conjugation to PβAE via transesterification
To study whether the transesterification mechanism can be used to link primary alcohol
containing compounds to already formed PβAE gels, naturally found riboflavin
(vitamin B2) with 1-primary and 3-secondary alcohol functional group was used as a
model compound to conjugate into RT-0.6 and RT-1.2 via transesterification process
(figure 7 D). After incubating the gels in 1 mg/ml of riboflavin dissolved in DMSO for
6, 12, 24 and 48 hours, it was observed that RT-0.6 showed higher conjugation than
RT-1.2 as seen in figure 7. When conjugated discs were observed under UV-Vis,
absorbances were collected at 444 nm and 600 nm (characteristic wavelength for
riboflavin). Absorbance value at 600 nm is the measure of optical density for each gel
due to its thickness. Hence, to get absorbance values due to only riboflavin, absorbance
at 600 nm was subtracted as a baseline from 444 nm and presented as Δabs. RT-0.6
showed Δabs of 0.22 ± 0.02, 0.28 ± 0.04, 0.5 ± 0.05 and 0.48 ± 0.06 after 6, 12, 24 and
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48 hours of incubation respectively. RT-1.2 had lower Δabs values than RT-0.6 of 0.15
± 0.5, 0.13 ± 0.01, 0.14 ± 0.5 and 0.23 ± 0.05 at the same time points (figure 7 A).
The riboflavin-conjugated gels were then subjected to hydrolytic degradation in PBS to
recover the riboflavin. Degradation products were again read at 444 nm and collected
absorbances gave a concentration of riboflavin in the solution using standard curve
(figure 7 B and 7 C). 0.85 ± 0.03, 1 ± 0.04, 1.3 ± 0.33 and 1.86 ± 0.06 μg/ml of riboflavin
was retrieved with RT-0.6 gels incubated for 6, 12, 24 and 48 hours respectively
followed by PBS degradation. For RT-1.2, a lower amount of riboflavin was recovered
as conjugation was less, which was 0.5 ± 0.01, 0.55 ± 0.15, 0.59 ± 0.16 and 1.1 ± 0.13
respectively under time interval degradation as for RT-0.6.
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Figure 7 Conjugation of riboflavin into R-0.6 and R-1.2 PβAE hydrogels by
incubation in 1 mg/ml riboflavin solution in DMSO.
A.) Δabs of the hydrogels discs measured after different time intervals of incubation in
riboflavin at 37o C. Δabs = abs (444nm)-abs (600nm). Baseline subtraction at 600 nm
was done for each sample separately to void the effect of optical density due to gel
thickness. B.) Absorbance of degradation products of riboflavin conjugated PβAE
hydrogels in PBS after different time intervals. C.) Concentration of riboflavin in PBS
calculated after analyzing the degradation products under UV-Vis at 444 nm. R-0.6
gels showed the higher characteristic absorbance of riboflavin in gels discs as well as
degradation products as compared to R-1.2 gels. This complies with transesterification
data obtained earlier in figure 2. N=3, error bars: std. dev.

Discussion
The degradation studies of PEG(400)DA-TTD based PβAE hydrogel synthesized at
different RTAAPs were carried out in ethanol at 37ºC. It was initially observed that
PβAEs synthesized using single step approach were unstable in ethanol. This was
different from previously reported data, where ethanol was used as a stable washing
solvent [306]. Originally, it was believed that degradation was due to the water
content in the solvent. However, degradation still proceeded even with dried solvents.
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This observation led to the theoretical conclusion that, β-amino ester bonds in the
PβAE hydrogels undergo transesterification with the alcohol to form a new ester.
It was hypothesized that if transesterification was a mechanism, then the unmodified
amines contained within the network could serve as a base to catalyze the
transesterification process. To test this hypothesis, the levels of unmodified amine were
varied by changing the total acrylate to total reactive hydrogen amine protons (RTAAP:
0.6 and 1.2). Lower RTAAP (0.6 in this case) PβAE gels with higher unreacted amine
content, catalyzed the transesterification reaction via activation of surrounding alcohol
into a nucleophilic entity (C2H5OH to C2H5O-) [307]. The activated form, C2H5Oresulted in faster disintegration of PβAE matrix via substitution at the ester linkage
(Figure 2).
Additionally, if the degradation of the PβAE gels is a function of transesterification,
then it would be expected that the rate of degradation would be dependent upon the
reactivity of the alcohol. Hence, the rate of alcohol substitution will be different for
alcohols of different chain lengths or degree of carbon substitution. To verify this
hypothesis, degradation properties of PβAE hydrogels were analyzed with different
alcohols at 37°C (Figures 3, 4 and 5). It was observed that the degradation of RT-0.6
PβAE hydrogel occurred fastest in ethanol followed by n-propanol and slowest with nbutanol amongst the three primary alcohols. The ethanol based transesterification
reaction is typically much faster than propanol or butanol due to the high polar and
acidic nature or lower carbon induced inductive effect due to shorter carbon chain
length [308]. As the length of the carbon chain increases, nucleophilicity of the
alkoxide anion decreases leading to a decrease in the reactivity of alkoxide anion. This
causes the slower reaction rate in the order of n-butanol, n-propanol and ethanol and
hence the degradation kinetics (figure 3). A similar trend was seen with the PβAE
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hydrogel degradation in primary, secondary and tertiary alcohols because of the same
concept of higher inductive effect with secondary as compared to primary alcohols.
Therefore, iso-propanol being less acidic than n-propanol, shows slower
transesterification kinetics than n-propanol (figure 4). The combined effect of chain
length and degree of substitution was seen with degradation carried out in ethanol, isopropanol and tert-butanol, where with tert-butanol, slowest degradation was observed
amongst all the alcohols used because of the presence of three alkyl groups on the
carbon-atom with –OH group and hence least acidic nature.
To confirm the transesterification reaction of the PβAE hydrogels, the degradation
products of the RT-0.6 obtained from water and ethanol were freeze dried and analyzed
with the help of an ATR-FTIR (Varian e-spectrophotometer). It has been reported
previously that PβAE hydrogels degrade via hydrolysis of ester groups in the crosslinks
to lower molecular weight degradation products and chains of poly(β-amino acids) and
diols [300, 309]. The presence of a broad acid peak at 1584 cm-1 in the water
degradation products of RT-0.6 with a subsequent decrease in intensity of the esterC=O peak at 1732 cm-1 clearly indicates the formation of low molecular weight acids
(Figure 6). The transesterification reaction of PβAE with alcohols was also confirmed
by the re-formation of new ester peaks at around 1732cm-1 from the ethanol degradation
products of RT-0.6.
Taking advantage of transesterification of PβAE network by alcohols, compounds of
medicinal value containing alcohol groups (e.g. riboflavin, ascorbic acid) can be
conjugated to the PβAE network without the use of additional linkers or reagents.
Riboflavin is a part of the Vitamin B family (Vitamin B2), naturally found in milk,
yeast, leafy vegetables with metabolic functional significance in activating other
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vitamins and reaction with flavoproteins [15, 310]. It contains one primary and three
secondary alcohol groups in the molecular structure (Figure 7 D).
The extent of riboflavin conjugation into PβAE could be analyzed using UV-Vis
because of its characteristic wavelength at 444 nm. As shown in Figure 7, PβAE upon
incubation in riboflavin solution was able to conjugate the alcoholic molecule into its
matrix and the amount of conjugation increased with time showing the progression of
transesterification. Higher conjugation was seen with RT-0.6 than RT-1.2 because of
the faster transesterification kinetics complying with previous studies (Figure 2). This
was observed at both levels, riboflavin conjugated gel discs (figure 7 A) and released
riboflavin after complete degradation of the gels (7 B).
Conclusion
It was found that PβAE synthesized by the single step non-free radical polymerization
method degrades in alcohol via a transesterification mechanism. Unreacted
primary/secondary amines in the PβAE network catalyze this transesterification
reaction and the rate of PβAE degradation in alcohol decreases with increase in
RTAAP. The degradation rate of PβAE in alcohol decreases with increasing chain
length of alcohol or in order of tertiary<secondary<primary alcohols. Taking advantage
of alcohol induced transesterification reaction in the PβAE network, molecules of
medicinal value with alcohol groups (e.g. riboflavin) can be covalently conjugated to
the PβAE network and the amount to be conjugated can be controlled with incubation
time until gel disintegration while release of riboflavin via water hydrolysis can be
controlled by selecting the PβAE gels of different RTAAPs.
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